Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Dermatology

  Free Subscription


Articles published in Br J Dermatol

Retrieve available abstracts of 973 articles:
HTML format
Text format



Single Articles


    May 2018
  1. WAN MT, Ming ME
    Nivolumab versus ipilimumab in the treatment of advanced melanoma: a critical appraisal.
    Br J Dermatol. 2018 May 15. doi: 10.1111/bjd.16785.
    PubMed     Text format     Abstract available


  2. CHRISTENSEN L, Cooper K, Honda K, Mansur D, et al
    Relapse rates in patients with unilesional primary cutaneous B cell lymphoma treated with radiation therapy: a single-institution experience.
    Br J Dermatol. 2018 May 15. doi: 10.1111/bjd.16783.
    PubMed     Text format     Abstract available


  3. ZHU TH, Zhu TR, Tran KA, Sivamani RK, et al
    Epithelial Barrier Dysfunctions in Atopic Dermatitis: A Skin-Gut-Lung Model Linking Microbiome Alteration and Immune Dysregulation.
    Br J Dermatol. 2018 May 15. doi: 10.1111/bjd.16734.
    PubMed     Text format     Abstract available


  4. CAYUELA A, Cayuela L, Rodriguez-Dominguez S, Lorente AI, et al
    Is melanoma mortality declining in Spain? Analysis of trends 1975-2016.
    Br J Dermatol. 2018 May 14. doi: 10.1111/bjd.16777.
    PubMed     Text format     Abstract available


  5. PILKINGTON SM, Dearman RJ, Kimber I, Griffiths CEM, et al
    Langerhans cells express human beta defensin-3: relevance for immunity during skin ageing.
    Br J Dermatol. 2018 May 14. doi: 10.1111/bjd.16770.
    PubMed     Text format     Abstract available


  6. GOLBARI NM, Lockwood SJ, Porter ML, Kimball AB, et al
    Assessment of Treatment-Seeking Behaviour in Patients with Psoriasis.
    Br J Dermatol. 2018 May 14. doi: 10.1111/bjd.16778.
    PubMed     Text format     Abstract available


  7. MOAWAD S, Reigneau M, de la Fouchardiere A, Soufir N, et al
    Clinical, dermoscopic, histological and molecular analysis of BAP1 inactivated melanocytic nevus/tumor in two familial cases of BAP1 syndrome.
    Br J Dermatol. 2018 May 13. doi: 10.1111/bjd.16740.
    PubMed     Text format     Abstract available


  8. EL KHOURY M, Assier H, Gener G, Paul M, et al
    Polysensitivity in delayed cutaneous adverse drug reactions to macrolides, clindamycin, and pristinamycin: clinical history and patch testing.
    Br J Dermatol. 2018 May 10. doi: 10.1111/bjd.16738.
    PubMed     Text format     Abstract available


  9. RYAN C, Menter A, Guenther L, Blauvelt A, et al
    Efficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled Phase 3b Study of Patients with Moderate-to-Severe Genital Psoriasis.
    Br J Dermatol. 2018 May 10. doi: 10.1111/bjd.16736.
    PubMed     Text format     Abstract available


  10. KIMBALL AB, Augustin M, Gordon KB, Krueger GG, et al
    Correlation of psoriasis activity with socioeconomic status: cross-sectional analysis of patients enrolled in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
    Br J Dermatol. 2018 May 10. doi: 10.1111/bjd.16737.
    PubMed     Text format     Abstract available


  11. BLAUVELT A, Reich K, Papp KA, Kimball AB, et al
    Safety of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Three Randomised Controlled Trials.
    Br J Dermatol. 2018 May 9. doi: 10.1111/bjd.16724.
    PubMed     Text format     Abstract available


  12. WEHNER MR, Dalma N, Landefeld C, Pare-Anastasiadou A, et al
    Natural history of lesions suspicious for basal cell carcinoma in older adults in Ikaria, Greece.
    Br J Dermatol. 2018 May 9. doi: 10.1111/bjd.16730.
    PubMed     Text format     Abstract available


  13. FUJISAWA Y
    Baseline neutrophil-to-lymphocyte ratio in patients with advanced melanoma treated with immune checkpoint inhibitors: reply from the authors.
    Br J Dermatol. 2018 May 7. doi: 10.1111/bjd.16689.
    PubMed     Text format    


  14. HARKINS CP, McAleer MA, Bennett D, McHugh M, et al
    The widespread use of topical antimicrobials enriches for resistance in Staphylococcus aureus isolated from Atopic Dermatitis patients.
    Br J Dermatol. 2018 May 5. doi: 10.1111/bjd.16722.
    PubMed     Text format     Abstract available


  15. SU KA, Habel LA, Achacoso NS, Friedman GD, et al
    Photosensitizing Antihypertensive Drug Use and Risk of Cutaneous Squamous Cell Carcinoma.
    Br J Dermatol. 2018 May 3. doi: 10.1111/bjd.16713.
    PubMed     Text format     Abstract available


  16. GARCIA-DOVAL I, Descalzo MA, Mason KJ, Cohen AD, et al
    Cumulative exposure to biologics and risk of cancer in psoriasis patients: A meta-analysis of Psonet studies from Israel, Italy, Spain, United Kingdom and Republic of Ireland.
    Br J Dermatol. 2018 May 3. doi: 10.1111/bjd.16715.
    PubMed     Text format     Abstract available


    April 2018
  17. DARRIGADE AS, Legrand A, Andreu N, Jacquemin C, et al
    Dual efficacy of dupilumab in a patient with concomitant atopic dermatitis and alopecia areata.
    Br J Dermatol. 2018 Apr 30. doi: 10.1111/bjd.16711.
    PubMed     Text format     Abstract available


  18. MIYAZAWA H, Fujita Y, Iwata H, Ishikawa Y, et al
    Two cases of generalized pustular psoriasis complicated with IgG4-related disease.
    Br J Dermatol. 2018 Apr 30. doi: 10.1111/bjd.16712.
    PubMed     Text format     Abstract available


  19. TETU P, Monfort JB, Barbaud A, Frances C, et al
    Failure of Rituximab in refractory erosive lichen planus.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16704.
    PubMed     Text format     Abstract available


  20. BAN L, Labbouz S, Grindlay D, Batchelor J, et al
    Risk of skin cancer in people with vitiligo: a systematic review and meta-analysis.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16703.
    PubMed     Text format     Abstract available


  21. WANG R, Song Y, Du M, Yang E, et al
    Skin microbiome changes in patients with interdigital tinea pedis.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16706.
    PubMed     Text format     Abstract available


  22. RAUWERDINK DJW, Roach REJ, Etty M, Kukutsch NA, et al
    Melanoma diagnosis during periodic surveillance of patients with multiple atypical naevi.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16708.
    PubMed     Text format     Abstract available


  23. COSTANZO A, Bianchi L, Flori ML, Malara G, et al
    Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16705.
    PubMed     Text format     Abstract available


  24. JENSEN P, Zachariae C, Skov L, Zachariae R, et al
    Sleep disturbance in psoriasis - a case-controlled study.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16702.
    PubMed     Text format     Abstract available


  25. FOO SH, Nightingale PG, Gazzani P, Bader E, et al
    A 10 year longitudinal follow up study of a UK paediatric transplant population to assess for skin cancer.
    Br J Dermatol. 2018 Apr 27. doi: 10.1111/bjd.16697.
    PubMed     Text format     Abstract available


  26. MCALEER MA, Jakasa I, Raj N, O'Donnell CPF, et al
    Early life regional and temporal variation in filaggrin-derived natural moisturising factor, filaggrin processing enzyme activity, corneocyte phenotypes and plasmin activity: Implications for atopic dermatitis.
    Br J Dermatol. 2018 Apr 25. doi: 10.1111/bjd.16691.
    PubMed     Text format     Abstract available


  27. NARBUTT J, Philipsen PA, Lesiak A, Liljendahl TS, et al
    Children sustain high levels of skin DNA photodamage, with a modest increase of serum 25(OH)D3 , after a summer holiday in Northern Europe.
    Br J Dermatol. 2018 Apr 24. doi: 10.1111/bjd.16668.
    PubMed     Text format     Abstract available


  28. CHALMERS JR, Thomas KS, Apfelbacher C, Williams HC, et al
    Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
    Br J Dermatol. 2018 Apr 19. doi: 10.1111/bjd.16543.
    PubMed     Text format     Abstract available


  29. EGEBERG A, Skov L
    Drug survival of secukinumab for moderate-to-severe plaque psoriasis: reply from authors.
    Br J Dermatol. 2018 Apr 19. doi: 10.1111/bjd.16690.
    PubMed     Text format    


  30. FUJIMURA T, Sato Y, Kambayashi Y, Tanita K, et al
    Three cases of advanced cutaneous angiosarcoma treated with eribulin: investigation of serum soluble CD163 and CXCL10 as possible biomarkers predicting the biological behaviour of angiosarcoma.
    Br J Dermatol. 2018 Apr 17. doi: 10.1111/bjd.16676.
    PubMed     Text format     Abstract available


  31. LANGAN EA, Gratz V, Billmann F, Zillikens D, et al
    Does the gastrointestinal microbiome contribute to the "obesity paradox" in melanoma survival?
    Br J Dermatol. 2018 Apr 16. doi: 10.1111/bjd.16681.
    PubMed     Text format     Abstract available


  32. CARLAVAN I, Bertino B, Rivier M, Martel P, et al
    Atrophic scar formation in acne patients involves long-acting immune responses with plasma cells and alteration of sebaceous glands.
    Br J Dermatol. 2018 Apr 16. doi: 10.1111/bjd.16680.
    PubMed     Text format     Abstract available


  33. KIM J, Kim YH, Park B, Seo HM, et al
    Multispectral ex vivo photoacoustic imaging of cutaneous melanoma for better selection of the excision margin.
    Br J Dermatol. 2018 Apr 16. doi: 10.1111/bjd.16677.
    PubMed     Text format     Abstract available


  34. VARMA S
    Frequency of squamous cell carcinoma in situ (SCCIS) and SCC in re-excisions of biopsy-proven cutaneous SCCIS.
    Br J Dermatol. 2018 Apr 16. doi: 10.1111/bjd.16674.
    PubMed     Text format     Abstract available


  35. MACHET L, Zaragoza J, Finon A, Garnier M, et al
    Baseline neutrophil to lymphocyte ratio in patients with advanced melanoma treated with immune check point inhibitors.
    Br J Dermatol. 2018 Apr 16. doi: 10.1111/bjd.16675.
    PubMed     Text format     Abstract available


  36. LEE EH, Klassen AF, Cano SJ, Nehal KS, et al
    FACE-Q Skin Cancer Module for Measuring Patient-Reported Outcomes Following Facial Skin Cancer Surgery.
    Br J Dermatol. 2018 Apr 14. doi: 10.1111/bjd.16671.
    PubMed     Text format     Abstract available


  37. SVENDSEN MT, Andersen F, Andersen KH, Pottegard A, et al
    An App Supporting Psoriasis Patients Improves Adherence to Topical Treatment: A randomised controlled trial.
    Br J Dermatol. 2018 Apr 14. doi: 10.1111/bjd.16667.
    PubMed     Text format     Abstract available


  38. MCNOE BM, Reeder AI, de Lange MP
    SunSmart schools: a New Zealand skin cancer primary prevention intervention blueprint for primary school settings.
    Br J Dermatol. 2018 Apr 14. doi: 10.1111/bjd.16670.
    PubMed     Text format     Abstract available


  39. GAN Y, Zhou M, He C, Chen Z, et al
    Lipidomics reveals skin surface lipid abnormity in male youth acne.
    Br J Dermatol. 2018 Apr 6. doi: 10.1111/bjd.16655.
    PubMed     Text format     Abstract available


  40. MENSA E, Recchioni R, Marcheselli F, Giuliodori K, et al
    MiR-146a-5p correlates with clinical efficacy in psoriasis patients treated with the TNF alpha inhibitor Adalimumab.
    Br J Dermatol. 2018 Apr 6. doi: 10.1111/bjd.16659.
    PubMed     Text format     Abstract available


  41. THOMPSON AR, Montgomery K
    Stress and more stress: the importance in skin disease of worrying about what others think.
    Br J Dermatol. 2018;178:821-822.
    PubMed     Text format    


  42. OOSTERHAVEN JAF
    Interpretability in atopic dermatitis: all about the anchor.
    Br J Dermatol. 2018;178:832-833.
    PubMed     Text format    


  43. APFELBACHER C
    The Cochrane Skin Group's COUSIN convened for the second time.
    Br J Dermatol. 2018;178:837-838.
    PubMed     Text format    


  44. AKEL R, Fuller C
    Updates in lichen sclerosis: British Association of Dermatologists guidelines for the management of lichen sclerosus 2018.
    Br J Dermatol. 2018;178:823-824.
    PubMed     Text format    


  45. BORRONI RG, Costanzo A
    HLA-C*06 and psoriasis: susceptibility, phenotype, course and response to treatment.
    Br J Dermatol. 2018;178:825.
    PubMed     Text format    


  46. HAAS L, Wiesner T, Obenauf AC
    A new era of proactive melanoma therapy: hit hard, hit early.
    Br J Dermatol. 2018;178:817-820.
    PubMed     Text format    


  47. KEZIC S
    Atopic dermatitis: risk estimates for hand eczema.
    Br J Dermatol. 2018;178:827.
    PubMed     Text format    


  48. MROWIETZ U
    Psoriasis, stress, age and more.
    Br J Dermatol. 2018;178:830-831.
    PubMed     Text format    


    March 2018
  49. JI Y, Yang K, Peng S, Chen S, et al
    Kaposiform haemangioendothelioma: clinical features, complications and risk factors for Kasabach-Merritt phenomenon.
    Br J Dermatol. 2018 Mar 30. doi: 10.1111/bjd.16601.
    PubMed     Text format     Abstract available


  50. ANGELOVA-FISCHER I, Fischer TW, Abels C, Zillikens D, et al
    Accelerated barrier recovery and enhancement of the barrier integrity and properties by topical application of a pH 4 compared to a pH 5.8 w/o emulsion in aged skin.
    Br J Dermatol. 2018 Mar 25. doi: 10.1111/bjd.16591.
    PubMed     Text format     Abstract available


  51. VU M, Adler NR, Wee E, Wolfe R, et al
    Impact of naevus association on survival for nodular and superficial spreading melanomas.
    Br J Dermatol. 2018 Mar 24. doi: 10.1111/bjd.16556.
    PubMed     Text format     Abstract available


  52. MAHEVAS T, Bertinchamp R, Battistella M, Reygagne P, et al
    Efficacy of oral sirolimus as salvage therapy in refractory lichen planus associated with immune deficiency.
    Br J Dermatol. 2018 Mar 24. doi: 10.1111/bjd.16555.
    PubMed     Text format     Abstract available


  53. YAN K, Xu W, Huang Y, Zhang Z, et al
    Methotrexate restores the function of peripheral blood Treg cells in psoriasis vulgaris via CD73/AMPK/mTOR pathway.
    Br J Dermatol. 2018 Mar 23. doi: 10.1111/bjd.16560.
    PubMed     Text format     Abstract available


  54. PASSARELLI MN, Barry EL, Zhang D, Gangar P, et al
    Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas.
    Br J Dermatol. 2018 Mar 23. doi: 10.1111/bjd.16571.
    PubMed     Text format     Abstract available


  55. LEE EB, Reynolds KA, Pithadia DJ, Wu JJ, et al
    Drug survival of secukinumab for moderate-to-severe plaque psoriasis.
    Br J Dermatol. 2018 Mar 23. doi: 10.1111/bjd.16572.
    PubMed     Text format     Abstract available


  56. FORSCHNER A, Keim U, Hofmann M, Spankuch I, et al
    Diagnostic accuracy of dermatofluoroscopy in cutaneous melanoma detection: Results of a prospective multicentre clinical study in 476 pigmented lesions.
    Br J Dermatol. 2018 Mar 22. doi: 10.1111/bjd.16565.
    PubMed     Text format     Abstract available


  57. ADAN F, Crijns MB, Zandstra WSE, Bekkenk MW, et al
    Cumulative risk of skin tumours in patients with Lynch syndrome.
    Br J Dermatol. 2018 Mar 15. doi: 10.1111/bjd.16552.
    PubMed     Text format     Abstract available


  58. HANSEN PR, Isaksen JL, Jemec GB, Kanters JK, et al
    Pulmonary function in subjects with psoriasis: A cross-sectional population study.
    Br J Dermatol. 2018 Mar 11. doi: 10.1111/bjd.16539.
    PubMed     Text format     Abstract available


  59. HERNANDEZ-BREIJO B, Jurado T, Rodriguez-Martin E, Martinez-Feito A, et al
    Differential blood cellular profile in patients with moderate to severe psoriasis treated with classical systemic therapies: A step forward in personalised medicine.
    Br J Dermatol. 2018 Mar 11. doi: 10.1111/bjd.16537.
    PubMed     Text format     Abstract available


  60. SCHMITZ L, Gambichler T, Kost C, Gupta G, et al
    Cutaneous squamous cell carcinomas are associated with basal proliferating actinic keratoses.
    Br J Dermatol. 2018 Mar 11. doi: 10.1111/bjd.16536.
    PubMed     Text format     Abstract available


  61. PEDROSA AF, Lisboa C, Faria-Ramos I, Silva RM, et al
    Malassezia species retrieved from skin with pityriasis versicolor, seborrheic dermatitis and skin free of lesions: a comparison of two sampling methods.
    Br J Dermatol. 2018 Mar 5. doi: 10.1111/bjd.16521.
    PubMed     Text format     Abstract available


  62. KIM HJ, Bonciani D, Zeidi M, Pena SM, et al
    Itch in dermatomyositis: the role of increased skin interleukin-31.
    Br J Dermatol. 2018 Mar 1. doi: 10.1111/bjd.16498.
    PubMed     Text format     Abstract available


  63. MELCHERS RC, Willemze R, Bekkenk MW, de Haas ERM, et al
    Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: Report of the Dutch Cutaneous Lymphoma Group.
    Br J Dermatol. 2018 Mar 1. doi: 10.1111/bjd.16501.
    PubMed     Text format     Abstract available


  64. MARCHAND A, Tallet A, Collin C, Cormier B, et al
    A rare BRAF T599dup mutation conferring sensitivity to BRAF inhibitor in a patient with metastatic melanoma.
    Br J Dermatol. 2018 Mar 1. doi: 10.1111/bjd.16499.
    PubMed     Text format     Abstract available


  65. FLEMING P
    Ixekizumab and psoriasis: an important entry into the therapeutic landscape.
    Br J Dermatol. 2018;178:585-586.
    PubMed     Text format    


  66. CAPON F
    The heterogeneous mutational landscape of pustular psoriasis.
    Br J Dermatol. 2018;178:589-590.
    PubMed     Text format    


  67. NANDA A
    Spectrum of cutaneous manifestations among patients with GATA2 deficiency.
    Br J Dermatol. 2018;178:593-594.
    PubMed     Text format    


  68. ABUABARA K, Flohr C
    Is new better than tried and tested? Topical atopic dermatitis treatment in context.
    Br J Dermatol. 2018;178:583-584.
    PubMed     Text format    


  69. BOUWES BAVINCK JN, van Zuuren EJ
    Light on fumaric acid esters therapy for psoriasis.
    Br J Dermatol. 2018;178:586-587.
    PubMed     Text format    


  70. TSAI YC
    Image Gallery: Contact dermatitis resulting from tarantula-hair injury mimicking ischaemia: a case with dermoscopy follow-up.
    Br J Dermatol. 2018;178:e227.
    PubMed     Text format    


  71. BARRAGAN-ESTUDILLO ZF, Jesus-Silva MA, Chavez-Bourgeois MM, Brito J, et al
    Image Gallery: Transition pattern in acral melanoma.
    Br J Dermatol. 2018;178:e225.
    PubMed     Text format    


    February 2018
  72. PAPP KA, Gordon KB, Langley RG, Lebwohl MG, et al
    Impact of Previous Biologic Use on Efficacy and Safety of Brodalumab and Ustekinumab in Patients with Moderate-to-Severe Plaque Psoriasis: Integrated Analysis of AMAGINE-2 and AMAGINE-3.
    Br J Dermatol. 2018 Feb 28. doi: 10.1111/bjd.16464.
    PubMed     Text format     Abstract available


  73. KIM Y, Cho JY, Oh SW, Kang M, et al
    Globular adiponectin acts as a melanogenic signal in human epidermal melanocytes.
    Br J Dermatol. 2018 Feb 27. doi: 10.1111/bjd.16488.
    PubMed     Text format     Abstract available


  74. ENGEBRETSEN KA, Kezic S, Jakasa I, Hedengran A, et al
    Effect of atopic skin stressors on natural moisturizing factors and cytokines in healthy adult epidermis.
    Br J Dermatol. 2018 Feb 27. doi: 10.1111/bjd.16487.
    PubMed     Text format     Abstract available


  75. STROBEL SB, Safferling K, Lahrmann B, Hoffmann JH, et al
    Altered density, composition and microanatomical distribution of infiltrating immune cells in cutaneous squamous cell carcinoma of organ transplant recipients.
    Br J Dermatol. 2018 Feb 25. doi: 10.1111/bjd.16477.
    PubMed     Text format     Abstract available


  76. NARLA S, Silverberg JI
    Association between childhood atopic dermatitis, cutaneous, extracutaneous and systemic infections.
    Br J Dermatol. 2018 Feb 25. doi: 10.1111/bjd.16482.
    PubMed     Text format     Abstract available


  77. HUNTER HJA, Morsman E, Mellody KT, Ogden SK, et al
    Acute psychosocial stress downregulates N-Methyl-d-aspartate receptors (NMDAR) in healthy human skin.
    Br J Dermatol. 2018 Feb 16. doi: 10.1111/bjd.16466.
    PubMed     Text format     Abstract available


  78. ORLOWSKA D, Selman LE, Beynon T, Radcliffe E, et al
    "It's a traumatic illness, traumatic to witness." A qualitative study of the experiences of bereaved family caregivers of patients with cutaneous T-cell lymphoma.
    Br J Dermatol. 2018 Feb 16. doi: 10.1111/bjd.16447.
    PubMed     Text format     Abstract available


  79. KOTTNER J, Jacobi L, Hahnel E, Alam M, et al
    Core outcome sets in dermatology: report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative.
    Br J Dermatol. 2018 Feb 14. doi: 10.1111/bjd.16324.
    PubMed     Text format     Abstract available


  80. KYRIAKOU A, Patsatsi A, Sotiriadis D, Goulis DG, et al
    Effects of treatment for psoriasis on circulating levels of leptin, adiponectin and resistin: a systematic review and meta-analysis.
    Br J Dermatol. 2018 Feb 12. doi: 10.1111/bjd.16437.
    PubMed     Text format     Abstract available


  81. MORTON CA, Dominicus R, Radny P, Dirschka T, et al
    A randomized, multi-national, non-inferiority, phase III trial to evaluate the safety and efficacy of BF-200 ALA gel versus MAL cream in the treatment of non-aggressive basal cell carcinoma with photodynamic therapy (PDT).
    Br J Dermatol. 2018 Feb 12. doi: 10.1111/bjd.16441.
    PubMed     Text format     Abstract available


  82. LONGO C, Lallas A, Kyrgidis A, Bassoli S, et al
    Wide skin markings pattern - melanoma descriptor or patient-related factor?: reply from authors.
    Br J Dermatol. 2018 Feb 7. doi: 10.1111/bjd.16430.
    PubMed     Text format     Abstract available


  83. RISHPON A, Marchetti M, Marghoob A
    Wide skin markings pattern - melanoma descriptor or patient-related factor?
    Br J Dermatol. 2018 Feb 6. doi: 10.1111/bjd.16420.
    PubMed     Text format     Abstract available


  84. VILLARREAL-MARTINEZ A, Bennassar A, Gonzalez S, Malvehy J, et al
    Application of in vivo reflectance confocal microscopy (RCM) and ex vivo fluorescence confocal microscopy (FCM) in most common subtypes of Basal Cell Carcinoma and correlation with histopathology.
    Br J Dermatol. 2018 Feb 6. doi: 10.1111/bjd.16421.
    PubMed     Text format     Abstract available


  85. LANGLEY RG, Papp K, Gooderham M, Zhang L, et al
    Efficacy and safety of continuous every 2-week dosing of ixekizumab over 52 weeks in patients with moderate-to-severe plaque psoriasis in a randomized phase 3 trial (IXORA-P).
    Br J Dermatol. 2018 Feb 6. doi: 10.1111/bjd.16426.
    PubMed     Text format     Abstract available


  86. FUJISAWA Y, Yoshino K, Otsuka A, Funakoshi T, et al
    Baseline neutrophil to lymphocyte ratio combined with serum LDH level associated with outcome of nivolumab immunotherapy in a Japanese advanced melanoma population.
    Br J Dermatol. 2018 Feb 6. doi: 10.1111/bjd.16427.
    PubMed     Text format     Abstract available


  87. TSAKOK T, Jabbar-Lopez ZK, Smith CH
    Subcutaneous methotrexate in patients with moderate to severe psoriasis: a critical appraisal.
    Br J Dermatol. 2018 Feb 5. doi: 10.1111/bjd.16424.
    PubMed     Text format     Abstract available


  88. ZHANG G, Chen H, Gao Y, Liu Y, et al
    Sirolimus for treatment of Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: A retrospective cohort study.
    Br J Dermatol. 2018 Feb 1. doi: 10.1111/bjd.16400.
    PubMed     Text format     Abstract available


  89. DANDO EE, Lim GFS, Ho J, James A, et al
    Image Gallery: Pigmented mammary Paget disease: a rare clinicopathological variant mimicking melanoma.
    Br J Dermatol. 2018;178:e143.
    PubMed     Text format    


  90. RAPHAEL AP, Soyer HP
    Automated diagnosis: shedding the light on skin cancer.
    Br J Dermatol. 2018;178:331-333.
    PubMed     Text format    


  91. CUST AE
    Prognostic features for acral lentiginous melanoma.
    Br J Dermatol. 2018;178:311-312.
    PubMed     Text format    


  92. RENCZ F
    Impact of dupilumab on health-related quality of life in patients with atopic dermatitis.
    Br J Dermatol. 2018;178:319-320.
    PubMed     Text format    


  93. BISSONNETTE R
    JAK inhibitors appear to have a bright future in the treatment of atopic dermatitis.
    Br J Dermatol. 2018;178:321.
    PubMed     Text format    


  94. MICALI G, Lacarrubba F
    Standardized classification tools in dermatology: time to focus on cutaneous warts.
    Br J Dermatol. 2018;178:330.
    PubMed     Text format    


  95. BELL KJL, Cust AE
    Beyond country-specific incidence and mortality: the global burden of melanoma.
    Br J Dermatol. 2018;178:315-316.
    PubMed     Text format    


  96. BALATO A, Raimondo A
    Novel interactions among ultraviolet B, skin and adipose tissue.
    Br J Dermatol. 2018;178:327-328.
    PubMed     Text format    


    January 2018
  97. WANG R, Dunlap RR, Darwish MA, Simpson EL, et al
    Initial validation of the Burden of Disease in Atopic Eczema instrument, a quality of life measure for adult atopic dermatitis.
    Br J Dermatol. 2018 Jan 30. doi: 10.1111/bjd.16398.
    PubMed     Text format     Abstract available


  98. KHOURY LR, Moller T, Zachariae C, Skov L, et al
    A prospective 52-week randomised controlled trial of patient-initiated care consultations for patients with psoriasis.
    Br J Dermatol. 2018 Jan 24. doi: 10.1111/bjd.16369.
    PubMed     Text format     Abstract available


  99. BORSARI S, Pampena R, Benati E, Bombonato C, et al
    In vivo dermoscopic and confocal microscopy multi-step algorithm to detect in situ melanomas.
    Br J Dermatol. 2018 Jan 21. doi: 10.1111/bjd.16364.
    PubMed     Text format     Abstract available


  100. STULL DE, Griffiths CEM, Gilloteau I, Zhao Y, et al
    Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis.
    Br J Dermatol. 2018 Jan 21. doi: 10.1111/bjd.16366.
    PubMed     Text format     Abstract available


  101. CHABY G, Valeyrie-Allanore L, Duong TA, Lebrun-Vignes B, et al
    Severe cutaneous adverse reactions due to inappropriate medication use.
    Br J Dermatol. 2018 Jan 20. doi: 10.1111/bjd.16365.
    PubMed     Text format     Abstract available


  102. MARONAS-JIMENEZ L, Ortiz-Romero PL
    Aprepitant did not modify global disease activity in cutaneous T cell lymphomas.
    Br J Dermatol. 2018 Jan 20. doi: 10.1111/bjd.16374.
    PubMed     Text format     Abstract available


  103. KWATRA SG, Boozalis E, Kwatra MM
    Effects of neuroimmune axis modulation by aprepitant on anti-pruritic and global disease severity in patients with cutaneous T-cell lymphoma.
    Br J Dermatol. 2018 Jan 20. doi: 10.1111/bjd.16363.
    PubMed     Text format     Abstract available


  104. GRILL C, Laila B, Rubod A, Aktary Z, et al
    Epidermal melanocytes of segmental vitiligo show altered expression of E-cadherin, but not P-cadherin.
    Br J Dermatol. 2018 Jan 16. doi: 10.1111/bjd.16352.
    PubMed     Text format     Abstract available


  105. DIZON MP, Yu AM, Singh RK, Wan J, et al
    Systematic review of atopic dermatitis disease definition in studies using routinely-collected health data.
    Br J Dermatol. 2018 Jan 16. doi: 10.1111/bjd.16340.
    PubMed     Text format     Abstract available


  106. DE BRUIN-WELLER M, Graham NMH, Pirozzi G, Shumel B, et al
    Could conjunctivitis in dupilumab treated atopic dermatitis patients be caused by colonization with Demodex and increased IL-17 levels? Reply from authors.
    Br J Dermatol. 2018 Jan 15. doi: 10.1111/bjd.16348.
    PubMed     Text format     Abstract available


  107. BACHELEZ H
    Pustular psoriasis and related pustular skin diseases.
    Br J Dermatol. 2018 Jan 15. doi: 10.1111/bjd.16232.
    PubMed     Text format     Abstract available


  108. THYSSEN JP
    Could conjunctivitis in dupilumab treated atopic dermatitis patients be caused by colonization with demodex and increased IL-17 levels?
    Br J Dermatol. 2018 Jan 15. doi: 10.1111/bjd.16330.
    PubMed     Text format     Abstract available


  109. KOTB IS, Lewis BJ, Barker RN, Ormerod AD, et al
    Differential effects of phototherapy, adalimumab and betamethasone/calcipotriol on effector and regulatory T cells in psoriasis.
    Br J Dermatol. 2018 Jan 12. doi: 10.1111/bjd.16336.
    PubMed     Text format     Abstract available


  110. YOSHIDA H, Nagaoka A, Komiya A, Aoki M, et al
    Reduction of hyaluronan and increased expression of HYBID (KIAA1199) correlate with clinical symptoms in photoaged skin.
    Br J Dermatol. 2018 Jan 12. doi: 10.1111/bjd.16335.
    PubMed     Text format     Abstract available


  111. SEO HM, Moon GT, Song YM, Gee HY, et al
    Expression of YAP and TAZ in molluscum contagiosum virus infected skin.
    Br J Dermatol. 2018 Jan 12. doi: 10.1111/bjd.16333.
    PubMed     Text format     Abstract available


  112. GRIFFITHS CEM, Jo SJ, Naldi L, Romiti R, et al
    A multidimensional assessment of the burden of psoriasis: Results from a multinational dermatologist and patient survey.
    Br J Dermatol. 2018 Jan 12. doi: 10.1111/bjd.16332.
    PubMed     Text format     Abstract available


  113. RANDA H, Lomholt JJ, Skov L, Zachariae R, et al
    Health-Related Quality of Life in adolescents with psoriasis: an interview-based study.
    Br J Dermatol. 2018 Jan 8. doi: 10.1111/bjd.16326.
    PubMed     Text format     Abstract available


  114. BEECKMAN D, Van den Bussche K, Alves P, Arnold Long MC, et al
    Towards an international language for Incontinence-Associated Dermatitis (IAD): design and evaluation of psychometric properties of the Ghent Global IAD Categorisation Tool (GLOBIAD) in 30 countries.
    Br J Dermatol. 2018 Jan 8. doi: 10.1111/bjd.16327.
    PubMed     Text format     Abstract available


  115. LAINO AM, Berry EG, Jagirdar K, Lee KJ, et al
    Iris pigmented lesions as a marker of cutaneous melanoma risk: an Australian case-control study.
    Br J Dermatol. 2018 Jan 8. doi: 10.1111/bjd.16323.
    PubMed     Text format     Abstract available


  116. THOMSON J, Wernham AGH, Williams HC
    Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a critical appraisal.
    Br J Dermatol. 2018 Jan 6. doi: 10.1111/bjd.16317.
    PubMed     Text format     Abstract available


  117. LEWIS FM, Tatnall FM, Velangi SS, Bunker CB, et al
    British Association of Dermatologists guidelines for the management of lichen sclerosus 2018.
    Br J Dermatol. 2018 Jan 4. doi: 10.1111/bjd.16241.
    PubMed     Text format     Abstract available


  118. TSCHANDL P, Wiesner T
    Advances in the diagnosis of pigmented skin lesions.
    Br J Dermatol. 2018;178:9-11.
    PubMed     Text format    


  119. VERYKIOU S, Edwards N, Hill D
    How breakthroughs in translational research have impacted treatment strategies for melanoma.
    Br J Dermatol. 2018;178:5-8.
    PubMed     Text format    


  120. CHASSET F, Haroche J
    Cutaneous manifestations of paediatric Erdheim-Chester disease, a histiocytosis of the 'L' group.
    Br J Dermatol. 2018;178:31-32.
    PubMed     Text format    


  121. PRINSEN CAC
    T-QoL: a quality of life outcome measure specifically developed for adolescents with skin diseases.
    Br J Dermatol. 2018;178:23-25.
    PubMed     Text format    


  122. SANCLEMENTE G
    What can we learn from psoriasis pharmacogenomics research?
    Br J Dermatol. 2018;178:17.
    PubMed     Text format    


  123. MILLINGTON GWM, Collins A, Lovell CR, Leslie TA, et al
    British Association of Dermatologists' guidelines for the investigation and management of generalized pruritus in adults without an underlying dermatosis, 2018.
    Br J Dermatol. 2018;178:34-60.
    PubMed     Text format    


  124. MUTHIAH S, Tang D, Nasr B, Verykiou S, et al
    A new era in holistic care: bridging the gap between dermatologists and oncologists for the treatment of malignant melanoma.
    Br J Dermatol. 2018;178:1-4.
    PubMed     Text format    


  125. RENCZ F
    Patients with psoriasis on a new trajectory: long-term improvement in quality of life with biologics.
    Br J Dermatol. 2018;178:29-30.
    PubMed     Text format    


  126. WIESNER T, Zbyszewski A
    Progress in the diagnosis and therapy of melanoma.
    Br J Dermatol. 2018;178:12-14.
    PubMed     Text format    


  127. NALDI L
    Biologic treatment for psoriasis and cancer: an increased risk for most cancers could not be ruled out.
    Br J Dermatol. 2018;178:19.
    PubMed     Text format    


  128. SILLING S, Akgul B
    Treatment success in cutaneous warts: morphology and human papillomavirus type matter.
    Br J Dermatol. 2018;178:30-31.
    PubMed     Text format    


  129. SEKHON S, Koo J
    Indirubin: a novel topical agent in the treatment of psoriasis.
    Br J Dermatol. 2018;178:21.
    PubMed     Text format    


  130. WEHNER MR
    Sunscreen and melanoma prevention: evidence and expectations.
    Br J Dermatol. 2018;178:15-16.
    PubMed     Text format    


    December 2017
  131. MCINERNEY-LEO AM, Wheeler L, Sturm RA, Tan JM, et al
    Point mutation in p14(ARF) -specific exon 1beta of CDKN2A causing familial melanoma and astrocytoma.
    Br J Dermatol. 2017 Dec 26. doi: 10.1111/bjd.16275.
    PubMed     Text format     Abstract available


  132. DE UNAMUNO BUSTOS B, Murria Estal R, Perez Simo G, Simarro Farinos J, et al
    Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.
    Br J Dermatol. 2017 Dec 26. doi: 10.1111/bjd.16254.
    PubMed     Text format     Abstract available


  133. AAREBROT AK, Solberg SM, Davies R, Bader LI, et al
    Phosphorylation of intracellular signaling molecules in peripheral blood cells from psoriasis patients on originator or biosimilar infliximab.
    Br J Dermatol. 2017 Dec 23. doi: 10.1111/bjd.16269.
    PubMed     Text format     Abstract available


  134. KRASUSKA M, Lavda AC, Thompson AR, Millings A, et al
    The role of adult attachment orientation and coping in psychological adjustment to living with skin conditions.
    Br J Dermatol. 2017 Dec 23. doi: 10.1111/bjd.16268.
    PubMed     Text format     Abstract available


  135. SALOMON G, Maza A, Boulinguez S, Paul C, et al
    Efficacy of anti-PD-1 on skin carcinomas and melanoma metastases in an Xeroderma Pigmentosum patient.
    Br J Dermatol. 2017 Dec 23. doi: 10.1111/bjd.16270.
    PubMed     Text format     Abstract available


  136. GOLBARI NM, Lockwood SJ, Porter ML, Kimball AB, et al
    Reply to: "An exploratory study using framework analysis to investigate health-seeking behaviour in patients with psoriasis".
    Br J Dermatol. 2017 Dec 22. doi: 10.1111/bjd.16266.
    PubMed     Text format     Abstract available


  137. GHETTI M, Topouzi H, Theocharidis G, Papa V, et al
    Sub-Populations of Dermal Skin Fibroblasts Secrete Distinct Extracellular Matrix: Implications for Using Skin Substitutes in the Clinic.
    Br J Dermatol. 2017 Dec 20. doi: 10.1111/bjd.16255.
    PubMed     Text format     Abstract available


  138. TSAI TF, Weng HJ, Wang TS
    Clinical experience of secukinumab in the treatment of erythrodermic psoriasis: a case series.
    Br J Dermatol. 2017 Dec 19. doi: 10.1111/bjd.16252.
    PubMed     Text format     Abstract available


  139. SVENSSON A, Ofenloch RF, Bruze M, Naldi L, et al
    Prevalence of skin disease in a population based sample of adults out of five European countries.
    Br J Dermatol. 2017 Dec 16. doi: 10.1111/bjd.16248.
    PubMed     Text format     Abstract available


  140. KLIJN SL, van den Reek JMPA, van de Wetering G, van der Kolk A, et al
    Biologic treatment sequences for plaque psoriasis: a cost-utility analysis based on 10 years of Dutch real-world evidence from BioCAPTURE.
    Br J Dermatol. 2017 Dec 16. doi: 10.1111/bjd.16247.
    PubMed     Text format     Abstract available


  141. DE WIT J, Totte JEE, van Buchem FJM, Pasmans SGMA, et al
    The prevalence of antibody responses against Staphylococcus aureus antigens in patients with atopic dermatitis: a systematic review and meta-analysis.
    Br J Dermatol. 2017 Dec 16. doi: 10.1111/bjd.16251.
    PubMed     Text format     Abstract available


  142. KAMSTRUP MR, Skov L, Zachariae C, Thyssen JP, et al
    Psoriasis and risk of malignant lymphoma: A population-based cohort study.
    Br J Dermatol. 2017 Dec 16. doi: 10.1111/bjd.16245.
    PubMed     Text format     Abstract available


  143. OLSEN CM, Wilson LF, Green AC, Biswas N, et al
    How many melanomas might be prevented if more people applied sunscreen regularly?
    Br J Dermatol. 2017 Dec 14. doi: 10.1111/bjd.16079.
    PubMed     Text format     Abstract available


  144. GERBENS LAA, Hamann SAS, Brouwer MWD, Roekevisch E, et al
    Methotrexate and azathioprine in severe atopic dermatitis: a 5-year follow up study of a randomised controlled trial.
    Br J Dermatol. 2017 Dec 13. doi: 10.1111/bjd.16240.
    PubMed     Text format     Abstract available


  145. PRUSSICK RB, Miele L
    Nonalcoholic fatty liver disease in patients with psoriasis: A consequence of systemic inflammatory burden?
    Br J Dermatol. 2017 Dec 13. doi: 10.1111/bjd.16239.
    PubMed     Text format     Abstract available


  146. NEMOTO O, Hirose K, Shibata S, Li K, et al
    Safety and Efficacy of guselkumab in Japanese patients with moderate-to-severe plaque psoriasis: A Randomised, Placebo-Controlled, Ascending Dose Study.
    Br J Dermatol. 2017 Dec 9. doi: 10.1111/bjd.16236.
    PubMed     Text format     Abstract available


  147. THYSSEN JP, Halling-Overgaard AS, Andersen YMF, Gislason G, et al
    The association between cardiovascular disease and type 2 diabetes in adults with atopic dermatitis: a systematic review and meta-analysis.
    Br J Dermatol. 2017 Dec 6. doi: 10.1111/bjd.16215.
    PubMed     Text format     Abstract available


  148. AHMED A, Solman L, Williams HC
    Magnitude of benefit for topical crisaborole in the treatment of atopic dermatitis in children and adults does not look promising: a critical appraisal.
    Br J Dermatol. 2017 Dec 3. doi: 10.1111/bjd.16046.
    PubMed     Text format     Abstract available


  149. EATON LH, Mellody KT, Pilkington SM, Dearman RJ, et al
    Impaired Langerhans' cell migration in psoriasis is due to an altered keratinocyte phenotype induced by interleukin-17.
    Br J Dermatol. 2017 Dec 1. doi: 10.1111/bjd.16172.
    PubMed     Text format     Abstract available


  150. GONZALEZ-QUESADA A, Bastida J, Rivero-Vera JC, Piris-Pinilla MA, et al
    Image Gallery: Metachronic occurrence of primary cutaneous marginal zone B-cell lymphoma and primary cutaneous Rosai-Dorfman disease in the same patient.
    Br J Dermatol. 2017;177:e355.
    PubMed     Text format    


  151. TOLLEFSON M, Siegel D
    Advancing paediatric psoriasis treatment options for children.
    Br J Dermatol. 2017;177:1470-1471.
    PubMed     Text format    


  152. SCARISBRICK JJ
    Brentuximab vedotin is an effective therapy for CD30(+) mycosis fungoides and cutaneous anaplastic large-cell lymphoma: what is the cost?
    Br J Dermatol. 2017;177:1474-1475.
    PubMed     Text format    


  153. LAIMER M
    MAPK14 as candidate for genetic susceptibility to diabetic foot ulcer.
    Br J Dermatol. 2017;177:1482-1483.
    PubMed     Text format    


  154. LUO Y, Liu J
    Image Gallery: Primary cutaneous precursor B-lymphoblastic lymphoma in an infant.
    Br J Dermatol. 2017;177:e353.
    PubMed     Text format    


  155. KIRBY B
    Worldwide perspective of biosimilars for psoriasis.
    Br J Dermatol. 2017;177:1473.
    PubMed     Text format    


  156. VILLANI R, Khosrotehrani K
    Oncogenes and morphogens: intricacies of targeted therapy in cutaneous basal cell carcinoma.
    Br J Dermatol. 2017;177:1472-1473.
    PubMed     Text format    


  157. GALLUCCI RM
    Transforming growth factor-beta and psoriasis: a new link.
    Br J Dermatol. 2017;177:1480-1481.
    PubMed     Text format    


    November 2017
  158. TOTTE JEE, Pardo LM, Fieten KB, de Wit J, et al
    The IgG response against Staphylococcus aureus is associated with severe atopic dermatitis in children.
    Br J Dermatol. 2017 Nov 30. doi: 10.1111/bjd.16153.
    PubMed     Text format     Abstract available


  159. PALLER AS
    Clarification of methodology and further results from the pivotal phase 3 study of crisaborole for mild-moderate atopic dermatitis.
    Br J Dermatol. 2017 Nov 30. doi: 10.1111/bjd.16047.
    PubMed     Text format    


  160. DE BRUIN-WELLER M, Thaci D, Smith CH, Reich K, et al
    Dupilumab with concomitant topical corticosteroids in adult patients with atopic dermatitis who are not adequately controlled with or are intolerant to ciclosporin A, or when this treatment is medically inadvisable: a placebo-controlled, randomized ph
    Br J Dermatol. 2017 Nov 28. doi: 10.1111/bjd.16156.
    PubMed     Text format     Abstract available


  161. CHAN SA, Wernham AGH, Stembridge N, Harper N, et al
    Do perioperative antibiotics reduce the risk of surgical site infections following excision of ulcerated skin cancers? a critically appraised topic.
    Br J Dermatol. 2017 Nov 28. doi: 10.1111/bjd.16157.
    PubMed     Text format     Abstract available


  162. HOLMES J, von Braunmuhl T, Berking C, Sattler E, et al
    Optical coherence tomography of basal cell carcinoma: influence of location, subtype, observer variability and image quality on diagnostic performance.
    Br J Dermatol. 2017 Nov 28. doi: 10.1111/bjd.16154.
    PubMed     Text format     Abstract available


  163. CHENG L, Sun B, Xiong Y, Hu L, et al
    The minor allele HCP5 rs3099844 A, PSORS1C1 rs3131003 G are associated with allopurinol-induced severe cutaneous adverse reactions in Han Chinese: a multicentre retrospective case-control clinical study.
    Br J Dermatol. 2017 Nov 28. doi: 10.1111/bjd.16151.
    PubMed     Text format     Abstract available


  164. RUFF SMD, Engebretsen KA, Zachariae C, Johansen JD, et al
    The association between atopic dermatitis and hand eczema: a systematic review and meta-analysis.
    Br J Dermatol. 2017 Nov 24. doi: 10.1111/bjd.16147.
    PubMed     Text format     Abstract available


  165. WARREN RB, Brnabic A, Saure D, Langley RG, et al
    Matching-Adjusted Indirect Comparison of Efficacy in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab Versus Secukinumab.
    Br J Dermatol. 2017 Nov 24. doi: 10.1111/bjd.16140.
    PubMed     Text format     Abstract available


  166. DING S, Chen J, Zeng Q, Lu J, et al
    Chronic sun exposure is associated with distinct histone acetylation changes in human skin.
    Br J Dermatol. 2017 Nov 18. doi: 10.1111/bjd.16129.
    PubMed     Text format     Abstract available


  167. KANG EG, Wu S, Gupta A, von Mackensen YL, et al
    A Phase I Randomised Controlled Trial to Evaluate Safety and Clinical Effect of Topically Applied GSK2981278 Ointment in a Psoriasis Plaque Test.
    Br J Dermatol. 2017 Nov 18. doi: 10.1111/bjd.16131.
    PubMed     Text format     Abstract available


  168. VASSEUR P, Pohin M, Jegou JF, Favot L, et al
    Liver fibrosis is associated with cutaneous inflammation in the imiquimod-induced murine model of psoriasiform dermatitis.
    Br J Dermatol. 2017 Nov 18. doi: 10.1111/bjd.16137.
    PubMed     Text format     Abstract available


  169. MARONAS-JIMENEZ L, Estrach T, Gallardo F, Perez A, et al
    Aprepitant improves refractory pruritus in primary cutaneous T-cell lymphomas: experience of the Spanish Working Group on Cutaneous Lymphomas.
    Br J Dermatol. 2017 Nov 18. doi: 10.1111/bjd.16128.
    PubMed     Text format     Abstract available


  170. WINSLOW UC, Nordestgaard BG, Afzal S
    High plasma 25-hydroxyvitamin D and high risk of non-melanoma skin cancer: a Mendelian randomisation study of 97849 individuals.
    Br J Dermatol. 2017 Nov 16. doi: 10.1111/bjd.16127.
    PubMed     Text format     Abstract available


  171. STOFFEL E, Maier H, Riedl E, Bruggen MC, et al
    Analysis of anti-TNF-induced skin lesions reveals strong Th1 activation with some distinct immunological characteristics.
    Br J Dermatol. 2017 Nov 16. doi: 10.1111/bjd.16126.
    PubMed     Text format     Abstract available


  172. SNAST I, Reiter O, Atzmony L, Leshem YA, et al
    Psychological stress and psoriasis. A systematic review and meta-analysis.
    Br J Dermatol. 2017 Nov 9. doi: 10.1111/bjd.16116.
    PubMed     Text format     Abstract available


  173. TZANEVA S, Geroldinger A, Trattner H, Tanew A, et al
    Fumaric acid esters in combination with a 6-week course of narrow-band UVB provides for an accelerated response as compared to fumaric acid esters monotherapy in patients with moderate to severe plaque psoriasis: A randomized prospective clinical stud
    Br J Dermatol. 2017 Nov 8. doi: 10.1111/bjd.16106.
    PubMed     Text format     Abstract available


  174. BURDEN-TEH E, Phillips RC, Thomas KS, Ratib S, et al
    A systematic review of diagnostic criteria for psoriasis in adults and children: Evidence from studies with a primary aim to develop or validate diagnostic criteria.
    Br J Dermatol. 2017 Nov 6. doi: 10.1111/bjd.16104.
    PubMed     Text format     Abstract available


  175. DEL PUERTO C, Navarrete-Dechent C, Molgo M, Camargo CA Jr, et al
    Immunohistochemical expression of vitamin D receptor in melanocytic nevi and cutaneous melanoma. A case-control study.
    Br J Dermatol. 2017 Nov 6. doi: 10.1111/bjd.16103.
    PubMed     Text format     Abstract available


  176. EGEBERG A, Ottosen MB, Gniadecki R, Broesby-Olsen S, et al
    Safety, efficacy, and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis.
    Br J Dermatol. 2017 Nov 1. doi: 10.1111/bjd.16102.
    PubMed     Text format     Abstract available


  177. FINLAY AY
    Real-world effect of biologics on quality of life in psoriasis.
    Br J Dermatol. 2017;177:1164-1165.
    PubMed     Text format    


  178. ROH MR
    Role of endothelial dysfunction in pathological cutaneous scarring.
    Br J Dermatol. 2017;177:1153.
    PubMed     Text format    


  179. FLORENCE L, Fuller LC
    Washing with water and glycerine improves skin barrier function and quality of life in patients with podoconiosis.
    Br J Dermatol. 2017;177:1166.
    PubMed     Text format    


  180. LUO Y, Liu J
    Image Gallery: Moth-eaten alopecia as the only cutaneous symptom of acquired secondary syphilis in a 2-year-old boy.
    Br J Dermatol. 2017;177:e227.
    PubMed     Text format    


  181. DANBY SG
    Staphylococcus aureus in atopic dermatitis: a diverse problem?
    Br J Dermatol. 2017;177:1164.
    PubMed     Text format    


  182. DRUCKER AM
    Making sense of measures of clinical signs for atopic dermatitis.
    Br J Dermatol. 2017;177:1158-1159.
    PubMed     Text format    


  183. SILVERBERG JI
    Are moisturizers effective in the treatment of atopic dermatitis?
    Br J Dermatol. 2017;177:1154.
    PubMed     Text format    


  184. HARWOOD CA, Arron ST, Proby CM, Asgari MM, et al
    Organ transplantation and cutaneous squamous cell carcinoma: progress, pitfalls and priorities in immunosuppression-associated keratinocyte carcinoma.
    Br J Dermatol. 2017;177:1150-1151.
    PubMed     Text format    


  185. RAZMI T M, De D, Handa S, Saikia UN, et al
    Image Gallery: Generalized circinate cutaneous lesions simulating circinate balanitis.
    Br J Dermatol. 2017;177:e224.
    PubMed     Text format    


  186. HAMMER K, Hugel R, Lange-Asschenfeldt B, Painsi C, et al
    Image Gallery: Cutaneous signs of acute pancreatitis.
    Br J Dermatol. 2017;177:e222.
    PubMed     Text format    


    October 2017
  187. GRANDO SA, Zachary CB
    THE NON-NEURONAL AND NON-MUSCULAR EFFECTS OF BOTULINUM TOXIN: A Graceful Opportunity for a Deadly Molecule to Treat a Human Disease in the Skin and Beyond.
    Br J Dermatol. 2017 Oct 31. doi: 10.1111/bjd.16080.
    PubMed     Text format     Abstract available


  188. HARWOOD CA, Toland AE, Proby CM, Euvrard S, et al
    The pathogenesis of cutaneous squamous cell carcinoma in organ transplant recipients.
    Br J Dermatol. 2017 Oct 30. doi: 10.1111/bjd.15956.
    PubMed     Text format     Abstract available


  189. BLOMBERG M, He SY, Harwood C, Arron ST, et al
    Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients.
    Br J Dermatol. 2017 Oct 30. doi: 10.1111/bjd.15950.
    PubMed     Text format     Abstract available


  190. DIXON LJ, Witcraft SM, McCowan NK, Brodell RT, et al
    Stress and Skin Disease Quality of Life: The Moderating Role of Anxiety Sensitivity Social Concerns.
    Br J Dermatol. 2017 Oct 27. doi: 10.1111/bjd.16082.
    PubMed     Text format     Abstract available


  191. CORDEL N, Hebert V, Vega Rua A, Herrmann-Storck C, et al
    In vivo Zika virus detection in human skin.
    Br J Dermatol. 2017 Oct 27. doi: 10.1111/bjd.16096.
    PubMed     Text format     Abstract available


  192. STAIMAN A, Hsu DY, Silverberg JI
    Epidemiology of Staphylococcal Scalded Skin Syndrome in United States Children.
    Br J Dermatol. 2017 Oct 27. doi: 10.1111/bjd.16097.
    PubMed     Text format     Abstract available


  193. EGGEN CAM, Lommerts JE, van Zuuren EJ, Limpens J, et al
    Laser treatment of congenital melanocytic nevi: a systematic review.
    Br J Dermatol. 2017 Oct 27. doi: 10.1111/bjd.16094.
    PubMed     Text format     Abstract available


  194. TRAN AD, Fogarty G, Nowak AK, Espinoza D, et al
    A systematic review and meta-analysis of utility estimates in melanoma.
    Br J Dermatol. 2017 Oct 27. doi: 10.1111/bjd.16098.
    PubMed     Text format     Abstract available


  195. CHEN L, Tsai TF
    HLA-Cw6 and psoriasis.
    Br J Dermatol. 2017 Oct 26. doi: 10.1111/bjd.16083.
    PubMed     Text format     Abstract available


  196. LANGAN EA, Griffiths CEM, Solbach W, Knobloch JK, et al
    The role of the microbiome in psoriasis: moving from disease description to treatment prediction?
    Br J Dermatol. 2017 Oct 26. doi: 10.1111/bjd.16081.
    PubMed     Text format     Abstract available


  197. VAKHARIA PP, Chopra R, Sacotte R, Patel N, et al
    Severity strata for five patient-reported outcomes in adults with atopic dermatitis.
    Br J Dermatol. 2017 Oct 19. doi: 10.1111/bjd.16078.
    PubMed     Text format     Abstract available


  198. SEO JW, Ha SM, Song KH
    Insulin-Like Growth Factor-II mRNA-Binding Protein 3 as a Novel Prognostic Biomarker for Acral Lentiginous Melanoma.
    Br J Dermatol. 2017 Oct 19. doi: 10.1111/bjd.16077.
    PubMed     Text format     Abstract available


  199. GELLER S, Myskowski PL, Kim YH, Moskowitz A, et al
    The optimal regimen of brentuximab vedotin for CD30+ cutaneous lymphoma: Are we there yet?
    Br J Dermatol. 2017 Oct 10. doi: 10.1111/bjd.16052.
    PubMed     Text format     Abstract available


  200. STROBER BE, Langley RGB, Menter A, Magid M, et al
    No Elevated Risk for Depression, Anxiety, or Suicidality with Secukinumab in a Pooled Analysis of Data from 10 Clinical Studies in Moderate-to-Severe Plaque Psoriasis.
    Br J Dermatol. 2017 Oct 9. doi: 10.1111/bjd.16051.
    PubMed     Text format     Abstract available


  201. PAPP KA, Leonardi CL, Blauvelt A, Reich K, et al
    Ixekizumab treatment for psoriasis: Integrated efficacy analysis of three double-blinded, controlled studies (UNCOVER-1, UNCOVER-2, UNCOVER-3).
    Br J Dermatol. 2017 Oct 9. doi: 10.1111/bjd.16050.
    PubMed     Text format     Abstract available


  202. RUNGAPIROMNAN W, Yiu ZZN, Warren RB, Griffiths CEM, et al
    Reply to 'Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials': reply from the authors.
    Br J Dermatol. 2017 Oct 9. doi: 10.1111/bjd.16043.
    PubMed     Text format     Abstract available


  203. BASSOLI S, Kyrgidis A, Ciardo S, Casari A, et al
    Uncovering the diagnostic dermoscopic features of flat melanomas located on the lower limbs.
    Br J Dermatol. 2017 Oct 7. doi: 10.1111/bjd.16030.
    PubMed     Text format     Abstract available


  204. VALLERAND IA, Patten SB
    Systemic retinoids and psychiatric disorders in patients with skin diseases: a multifactorial relationship.
    Br J Dermatol. 2017 Oct 3. doi: 10.1111/bjd.16018.
    PubMed     Text format     Abstract available


  205. NGUYEN MO, Nguyen HT, Asgari MM
    Towards the use of precision medicine in predicting cutaneous squamous cell carcinoma risk among solid organ transplant recipients.
    Br J Dermatol. 2017;177:901-902.
    PubMed     Text format    


  206. EGEBERG A
    Cardiometabolic disease in atopic dermatitis: the heart of the matter.
    Br J Dermatol. 2017;177:898-899.
    PubMed     Text format    


  207. SCHAIDER H, Sturm RA
    The evolving universe of BRAF mutations in melanoma.
    Br J Dermatol. 2017;177:893.
    PubMed     Text format    


  208. EGEBERG A
    Getting tired of psoriasis?
    Br J Dermatol. 2017;177:899-900.
    PubMed     Text format    


  209. HOFMANN H
    A foot tumour as late cutaneous Lyme borreliosis: a new entity or a variant of an inflammatory proliferative reaction to Borrelia burgdorferi?
    Br J Dermatol. 2017;177:906-907.
    PubMed     Text format    


  210. HAY R
    Staphylococcus aureus and psoriasis: time for a re-appraisal?
    Br J Dermatol. 2017;177:894-895.
    PubMed     Text format    


  211. ROBINSON JK, Spring B
    Personalized melanoma genomic risk information:perception of shared risk initiates sharing with family.
    Br J Dermatol. 2017;177:890-891.
    PubMed     Text format    


  212. ZYCHOWSKA M, Maj J
    Image Gallery: Cutaneous metastases from hidden carcinoma of the penis.
    Br J Dermatol. 2017;177:e161.
    PubMed     Text format    


  213. SODERLUND-VENERMO M
    Clinical significance of parvovirus B19 DNA in cutaneous biopsies.
    Br J Dermatol. 2017;177:900-901.
    PubMed     Text format    


  214. BALAK DMW
    First-line systemic treatment of psoriasis: staying conventional or going biologic?
    Br J Dermatol. 2017;177:897-898.
    PubMed     Text format    


  215. CHU L, Zhang M, Ran Y
    Further progress for therapeutic solutions in psoriasis.
    Br J Dermatol. 2017;177:896-897.
    PubMed     Text format    


  216. SEMINARA NM, Pomeranz MK
    Unravelling the links between malignancy, cytokines and neutrophilic eruptions.
    Br J Dermatol. 2017;177:905-906.
    PubMed     Text format    


  217. ASERO R
    Towards a better categorization of patients with chronic urticaria.
    Br J Dermatol. 2017;177:903-904.
    PubMed     Text format    


  218. TAN J
    Acne guidelines: pearls, pitfalls and questions.
    Br J Dermatol. 2017;177:892-893.
    PubMed     Text format    


  219. YUAN H, Pan M
    Endoscopic characteristics of oesophagus involvement in mucous membrane pemphigoid.
    Br J Dermatol. 2017;177:902-903.
    PubMed     Text format    


  220. BETZ RC
    A path through the reticulate pigmentation disorder jungle.
    Br J Dermatol. 2017;177:893-894.
    PubMed     Text format    


  221. VOSSEN ARJV, van der Zee HH, Prens EP
    Sequence variants in hidradenitis suppurativa: in search of the pathogenic mechanisms.
    Br J Dermatol. 2017;177:895-896.
    PubMed     Text format    


    September 2017
  222. NAKAGAWA H, Nemoto O, Igarashi A, Nagata T, et al
    Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: A phase 2, multi-centre, randomised, vehicle-controlled clinical study.
    Br J Dermatol. 2017 Sep 28. doi: 10.1111/bjd.16014.
    PubMed     Text format     Abstract available


  223. SCHMIEDER GJ, Draelos ZD, Pariser DM, Banfield C, et al
    Efficacy and safety of the Janus Kinase 1 inhibitor PF-04965842 in patients with moderate to severe psoriasis: phase 2, randomized, double-blind, placebo-controlled study.
    Br J Dermatol. 2017 Sep 26. doi: 10.1111/bjd.16004.
    PubMed     Text format     Abstract available


  224. HOGENDOORN GK, Bruggink SC, Hermans KE, Kouwenhoven STP, et al
    Developing and validating the CWARTS diagnostic tool, a novel clinical assessment and classification system for cutaneous warts.
    Br J Dermatol. 2017 Sep 26. doi: 10.1111/bjd.15999.
    PubMed     Text format     Abstract available


  225. NOREN P, Hagstromer L, Alimohammadi M, Melin L, et al
    The positive effects of habit reversal treatment of scratching in children with atopic dermatitis: A randomised controlled study.
    Br J Dermatol. 2017 Sep 23. doi: 10.1111/bjd.16009.
    PubMed     Text format     Abstract available


  226. GORDON KB, Blauvelt A, Foley P, Song M, et al
    Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: A pooled analysis of the Phase 3 VOYAGE 1 and VOYAGE 2 studies.
    Br J Dermatol. 2017 Sep 22. doi: 10.1111/bjd.16008.
    PubMed     Text format     Abstract available


  227. MAGLIE R, Di Cesare A, Lazzeri L, Pescitelli L, et al
    Lichen Planus triggered by infliximab biosimilar CT-P13 and recurred during secukinumab treatment.
    Br J Dermatol. 2017 Sep 22. doi: 10.1111/bjd.16003.
    PubMed     Text format     Abstract available


  228. MACARTHUR KM, Cohen BA
    Tailoring Diagnostic Studies in Hand, Foot, and Mouth Disease: Utility of PCR testing of Lesional Skin.
    Br J Dermatol. 2017 Sep 21. doi: 10.1111/bjd.15991.
    PubMed     Text format     Abstract available


  229. SIGURGEIRSSON B, Luger T
    A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - author response.
    Br J Dermatol. 2017 Sep 21. doi: 10.1111/bjd.15849.
    PubMed     Text format    


  230. NAGTZAAM IF, Peeters VPM, Vreeburg M, Wagner A, et al
    Novel CLDN1 mutation in ichthyosis-hypotrichosis-sclerosing-cholangitis syndrome without signs of liver disease.
    Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15996.
    PubMed     Text format     Abstract available


  231. HIETIKKO M, Hervonen K, Salmi T, Ilus T, et al
    Disappearance of epidermal transglutaminase and IgA deposits from the papillary dermis of dermatitis herpetiformis patients after a long-term gluten-free diet.
    Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15995.
    PubMed     Text format     Abstract available


  232. HOTZ A, Fagerberg C, Vahlquist A, Bygum A, et al
    Identification of Mutations in SDR9C7 in 6 Families with Autosomal Recessive Congenital Ichthyosis.
    Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15994.
    PubMed     Text format     Abstract available


  233. MAJEED-ARISS R, McPhee M, Bundy C, Griffiths CEM, et al
    Developing a protocol to identify and prioritise research questions for psoriasis: A James Lind Alliance Priority Setting Partnership.
    Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15992.
    PubMed     Text format     Abstract available


  234. CHEE SN, Novakovic L, Fassihi H, Garibaldinos T, et al
    Chronic actinic dermatitis: successful treatment with PUVA photochemotherapy.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15969.
    PubMed     Text format     Abstract available


  235. STRANZENBACH R, Dippel E, Schlaak M, Stadler R, et al
    Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma: reply from authors.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15972.
    PubMed     Text format     Abstract available


  236. LEWIS DJ, Kim YH, Duvic M
    Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15970.
    PubMed     Text format     Abstract available


  237. EGEBERG A, Nast A
    The value and pitfalls of biologics registries for psoriasis.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15971.
    PubMed     Text format     Abstract available


  238. WOLNER ZJ, Bajaj S, Flores E, Carrera C, et al
    Variation in dermoscopic features of basal cell carcinoma as a function of anatomic location and pigmentation status.
    Br J Dermatol. 2017 Sep 8. doi: 10.1111/bjd.15964.
    PubMed     Text format     Abstract available


  239. KESSELS JPHM, Kreukels H, Nelemans PJ, Roozeboom MH, et al
    Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolevulinic acid 20% versus two stage topical methylaminolevulinic acid: results of a randomized controlled trial.
    Br J Dermatol. 2017 Sep 8. doi: 10.1111/bjd.15967.
    PubMed     Text format     Abstract available


  240. SATTLER EC, Ertl-Wagner B, Pellegrini C, Peris K, et al
    Cutaneous melanoma in Birt-Hogg-Dube syndrome - part of the clinical spectrum?
    Br J Dermatol. 2017 Sep 4. doi: 10.1111/bjd.15937.
    PubMed     Text format     Abstract available


  241. KRASUSKA M, Millings A, Lavda AC, Thompson AR, et al
    Compassion focussed self-help for skin conditions in individuals with insecure attachment: A pilot evaluation of the acceptability and potential effectiveness.
    Br J Dermatol. 2017 Sep 4. doi: 10.1111/bjd.15934.
    PubMed     Text format     Abstract available


  242. WEIDINGER S, Baurecht H, Schmitt J
    A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal.
    Br J Dermatol. 2017 Sep 4. doi: 10.1111/bjd.15827.
    PubMed     Text format     Abstract available


  243. GUALENI B, Coulman SA, Shah D, Eng PF, et al
    Minimally-invasive and targeted therapeutic cell delivery to the skin using microneedle devices.
    Br J Dermatol. 2017 Sep 2. doi: 10.1111/bjd.15923.
    PubMed     Text format     Abstract available


  244. DRUCKER AM, Eyerich K, de Bruin-Weller MS, Thyssen JP, et al
    Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement.
    Br J Dermatol. 2017 Sep 2. doi: 10.1111/bjd.15928.
    PubMed     Text format     Abstract available


  245. CORK MJ, Danby SG
    The British Skin Foundation: 20 years of supporting dermatology research.
    Br J Dermatol. 2017;177:608-609.
    PubMed     Text format    


  246. QU H, Zhao Z, Yu J
    Image Gallery: Cutaneous presentation of disseminated cryptococcosis in a patient with undiagnosed HIV infection.
    Br J Dermatol. 2017;177:e73.
    PubMed     Text format    


  247. PRINSEN CAC
    Changing patients' understanding of psoriasis is promising.
    Br J Dermatol. 2017;177:616-617.
    PubMed     Text format    


  248. ROTA M
    Evidence for an association between alcohol intake and an increased risk of nonmelanoma skin cancer.
    Br J Dermatol. 2017;177:611-612.
    PubMed     Text format    


  249. ZNAOR A
    Melanoma burden, healthcare utilization and the potential for overdiagnosis in the elderly U.S. population.
    Br J Dermatol. 2017;177:625.
    PubMed     Text format    


  250. GISONDI P
    High prevalence of alcohol use disorders in patients with inflammatory skin diseases applies to both psoriasis and eczema.
    Br J Dermatol. 2017;177:606-607.
    PubMed     Text format    


  251. COWDELL F
    Health-seeking behaviour in people with psoriasis.
    Br J Dermatol. 2017;177:615-616.
    PubMed     Text format    


  252. DOBREV H
    Organization of the dermal matrix impacts the biomechanical properties of skin.
    Br J Dermatol. 2017;177:622-623.
    PubMed     Text format    


  253. PUIG L
    Choice of first-line biologic therapy in psoriasis: understanding the past and shaping the future?
    Br J Dermatol. 2017;177:623-624.
    PubMed     Text format    


  254. QU H, Song Y, Li R, Yu J, et al
    Image Gallery: An unusual cutaneous presentation of disseminated penicilliosis marneffei in an immunocompetent patient.
    Br J Dermatol. 2017;177:e67.
    PubMed     Text format    


  255. HABER R, Bourrat E, Derache AF, Rivet J, et al
    Image Gallery: Juvenile cutaneous chronic graft-versus-host disease presenting as bullous pemphigoid.
    Br J Dermatol. 2017;177:e69.
    PubMed     Text format    


  256. EMTESTAM L, Sartorius K
    Glucagon-like peptide-1 agonists for treatment of hidradenitis suppurativa.
    Br J Dermatol. 2017;177:625-627.
    PubMed     Text format    


  257. SHARMA VK, Bhatia R
    Vitiligo and the psyche.
    Br J Dermatol. 2017;177:612-613.
    PubMed     Text format    


  258. PRIOR J
    Qualitative study of online discussion forums about acne.
    Br J Dermatol. 2017;177:616.
    PubMed     Text format    


  259. ARENTS BWM
    Eczema treatment: it takes time to do no harm.
    Br J Dermatol. 2017;177:613-614.
    PubMed     Text format    


  260. RAO S, Arbiser JL
    Promoting intolerance: learning from warts.
    Br J Dermatol. 2017;177:621-622.
    PubMed     Text format    


  261. TENSEN CP, Vermeer MH
    MicroRNA-155 potentiates tumour development in mycosis fungoides.
    Br J Dermatol. 2017;177:618-620.
    PubMed     Text format    


  262. HOLMES S, Harries M
    Re: Frontal Fibrosing Alopecia Severity Index (FFASI): a call for a more inclusive and globally relevant severity index for frontal fibrosing alopecia: reply from the authors.
    Br J Dermatol. 2017;177:884.
    PubMed     Text format    


  263. DLOVA NC, Dadzie OE
    Frontal Fibrosing Alopecia Severity Index (FFASI): a call for a more inclusive and globally relevant severity index for frontal fibrosing alopecia.
    Br J Dermatol. 2017;177:883-884.
    PubMed     Text format    


    August 2017
  264. CHARMAN C
    A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - comment.
    Br J Dermatol. 2017 Aug 31. doi: 10.1111/bjd.15848.
    PubMed     Text format    


  265. SANDERS MGH, Pardo LM, Franco OH, Ginger RS, et al
    Prevalence and determinants of seborrheic dermatitis in a middle aged and elderly population: the Rotterdam Study.
    Br J Dermatol. 2017 Aug 30. doi: 10.1111/bjd.15908.
    PubMed     Text format     Abstract available


  266. TSIANAKAS A, Luger TA, Radin A
    Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: Results from a randomized, placebo-controlled clinical trial.
    Br J Dermatol. 2017 Aug 27. doi: 10.1111/bjd.15905.
    PubMed     Text format     Abstract available


  267. SCHMITT J, Haufe E, Trautmann F, Schulze HJ, et al
    Is UV-exposure acquired at work the most important risk factor for cutaneous squamous cell carcinoma? Results of the population-based case-control study FB-181.
    Br J Dermatol. 2017 Aug 27. doi: 10.1111/bjd.15906.
    PubMed     Text format     Abstract available


  268. AREVALO-BERMUDEX M, Pita-Fernandez S, Paradela S, Fonseca Capdevila E, et al
    Cutaneous lupus erythematosus. Quality of life and related factors in a cohort of 260 patients of A Coruna, Spain.
    Br J Dermatol. 2017 Aug 20. doi: 10.1111/bjd.15902.
    PubMed     Text format     Abstract available


  269. LIN YK, See LC, Huang YH, Chi CC, et al
    Comparison of indirubin concentrations in indigo naturalis ointment for psoriasis treatment: a randomized, double-blind, dosage-controlled trial.
    Br J Dermatol. 2017 Aug 17. doi: 10.1111/bjd.15894.
    PubMed     Text format     Abstract available


  270. KIM HJ, Langenhan JL, Robinson Es ES, Privette E, et al
    Effect of Long-term Treatment with TNFalpha Inhibitors on Single-dose UV-induced Changes in Human Skin.
    Br J Dermatol. 2017 Aug 17. doi: 10.1111/bjd.15897.
    PubMed     Text format     Abstract available


  271. MATTII M, Lovaszi M, Garzorz N, Atenhan A, et al
    Sebocytes contribute to skin inflammation by promoting the differentiation of Th17 cells.
    Br J Dermatol. 2017 Aug 11. doi: 10.1111/bjd.15879.
    PubMed     Text format     Abstract available


  272. STEWART CL, Cornejo CM, Wanat KA, Sander I, et al
    The Immune Reconstitution of the Skin Following Sex Mismatched Allogeneic Hematopoietic Stem Cell Transplant: A prospective case series utilizing fluorescent in situ hybridization and immunohistochemistry.
    Br J Dermatol. 2017 Aug 10. doi: 10.1111/bjd.15878.
    PubMed     Text format     Abstract available


  273. ETTINGER M, Schreml J, Wirsching K, Berneburg M, et al
    Skin signs of primary immunodeficiencies - how to find the genes to check.
    Br J Dermatol. 2017 Aug 9. doi: 10.1111/bjd.15870.
    PubMed     Text format     Abstract available


  274. MOSSNER R, Wilsmann-Theis D, Oji V, Gkogkolou P, et al
    The genetic basis for most patients with pustular skin disease remains elusive.
    Br J Dermatol. 2017 Aug 5. doi: 10.1111/bjd.15867.
    PubMed     Text format     Abstract available


  275. YOULDEN DR, Baade PD, Aitken JF, Green AC, et al
    Prognostic importance of a second invasive primary melanoma according to tumor stage.
    Br J Dermatol. 2017 Aug 3. doi: 10.1111/bjd.15863.
    PubMed     Text format     Abstract available


  276. NAST A, Dilleen M, Liyanage W, Aikman L, et al
    Time, PASI and DLQI of psoriasis patients who "drop out" of clinical trials on etanercept due to "lack of efficacy" - a pooled analysis from ten clinical trials.
    Br J Dermatol. 2017 Aug 3. doi: 10.1111/bjd.15864.
    PubMed     Text format     Abstract available


  277. HAMBLY R, Kelly A, Gilhooley E, Nic Dhonncha E, et al
    Medication adherence among psoriasis patients on traditional systemic and biologic treatment.
    Br J Dermatol. 2017 Aug 1. doi: 10.1111/bjd.15856.
    PubMed     Text format     Abstract available


  278. GUIDA M, Ruggieri E, Fucci L, Ressa M, et al
    Image Gallery: A case of cutaneous giant angiosarcoma treated successfully with electrochemotherapy.
    Br J Dermatol. 2017;177:e27.
    PubMed     Text format    


  279. BERK-KRAUSS J, Stein JA
    The role of access to care in acral lentiginous melanoma survival.
    Br J Dermatol. 2017;177:341-342.
    PubMed     Text format    


  280. DE BRITO M, Gazzani P, Amel-Kashipaz R, Vydianath B, et al
    Image Gallery: Secondary cutaneous involvement of the ear with systemic small lymphocytic lymphoma: a rare manifestation.
    Br J Dermatol. 2017;177:e26.
    PubMed     Text format    


  281. FOULKES AC, Brown SJ
    Genetic prediction of treatment response in psoriasis is still a work in progress.
    Br J Dermatol. 2017;177:344-345.
    PubMed     Text format    


  282. ROSEN CF
    Fatigue and psoriasis.
    Br J Dermatol. 2017;177:346-347.
    PubMed     Text format    


  283. UITTO J, Youssefian L, Vahidnezhad H
    Expanding mutation landscape and phenotypic spectrum of autosomal recessive congenital ichthyosis.
    Br J Dermatol. 2017;177:342-343.
    PubMed     Text format    


  284. KRAMER ON, Jerdan K, Worobec SM
    Image Gallery: Haemorrhagic shock due to a cutaneous pyogenic granuloma.
    Br J Dermatol. 2017;177:e24.
    PubMed     Text format    


  285. HARRIS V, Smith SD
    Lifting the biofilm lid on the antibacterial and antibiofilm effects of sodium hypochlorite against Staphylococcus aureus in atopic dermatitis.
    Br J Dermatol. 2017;177:347-348.
    PubMed     Text format    


  286. NIJSTEN T, Leigh IM
    Keratinocyte skin cancers in the spotlight.
    Br J Dermatol. 2017;177:334-335.
    PubMed     Text format    


  287. HILL D, Lovat P
    Cover Image: Invasion of a cutaneous melanoma tumour.
    Br J Dermatol. 2017;177:599.
    PubMed     Text format    


  288. ABBOTT P
    Patient-centred health care for people with chronic skin conditions.
    Br J Dermatol. 2017;177:329-330.
    PubMed     Text format    


  289. KIRBY B
    Drug survival of methotrexate in psoriasis.
    Br J Dermatol. 2017;177:345-346.
    PubMed     Text format    


  290. COSTA FECHINE CO, Anzai A, Valente NY, Romiti R, et al
    Image Gallery: Folliculitis keloidalis on white-skinned scalp vertex.
    Br J Dermatol. 2017;177:e25.
    PubMed     Text format    


  291. SAMUEL RJ, Reynolds NJ
    Ustekinumab for severe atopic dermatitis: an important negative study.
    Br J Dermatol. 2017;177:339-341.
    PubMed     Text format    


  292. DAWE RS
    Maintenance therapy with psoralen-ultraviolet A for mycosis fungoides: in the absence of evidence sitting on the fence is appropriate.
    Br J Dermatol. 2017;177:337-338.
    PubMed     Text format    


  293. STEFANAKI C, Stratigos A
    Alopecia in Cronkhite-Canada syndrome.
    Br J Dermatol. 2017;177:348-349.
    PubMed     Text format    


  294. VIEYRA-GARCIA P, Wolf P
    Psoralen-ultraviolet A maintenance in mycosis fungoides: the underlying question.
    Br J Dermatol. 2017;177:336-337.
    PubMed     Text format    


  295. TAN J
    Updating the diagnosis, classification and assessment of rosacea by effacement of subtypes: reply from the author.
    Br J Dermatol. 2017;177:598-599.
    PubMed     Text format    


  296. WILKIN J
    Updating the diagnosis, classification and assessment of rosacea by effacement of subtypes.
    Br J Dermatol. 2017;177:597-598.
    PubMed     Text format    


  297. GELLER S, Sprecher E
    IgA pemphigus: lumping or splitting?
    Br J Dermatol. 2017;177:581-582.
    PubMed     Text format    


  298. BRUNASSO AMG, Massone C
    Alitretinoin therapy for palmoplantar pustulosis.
    Br J Dermatol. 2017;177:578-579.
    PubMed     Text format    


  299. TSAKOK T, Roberts E, Bridgett C, Staughton RCD, et al
    The effectiveness of habit reversal on treatment outcome and quality of life in patients with chronic eczema: a prospective observational study in the U.K.
    Br J Dermatol. 2017;177:554-556.
    PubMed     Text format    


    July 2017
  300. BASRA MKA, Salek MS, Fenech D, Finlay AY, et al
    Conceptualisation, development and validation of T-QoL(c) (Teenagers' Quality of Life): a patient-focused measure to assess quality of life of adolescents with skin diseases.
    Br J Dermatol. 2017 Jul 31. doi: 10.1111/bjd.15853.
    PubMed     Text format     Abstract available


  301. ADLER NR, Kelly JW, Haydon A, McLean CA, et al
    Clinicopathological characteristics and prognosis of patients with multiple primary melanomas.
    Br J Dermatol. 2017 Jul 28. doi: 10.1111/bjd.15855.
    PubMed     Text format     Abstract available


  302. PAPP K, Bachelez H, Costanzo A, Foley P, et al
    Clinical Similarity of the Biosimilar ABP 501 Compared With Adalimumab After Single Transition: Long-Term Results From a Randomised, Double-Blind, 52-Week, Phase 3 Study in Moderate-to-Severe Plaque Psoriasis Patients.
    Br J Dermatol. 2017 Jul 28. doi: 10.1111/bjd.15857.
    PubMed     Text format     Abstract available


  303. YEN H, Dhana A, Okhovat JP, Qureshi A, et al
    Alcohol intake and risk of nonmelanoma skin cancer: a systematic review and dose-response meta-analysis.
    Br J Dermatol. 2017 Jul 26. doi: 10.1111/bjd.15647.
    PubMed     Text format     Abstract available


  304. DIAS-SANTAGATA D, Selim MA, Su Y, Peng Y, et al
    KIT Mutations and CD117 Overexpression Are Markers of Better Progression-Free Survival in Vulvar Melanomas.
    Br J Dermatol. 2017 Jul 22. doi: 10.1111/bjd.15836.
    PubMed     Text format     Abstract available


  305. ORTEGA LOAYZA AG, Nugent WH, Lucero OM, Washington SL, et al
    Dysregulation of inflammatory gene expression in lesional and non-lesional skin of patients with pyoderma gangrenosum.
    Br J Dermatol. 2017 Jul 22. doi: 10.1111/bjd.15837.
    PubMed     Text format     Abstract available


  306. ALONSO N, Canueto J, Ciria S, Bueno E, et al
    Novel clinical and molecular findings in Spanish patients with Nevoid Basal Cell Carcinoma Syndrome.
    Br J Dermatol. 2017 Jul 22. doi: 10.1111/bjd.15835.
    PubMed     Text format     Abstract available


  307. BUSARD CIM, Nolte JYC, Pasch MC, Spuls PI, et al
    Reporting of outcomes in randomised controlled trials on nail psoriasis; a Systematic Review.
    Br J Dermatol. 2017 Jul 19. doi: 10.1111/bjd.15831.
    PubMed     Text format     Abstract available


  308. PELEVA E, Exton LS, Kelley K, Mason KJ, et al
    Risk of Cancer in Patients with Psoriasis on Biologic Therapies: A Systematic Review.
    Br J Dermatol. 2017 Jul 19. doi: 10.1111/bjd.15830.
    PubMed     Text format     Abstract available


  309. ROPKE M, Bulai Livideanu C, Kaldate R, Snel A, et al
    Changes in IL-17A, macrophage-derived chemokine and adiponectin following treatment of psoriasis with calcipotriol plus betamethasone dipropionate aerosol foam: results from the PSO-ABLE study.
    Br J Dermatol. 2017 Jul 19. doi: 10.1111/bjd.15814.
    PubMed     Text format     Abstract available


  310. TERAMOTO Y, Keim U, Gesierich A, Schuler G, et al
    Acral lentiginous melanoma - a skin cancer with unfavourable prognostic features. A study of the German Central Malignant Melanoma Registry (CMMR) in 2050 patients.
    Br J Dermatol. 2017 Jul 14. doi: 10.1111/bjd.15803.
    PubMed     Text format     Abstract available


  311. STRANZENBACH R, Dippel E, Schlaak M, Stadler R, et al
    Brentuximab vedotin in CD30+ cutaneous lymphoma: How do we treat - How shall we treat? A review of the literature.
    Br J Dermatol. 2017 Jul 13. doi: 10.1111/bjd.15801.
    PubMed     Text format     Abstract available


  312. MENG W, Veluchamy A, Hebert HL, Campbell A, et al
    A genome-wide association study suggested that the mitogen-activated protein kinase 14 gene (MAPK14) is associated with diabetic foot ulcer.
    Br J Dermatol. 2017 Jul 3. doi: 10.1111/bjd.15787.
    PubMed     Text format     Abstract available


  313. GIBBS DC, Ward SV, Orlow I, Cadby G, et al
    Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas.
    Br J Dermatol. 2017 Jul 1. doi: 10.1111/bjd.15784.
    PubMed     Text format     Abstract available


  314. ESSERS BAB, Arits AH, Hendriks MR, Mosterd K, et al
    Patient preferences for the attributes of a non-invasive treatment for superficial Basal cell carcinoma: a discrete choice experiment.
    Br J Dermatol. 2017 Jul 1. doi: 10.1111/bjd.15782.
    PubMed     Text format     Abstract available


  315. PAINSI C, Lange-Asschenfeldt B
    Image Gallery: Pink papules within a tattoo linked to Mycobacterium chelonae infection.
    Br J Dermatol. 2017;177:e1.
    PubMed     Text format    


  316. ISHII N
    Prognostic factors of patients with linear IgA bullous dermatosis.
    Br J Dermatol. 2017;177:16-17.
    PubMed     Text format    


  317. JACOB SE
    Percutaneous absorption risks in atopic dermatitis.
    Br J Dermatol. 2017;177:11-12.
    PubMed     Text format    


  318. PINK AE, Smith CH
    Biologics for psoriasis: more drugs, new patient categories, but fresh challenges for clinical dermatologists.
    Br J Dermatol. 2017;177:7-8.
    PubMed     Text format    


  319. MCCOURT C
    Antimalarials in cutaneous lupus erythematous subtypes.
    Br J Dermatol. 2017;177:14-15.
    PubMed     Text format    


  320. STOFF BK
    A new potential option for topical treatment of basal cell carcinoma?
    Br J Dermatol. 2017;177:12-13.
    PubMed     Text format    


  321. EGEBERG A, Nast A
    A critical eye on registry data in psoriasis.
    Br J Dermatol. 2017;177:245-246.
    PubMed     Text format    


  322. BAGOT M
    Folliculotropic mycosis fungoides is a heterogenous group.
    Br J Dermatol. 2017;177:17-18.
    PubMed     Text format    


  323. HAMMERS CM, Payne AS
    Clinical significance of immunoglobulin E in bullous pemphigoid.
    Br J Dermatol. 2017;177:13-14.
    PubMed     Text format    


  324. DAWE RS, McGuire VA
    Mild classical xeroderma pigmentosum.
    Br J Dermatol. 2017;177:21-22.
    PubMed     Text format    


  325. CALZAVARA-PINTON PG, Caravello S
    A practical approach to the initial dose and subsequent increments for ultraviolet A1 phototherapy.
    Br J Dermatol. 2017;177:19-20.
    PubMed     Text format    


  326. HATTA N
    New technology discloses the tumour margin of extramammary Paget disease?
    Br J Dermatol. 2017;177:18-19.
    PubMed     Text format    


  327. CHONG BF
    Pathogenesis of morphoea: knowledge gaps in subtypes and comparisons to systemic sclerosis.
    Br J Dermatol. 2017;177:9-10.
    PubMed     Text format    


  328. MAHER NG, Guitera P
    Imiquimod treatment for lentigo maligna: LIMIT-1 trial.
    Br J Dermatol. 2017;177:324-325.
    PubMed     Text format    


  329. STRAZZULLA LC, Avila L, Lo Sicco K, Shapiro J, et al
    Response to 'Frontal fibrosing alopecia in men: an association with facial moisturizers and sunscreens'.
    Br J Dermatol. 2017;177:323.
    PubMed     Text format    


    June 2017
  330. SMEDINGA H, Verkouteren JAC, Steyerberg EW, Hofman A, et al
    Occurrence of metachronous basal cell carcinomas: a prognostic model.
    Br J Dermatol. 2017 Jun 30. doi: 10.1111/bjd.15771.
    PubMed     Text format     Abstract available


  331. HOGENDOORN GK, Bruggink SC, de Koning MNC, Eekhof JAH, et al
    Morphological characteristics and HPV genotype predict the treatment response in cutaneous warts.
    Br J Dermatol. 2017 Jun 24. doi: 10.1111/bjd.15758.
    PubMed     Text format     Abstract available


  332. VAN VUGT LJ, van den Reek JMPA, Coenen MJH, de Jong EMGJ, et al
    A systematic review of pharmacogenetic studies on the response to biologics in psoriasis patients.
    Br J Dermatol. 2017 Jun 24. doi: 10.1111/bjd.15753.
    PubMed     Text format     Abstract available


  333. COHEN AD, Wu JJ, Puig L, Chimenti S, et al
    Biosimilars for Psoriasis: Worldwide Overview of Regulatory Guidelines, Uptake and Implications for Dermatology Clinical Practice.
    Br J Dermatol. 2017 Jun 24. doi: 10.1111/bjd.15756.
    PubMed     Text format     Abstract available


  334. RICCERI F, Pescitelli L, Lazzeri L, Prignano F, et al
    Clinical experience with infliximab biosimilar in psoriasis.
    Br J Dermatol. 2017 Jun 24. doi: 10.1111/bjd.15755.
    PubMed     Text format     Abstract available


  335. HJALTE F, Steen Carlsson K, Schmitt-Egenolf M
    Sustained PASI, DLQI and EQ-5D response of biological treatment in psoriasis: 10 years of real-world data in the Swedish National Psoriasis Register.
    Br J Dermatol. 2017 Jun 23. doi: 10.1111/bjd.15757.
    PubMed     Text format     Abstract available


  336. LOWE AJ, Su JC, Allen KJ, Abramson MJ, et al
    A randomised trial of a barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitisation: The PEBBLES Pilot Study.
    Br J Dermatol. 2017 Jun 22. doi: 10.1111/bjd.15747.
    PubMed     Text format     Abstract available


  337. LANGLEY RG, Tsai TF, Flavin S, Song M, et al
    Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: Results of the randomized, double-blind, Phase 3 NAVIGATE trial.
    Br J Dermatol. 2017 Jun 21. doi: 10.1111/bjd.15750.
    PubMed     Text format     Abstract available


  338. SMIT AK, Keogh LA, Newson AJ, Butow PN, et al
    Does personalised melanoma genomic risk information trigger conversations about skin cancer prevention and skin examination with family, friends and health professionals?
    Br J Dermatol. 2017 Jun 19. doi: 10.1111/bjd.15744.
    PubMed     Text format     Abstract available


  339. AGUSTI J, Bella-Navarro R, Garcia-Garcia AB, Bueno E, et al
    Familial seborrhoeic keratosis associated with multiple "pure reticulated acanthomas" and infundibulocystic basal cell carcinomas.
    Br J Dermatol. 2017 Jun 18. doi: 10.1111/bjd.15736.
    PubMed     Text format     Abstract available


  340. ADLER NR, Graudins LV, Aung AK
    The importance of risk communication and documentation for patients with cutaneous adverse drug reactions.
    Br J Dermatol. 2017 Jun 18. doi: 10.1111/bjd.15737.
    PubMed     Text format     Abstract available


  341. OLTEANU C, Dodiuk-Gad R, Hashimoto R, Shear N, et al
    Letter to the Editor concerning the article "Long term complications of Stevens-Johnson syndrome/Toxic epidermal necrolysis: The spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multi-disciplinary follow up.
    Br J Dermatol. 2017 Jun 18. doi: 10.1111/bjd.15734.
    PubMed     Text format     Abstract available


  342. DRUCKER AM, Qureshi AA, Dummer TJB, Parker L, et al
    Atopic dermatitis and risk of hypertension, type-2 diabetes, myocardial infarction and stroke in a cross-sectional analysis from the Canadian Partnership for Tomorrow Project.
    Br J Dermatol. 2017 Jun 15. doi: 10.1111/bjd.15727.
    PubMed     Text format     Abstract available


  343. ALWAN W, Lynch M, McFadden J, White IR, et al
    Patch testing in psoriasis patients: results of a 30-year retrospective study.
    Br J Dermatol. 2017 Jun 15. doi: 10.1111/bjd.15730.
    PubMed     Text format     Abstract available


  344. KIM SK, Barker CA
    Outcomes of radiation therapy for advanced T3/T4 non-melanoma cutaneous squamous cell and basal cell carcinoma.
    Br J Dermatol. 2017 Jun 15. doi: 10.1111/bjd.15728.
    PubMed     Text format     Abstract available


  345. BLAUVELT A, Ferris LK, Yamauchi PS, Qureshi A, et al
    Extension of ustekinumab maintenance dosing interval in moderate-to-severe psoriasis: results of a Phase 3b, randomized, double-blinded, active-controlled, multicenter study (PSTELLAR).
    Br J Dermatol. 2017 Jun 10. doi: 10.1111/bjd.15722.
    PubMed     Text format     Abstract available


  346. PAPP KA, Bachelez H, Blauvelt A, Winthrop KL, et al
    Infections from 7 Clinical Trials of Ixekizumab, an Anti-Interleukin-17A Monoclonal Antibody, in Patients with Moderate-to-Severe Psoriasis.
    Br J Dermatol. 2017 Jun 10. doi: 10.1111/bjd.15723.
    PubMed     Text format     Abstract available


  347. EGU DT, Walter E, Spindler V, Waschke J, et al
    Inhibition of p38MAPK signaling prevents epidermal blistering and alterations of desmosome structure induced by pemphigus autoantibodies in human epidermis.
    Br J Dermatol. 2017 Jun 10. doi: 10.1111/bjd.15721.
    PubMed     Text format     Abstract available


  348. LEE WJ, Kim YJ, Lee YJ, Won CH, et al
    VEGF protein expression is associated with a poor prognosis in cutaneous extranodal NK/T-cell lymphoma patients.
    Br J Dermatol. 2017 Jun 9. doi: 10.1111/bjd.15720.
    PubMed     Text format     Abstract available


  349. HOFFMANN JHO, Knoop C, Enk AH, Hadaschik EN, et al
    Long persistence of TNF-alpha antagonist induced autoantibodies under subsequent treatment with Ustekinumab but no adverse effects: a case study of 14 psoriasis patients.
    Br J Dermatol. 2017 Jun 5. doi: 10.1111/bjd.15701.
    PubMed     Text format     Abstract available


  350. BONNEKOH H, Scheffel J, Maurer M, Krause K, et al
    The use of skin biomarker profiles to distinguish Schnitzler's syndrome from chronic spontaneous urticaria: results of a pilot study.
    Br J Dermatol. 2017 Jun 5. doi: 10.1111/bjd.15705.
    PubMed     Text format     Abstract available


  351. STICHERLING M, Mrowietz U, Augustin M, Thaci D, et al
    Secukinumab is Superior to Fumaric Acid Esters in Treating Subjects with Moderate to Severe Plaque Psoriasis who are Naive to Systemic Treatments: Results from the Randomized Controlled PRIME Trial.
    Br J Dermatol. 2017 Jun 5. doi: 10.1111/bjd.15707.
    PubMed     Text format     Abstract available


  352. DI FUSCO D, Laudisi F, Dinallo V, Monteleone I, et al
    Smad7 positively regulates keratinocyte proliferation in psoriasis.
    Br J Dermatol. 2017 Jun 5. doi: 10.1111/bjd.15703.
    PubMed     Text format     Abstract available


  353. BISSONNETTE R, Luger T, Thaci D, Toth D, et al
    Secukinumab Sustains Good Efficacy and Favourable Safety in Moderate to Severe Psoriasis up to 3 Years of Treatment: Results from A Double-Blind Extension Study.
    Br J Dermatol. 2017 Jun 5. doi: 10.1111/bjd.15706.
    PubMed     Text format     Abstract available


  354. KIESELOVA K, Santiago F, Henrique M, Cunha F, et al
    Image Gallery: Cutaneous lesions in the external auditory canal causing hearing loss.
    Br J Dermatol. 2017;176:e119.
    PubMed     Text format    


  355. BALATO A, Caiazzo G
    Mesenchymal stem cells participate to inflammatory skin process of atopic dermatitis.
    Br J Dermatol. 2017;176:1437-1438.
    PubMed     Text format    


  356. DRUCKER AM
    Treating moderate-to-severe atopic dermatitis: what do dermatologists do with limited evidence?
    Br J Dermatol. 2017;176:1441-1442.
    PubMed     Text format    


  357. PAMPALAKIS G, Sotiropoulou G
    Insights into the regulation of proteolytic pathways in skin differentiation.
    Br J Dermatol. 2017;176:1433-1434.
    PubMed     Text format    


  358. CERIO R, Moir G
    Palliative electrochemotherapy treatment of metastatic malignant melanoma.
    Br J Dermatol. 2017;176:1427.
    PubMed     Text format    


  359. JONES G
    Methotrexate increases the risk of melanoma: or does it?
    Br J Dermatol. 2017;176:1429-1430.
    PubMed     Text format    


  360. TRAUPE H
    Psoriasis and the interleukin-10 family: evidence for a protective genetic effect, but not an easy target as a drug.
    Br J Dermatol. 2017;176:1438-1439.
    PubMed     Text format    


  361. AGNER T
    Biomarkers in contact dermatitis.
    Br J Dermatol. 2017;176:1434-1435.
    PubMed     Text format    


  362. MOSCARELLA E, Ametrano O, Diplomatico M, De Chiara C, et al
    Image Gallery: Kaposiform haemangioendothelioma.
    Br J Dermatol. 2017;176:e124.
    PubMed     Text format    


  363. ITO T
    Immune checkpoint inhibitor-associated alopecia areata.
    Br J Dermatol. 2017;176:1444-1445.
    PubMed     Text format    


  364. MURPHY M, Carmichael AJ
    Development of a multidimensional assessment tool for uraemic pruritus in dialysis patients - laying a foundation stone for itch research.
    Br J Dermatol. 2017;176:1432-1433.
    PubMed     Text format    


  365. BECATTI M
    Oxidative stress and high-mobility group box 1 (HMGB1) protein release in vitiligo.
    Br J Dermatol. 2017;176:1436-1437.
    PubMed     Text format    


  366. PATSATSI A, Murrell DF
    Multiple sclerosis is the neurological disorder most highly associated with bullous pemphigoid.
    Br J Dermatol. 2017;176:1428-1429.
    PubMed     Text format    


  367. LEGAT FJ, Wolf P
    Daylight photodynamic therapy: where and when is it possible?
    Br J Dermatol. 2017;176:1440-1441.
    PubMed     Text format    


  368. BOWER C
    Field treatment of actinic keratosis on the scalp.
    Br J Dermatol. 2017;176:1425-1426.
    PubMed     Text format    


  369. BASU TN
    Neutrophilic eccrine hidradenitis can be induced by BRAF inhibitors.
    Br J Dermatol. 2017;176:1443-1444.
    PubMed     Text format    


  370. TWO AM
    Minocycline as an alternative to doxycycline in the treatment of rosacea.
    Br J Dermatol. 2017;176:1426.
    PubMed     Text format    


  371. MCGRATH JA
    A new clinical diagnostic matrix for epidermolysis bullosa.
    Br J Dermatol. 2017;176:1442-1443.
    PubMed     Text format    


    May 2017
  372. CONDORELLI AG, Fortugno P, Cianfarani F, Proto V, et al
    Lack of K140 immunoreactivity in junctional epidermolysis bullosa skin and keratinocytes associates with misfolded laminin EGF-like (LE) motif 2 of the beta3 short arm.
    Br J Dermatol. 2017 May 31. doi: 10.1111/bjd.15690.
    PubMed     Text format     Abstract available


  373. GONZALEZ N, Patel P, Han G
    A Dissimilar Biosimilar?: Lichenoid Drug Eruption Induced by an Infliximab Biosimilar.
    Br J Dermatol. 2017 May 30. doi: 10.1111/bjd.15686.
    PubMed     Text format     Abstract available


  374. GRIFFITHS CEM, van der Walt JM, Ashcroft DM, Flohr C, et al
    The global state of psoriasis disease epidemiology: a workshop report.
    Br J Dermatol. 2017 May 28. doi: 10.1111/bjd.15610.
    PubMed     Text format     Abstract available


  375. RIBERO S, Carrera C, Tell-Marti G, Pastorino C, et al
    Amelanotic melanoma in oculocutaneous albinism: a genetic, dermoscopic and reflectance confocal microscopy study.
    Br J Dermatol. 2017 May 27. doi: 10.1111/bjd.15687.
    PubMed     Text format     Abstract available


  376. EGEBERG A, Griffiths CEM, Mallbris L, Gislason GH, et al
    The association between psoriasis and coeliac disease.
    Br J Dermatol. 2017 May 27. doi: 10.1111/bjd.15684.
    PubMed     Text format     Abstract available


  377. DOU J, Zhang L, Xie X, Ye L, et al
    Integrative analyses reveal biological pathways and key genes in psoriasis.
    Br J Dermatol. 2017 May 25. doi: 10.1111/bjd.15682.
    PubMed     Text format     Abstract available


  378. REICH K, Pinter A, Lacour JP, Ferrandiz C, et al
    Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a Phase 3 study.
    Br J Dermatol. 2017 May 19. doi: 10.1111/bjd.15666.
    PubMed     Text format     Abstract available


  379. SMITH CH, Jabbar-Lopez ZK, Yiu ZZ, Bale T, et al
    British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017.
    Br J Dermatol. 2017 May 17. doi: 10.1111/bjd.15665.
    PubMed     Text format     Abstract available


  380. RODRIGUEZ-JIMENEZ P, Chicharro P, Godoy A, Llamas-Velasco M, et al
    No evidence for induction of autoantibodies or autoimmunity during treatment of psoriasis with ustekinumab.
    Br J Dermatol. 2017 May 16. doi: 10.1111/bjd.15654.
    PubMed     Text format     Abstract available


  381. CASSIUS C, Moguelet P, Monfort JB, Fessi H, et al
    Calciphylaxis in hemodialysed patients: Diagnostic value of calcifications in cutaneous biopsy.
    Br J Dermatol. 2017 May 12. doi: 10.1111/bjd.15655.
    PubMed     Text format     Abstract available


  382. GISONDI P, Bianchi L, Conti A, Dapavo P, et al
    Infliximab biosimilar CT-P13 in the treatment of chronic plaque psoriasis. Data from the Psobiosimilars registry.
    Br J Dermatol. 2017 May 12. doi: 10.1111/bjd.15659.
    PubMed     Text format     Abstract available


  383. BLAUVELT A, Reich K, Warren RB, Szepietowski JC, et al
    Secukinumab re-initiation achieves regain of high response levels in patients who interrupt treatment for moderate to severe plaque psoriasis.
    Br J Dermatol. 2017 May 12. doi: 10.1111/bjd.15656.
    PubMed     Text format     Abstract available


  384. IP SCI, Cottle DL, Jones LK, Weir JM, et al
    BJD Research Letter: A profile of lipid dysregulation in Harlequin Ichthyosis.
    Br J Dermatol. 2017 May 10. doi: 10.1111/bjd.15642.
    PubMed     Text format     Abstract available


  385. CHOPRA R, Vakharia PP, Sacotte R, Patel N, et al
    Severity strata for EASI, mEASI, oSCORAD, SCORAD, ADSI and BSA in adolescents and adults with atopic dermatitis.
    Br J Dermatol. 2017 May 9. doi: 10.1111/bjd.15641.
    PubMed     Text format     Abstract available


  386. TAPIA JC, Chavez K, Malaga G, Bravo F, et al
    Treatment satisfaction and need for shared decision-making in patients with psoriasis from Peru.
    Br J Dermatol. 2017 May 9. doi: 10.1111/bjd.15639.
    PubMed     Text format     Abstract available


  387. TASANI M, Ancliff P, Glover M
    Sirolimus therapy for children with problematic Kaposiform haemangioendothelioma and tufted angioma.
    Br J Dermatol. 2017 May 9. doi: 10.1111/bjd.15640.
    PubMed     Text format     Abstract available


  388. KOLIOS AGA, Biedermann L, Weber A, Navarini AA, et al
    Paradoxical ulcerative colitis during Adalimumab treatment of psoriasis resolved by switch to Ustekinumab.
    Br J Dermatol. 2017 May 6. doi: 10.1111/bjd.15631.
    PubMed     Text format     Abstract available


  389. BAUVIN O, L Schmutz J, Busato T, Cribier B, et al
    A foot tumor as late cutaneous Lyme borreliosis: a new entity?
    Br J Dermatol. 2017 May 6. doi: 10.1111/bjd.15633.
    PubMed     Text format     Abstract available


  390. SIMONSEN AB, Johansen JD, Deleuran M, Mortz CG, et al
    Contact allergy in children with atopic dermatitis: a systematic review.
    Br J Dermatol. 2017 May 3. doi: 10.1111/bjd.15628.
    PubMed     Text format     Abstract available


  391. YANG CW, Tsai TF
    Image Gallery: Resolution of lichen striatus in a patient with coexisting chronic plaque psoriasis and vitiligo during secukinumab treatment.
    Br J Dermatol. 2017;176:e96.
    PubMed     Text format    


  392. GRIEWANK KG
    Epidermal growth factor receptor gaining impact in cutaneous squamous cell carcinoma.
    Br J Dermatol. 2017;176:1126-1127.
    PubMed     Text format    


  393. MAGIN P
    Aggression and its associations in patients with skin disease.
    Br J Dermatol. 2017;176:1118-1119.
    PubMed     Text format    


  394. KAUR P
    Hair-follicle dermal papilla and sheath fibroblasts provide a supportive microenvironment for human skin regeneration.
    Br J Dermatol. 2017;176:1123-1124.
    PubMed     Text format    


  395. PUIG L, Putrik P
    Psoriasis: inequality or individualized care?
    Br J Dermatol. 2017;176:1111-1113.
    PubMed     Text format    


  396. ZHUANG K, Tang J, Ran Y
    Image Gallery: Acute primary cutaneous nocardiosis due to Nocardia brasiliensis.
    Br J Dermatol. 2017;176:e97.
    PubMed     Text format    


  397. JIMENEZ F
    Incorporating hair follicle cells in artificial skin.
    Br J Dermatol. 2017;176:1124-1125.
    PubMed     Text format    


  398. APFELBACHER CJ, Ofenloch RF
    The impact of skin conditions on generic health-related quality of life.
    Br J Dermatol. 2017;176:1109-1110.
    PubMed     Text format    


  399. RYAN C
    Identification of pharmacogenetic markers of treatment response to biologic therapies in psoriasis - is there a benefit?
    Br J Dermatol. 2017;176:1127-1128.
    PubMed     Text format    


  400. SWETTER SM
    Challenges of treating melanoma in situ, lentigo maligna type: is pathological clearance the gold standard?
    Br J Dermatol. 2017;176:1115-1116.
    PubMed     Text format    


  401. ELLIS RA
    T-type calcium channels as potential biomarkers in melanoma.
    Br J Dermatol. 2017;176:1122.
    PubMed     Text format    


  402. WANG L, Long H, Wen H, Liu Z, et al
    Image Gallery: Generalized mucosal and cutaneous papillomatosis, a unique sign of malignant acanthosis nigricans.
    Br J Dermatol. 2017;176:e99.
    PubMed     Text format    


  403. KRENGEL S, Reyes-Mugica M
    Melanoma risk in congenital melanocytic naevi.
    Br J Dermatol. 2017;176:1114.
    PubMed     Text format    


  404. RAMOT Y
    Psoriasis and osteoporosis: the debate continues.
    Br J Dermatol. 2017;176:1117-1118.
    PubMed     Text format    


  405. FARRAR MD
    Topical photodynamic therapy: the preferred choice for cutaneous field-cancerization?
    Br J Dermatol. 2017;176:1116-1117.
    PubMed     Text format    


  406. SCARISBRICK JJ
    Prognostic factors in mycosis fungoides: international advances in the validation of prognostic indices.
    Br J Dermatol. 2017;176:1129-1130.
    PubMed     Text format    


  407. BRAATHEN LR
    Long methylaminolaevulinate application does not increase clinical efficacy of photodynamic therapy in actinic keratosis, but leads to collateral damage.
    Br J Dermatol. 2017;176:1121-1122.
    PubMed     Text format    


  408. TAMURA D, Khan SG, DiGiovanna JJ
    Molecular diagnosis of xeroderma pigmentosum variant in an isolated population: the interface between precision medicine and public health.
    Br J Dermatol. 2017;176:1125-1126.
    PubMed     Text format    


  409. APFELBACHER CJ
    Research questions for the treatment of alopecia areata have been prioritized.
    Br J Dermatol. 2017;176:1128-1129.
    PubMed     Text format    


  410. CUST AE
    Estimating the future health service burden of keratinocyte cancers in the U.K.
    Br J Dermatol. 2017;176:1107-1108.
    PubMed     Text format    


  411. HASHIMOTO T, Mizoguchi A
    Interleukin-10-producing B-cells in autoimmune bullous diseases.
    Br J Dermatol. 2017;176:1119-1120.
    PubMed     Text format    


  412. LEIJTEN EFA, Sigurdsson V, Wenink MH, Radstake TRDJ, et al
    Screening for psoriatic arthritis using the Psoriasis Epidemiology Screening Tool questionnaire: examining the optimal cut-off.
    Br J Dermatol. 2017;176:1357-1359.
    PubMed     Text format    


    April 2017
  413. DIXON A, Steinman H, Anderson S, Nirenberg A, et al
    Routine usage of sentinel node biopsy in melanoma management must cease: reply from authors.
    Br J Dermatol. 2017 Apr 29. doi: 10.1111/bjd.15626.
    PubMed     Text format     Abstract available


  414. AMIN M, No DJ, Wu JJ
    Reply to 'Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials'.
    Br J Dermatol. 2017 Apr 29. doi: 10.1111/bjd.15620.
    PubMed     Text format     Abstract available


  415. WEI L, Allain DC, Bernhardt MN, Gillespie JL, et al
    Variants at the OCA2/HERC2 locus affect time to first cutaneous squamous cell carcinoma in solid organ transplant recipients collected using two different study designs.
    Br J Dermatol. 2017 Apr 29. doi: 10.1111/bjd.15618.
    PubMed     Text format     Abstract available


  416. SALEH DB
    RE: Routine usage of sentinel node biopsy in melanoma management must cease.
    Br J Dermatol. 2017 Apr 29. doi: 10.1111/bjd.15619.
    PubMed     Text format     Abstract available


  417. POLAT A, Dinulescu M, Fraitag S, Nimubona S, et al
    Skin manifestations among GATA2-deficient patients.
    Br J Dermatol. 2017 Apr 25. doi: 10.1111/bjd.15548.
    PubMed     Text format     Abstract available


  418. ASGARI MM, Shen L, Sokil MM, Yeh I, et al
    Prognostics factors and survival in acral lentiginous melanoma.
    Br J Dermatol. 2017 Apr 22. doi: 10.1111/bjd.15600.
    PubMed     Text format     Abstract available


  419. TIAO J, Feng R, Berger EM, Brandsema JF, et al
    Evaluation of the Reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) and the Cutaneous Assessment Tool Binary Method (CAT-BM) in Juvenile Dermatomyositis Among Pediatric Dermatologists, Rheumatologists, and Neurologis
    Br J Dermatol. 2017 Apr 19. doi: 10.1111/bjd.15596.
    PubMed     Text format     Abstract available


  420. SANLORENZO M, Vujic I, De Giorgi V, Tomasini C, et al
    Fluorescence-Advanced-Videodermatoscopy (FAV): a new method for in-vivo skin evaluation.
    Br J Dermatol. 2017 Apr 19. doi: 10.1111/bjd.15594.
    PubMed     Text format     Abstract available


  421. ROCHA L, Menzies SW, Lo S, Avramidis M, et al
    Analysis of an electrical impedance spectroscopy system in short-term digital dermoscopy imaging of melanocytic lesions.
    Br J Dermatol. 2017 Apr 19. doi: 10.1111/bjd.15595.
    PubMed     Text format     Abstract available


  422. CHEOK S, Yee F, Ma JYS, Leow R, et al
    Prevalence and Descriptive Epidemiology of Atopic Dermatitis and Its Impact on Quality of Life in Singapore.
    Br J Dermatol. 2017 Apr 17. doi: 10.1111/bjd.15587.
    PubMed     Text format     Abstract available


  423. CHEN S, Kong X, Wei X, Sun Y, et al
    Targeted next-generation sequencing identifies 9 novel FLG variants in Chinese Han patients with ichthyosis vulgaris.
    Br J Dermatol. 2017 Apr 13. doi: 10.1111/bjd.15588.
    PubMed     Text format     Abstract available


  424. STAROKADOMSKYY P, Sifuentes-Dominguez L, Gemelli T, Zinn AR, et al
    Evolution of the skin manifestations of X-linked Pigmentary Reticulate Disorder.
    Br J Dermatol. 2017 Apr 13. doi: 10.1111/bjd.15586.
    PubMed     Text format     Abstract available


  425. ARASE N, Tanimura K, Jin H, Yamaoka T, et al
    Novel autoantibody against the beta2-glycoprotein I/HLA-DR complex in patients with refractory cutaneous ulcers.
    Br J Dermatol. 2017 Apr 12. doi: 10.1111/bjd.15571.
    PubMed     Text format     Abstract available


  426. BOYDEN LM, Craiglow BG, Hu RH, Zhou J, et al
    Phenotypic Spectrum of Autosomal Recessive Congenital Ichthyosis Due to PNPLA1 Mutation.
    Br J Dermatol. 2017 Apr 12. doi: 10.1111/bjd.15570.
    PubMed     Text format     Abstract available


  427. NELSON PA, Kane K, Pearce CJ, Bundy C, et al
    'New to me' - changing patient understanding of psoriasis and identifying mechanisms of change: The Pso Well(R) patient materials mixed methods feasibility study.
    Br J Dermatol. 2017 Apr 12. doi: 10.1111/bjd.15574.
    PubMed     Text format     Abstract available


  428. HUANG C, Liu L, You Z, Zhao Y, et al
    Endothelial Dysfunction and Mechanobiology in Pathological Cutaneous Scarring: Lessons Learned from Soft Tissue Fibrosis.
    Br J Dermatol. 2017 Apr 12. doi: 10.1111/bjd.15576.
    PubMed     Text format     Abstract available


  429. KADOUCH DJ, Elshot YS, Zupan-Kajcovski B, van Haersma de With AS, et al
    One-stop-shop with confocal microscopy imaging versus standard care for surgical treatment of basal cell carcinoma: an open label, non-inferiority, randomized controlled multicenter trial.
    Br J Dermatol. 2017 Apr 9. doi: 10.1111/bjd.15559.
    PubMed     Text format     Abstract available


  430. GUALANO MR, Osella-Abate S, Scaioli G, Marra E, et al
    Prognostic role of Histologic regression in primary cutaneous melanoma: A Systematic Review and Meta-analysis.
    Br J Dermatol. 2017 Apr 7. doi: 10.1111/bjd.15552.
    PubMed     Text format     Abstract available


  431. DAVISON NJ, Warren RB, Mason KJ, McElhone K, et al
    Identification of factors that may influence the selection of first-line biologic therapy for people with psoriasis: a prospective, multi-centre cohort study.
    Br J Dermatol. 2017 Apr 7. doi: 10.1111/bjd.15551.
    PubMed     Text format     Abstract available


  432. JACQUEMIN C, Rambert J, Guillet S, Thiolat D, et al
    HSP70 potentiates interferon-alpha production by plasmacytoid dendritic cells: relevance for cutaneous lupus and vitiligo pathogenesis.
    Br J Dermatol. 2017 Apr 5. doi: 10.1111/bjd.15550.
    PubMed     Text format     Abstract available


  433. BROOKS J, Ersser SJ, Cowdell F, Gardiner E, et al
    A Randomised Controlled Trial to evaluate the effect of a new skin care regimen on skin barrier function in those with podoconiosis in Ethiopia.
    Br J Dermatol. 2017 Apr 4. doi: 10.1111/bjd.15543.
    PubMed     Text format     Abstract available


  434. KEMPF W
    Cutaneous lymphomas in childhood and adolescence: much needed new data.
    Br J Dermatol. 2017;176:857-858.
    PubMed     Text format    


  435. HUNTER HJA
    Can positron emission tomography (PET) unravel the link between adipose tissue, vascular inflammation and cardiovascular risk in patients with psoriasis?
    Br J Dermatol. 2017;176:864-865.
    PubMed     Text format    


  436. CHANSKY PB, Mittal L, Werth VP
    Dermatological evaluation in patients with skin of colour: the effect of erythema on outcome measures in atopic dermatitis.
    Br J Dermatol. 2017;176:853-854.
    PubMed     Text format    


  437. NALDI L
    Finding a HOME for outcome measures in atopic dermatitis.
    Br J Dermatol. 2017;176:852-853.
    PubMed     Text format    


  438. ORMEROD AD
    Five-year efficacy of biologics for psoriasis in the real world of daily practice.
    Br J Dermatol. 2017;176:856-857.
    PubMed     Text format    


  439. BERTOLINI M, Rossi A, Paus R
    Cover Image: Are melanocyte-associated peptides the elusive autoantigens in alopecia areata?
    Br J Dermatol. 2017;176:1106.
    PubMed     Text format    


  440. NIJSTEN T, Wakkee M
    The four Ws of skin cancer surveillance in patients with melanoma: Why? Who? When? Where?
    Br J Dermatol. 2017;176:839-841.
    PubMed     Text format    


  441. HAUSSER I
    Ichthyoses: new insights unravel defects in skin barrier function resulting in diverse clinical and morphological phenotypes.
    Br J Dermatol. 2017;176:863-864.
    PubMed     Text format    


  442. WATTS CG
    The challenge of skin surveillance: observe or biopsy?
    Br J Dermatol. 2017;176:851-852.
    PubMed     Text format    


  443. THOMPSON AR, Bewley AP
    Meeting the psychological needs of dermatology patients.
    Br J Dermatol. 2017;176:858-859.
    PubMed     Text format    


  444. OFENLOCH RF
    Health-related quality of life in hidradenitis suppurativa.
    Br J Dermatol. 2017;176:861-862.
    PubMed     Text format    


  445. AGNER T, Nixon R
    Hand eczema is to be taken seriously ....
    Br J Dermatol. 2017;176:854-855.
    PubMed     Text format    


  446. BROWN SJ
    Evidence-based medicine for atopic eczema: identifying the knowns and unknowns.
    Br J Dermatol. 2017;176:842-844.
    PubMed     Text format    


  447. SCHREML S, Berneburg M
    The global burden of diabetic wounds.
    Br J Dermatol. 2017;176:845-846.
    PubMed     Text format    


  448. IBBOTSON SH
    Shedding light on drug photosensitivity reactions.
    Br J Dermatol. 2017;176:850-851.
    PubMed     Text format    


  449. CHU CY
    Measuring quality of life in infants, children and adolescents with eczema.
    Br J Dermatol. 2017;176:848-849.
    PubMed     Text format    


  450. HAMPTON P, Meggitt S
    Better definition of hidradenitis suppurativa subtypes is needed to progress disease-specific treatment outcomes.
    Br J Dermatol. 2017;176:862-863.
    PubMed     Text format    


  451. STOODLEY P
    Evidence for a biofilm-based treatment strategy in the management of chronic hidradenitis suppurativa.
    Br J Dermatol. 2017;176:855-856.
    PubMed     Text format    


  452. WHITE IR
    Quantitative risk assessment and the burden of fragrance contact allergy.
    Br J Dermatol. 2017;176:860-861.
    PubMed     Text format    


    March 2017
  453. KARIM N, Murtaza G, Naeem M
    Whole Exome Sequencing Identified a Novel Frameshift Mutation in SDR9C7 underlying Autosomal Recessive Congenital Ichthyosis in a Pakistani Family.
    Br J Dermatol. 2017 Mar 31. doi: 10.1111/bjd.15535.
    PubMed     Text format     Abstract available


  454. DLOVA NC, Chateau A, Khoza N, Skenjane A, et al
    Prevalence of skin diseases treated at public referral hospitals in KwaZulu-Natal, South Africa.
    Br J Dermatol. 2017 Mar 31. doi: 10.1111/bjd.15534.
    PubMed     Text format     Abstract available


  455. DYRING-ANDERSEN B, Velte Honore T, Madelung A, Bzorek M, et al
    IL-17A and IL-22 producing neutrophils in psoriatic skin.
    Br J Dermatol. 2017 Mar 31. doi: 10.1111/bjd.15533.
    PubMed     Text format     Abstract available


  456. KOIKE Y, Okubo M, Kiyohara T, Fukuchi R, et al
    Granulocyte and monocyte apheresis can control juvenile generalised pustular psoriasis with mutation of the IL36RN gene.
    Br J Dermatol. 2017 Mar 30. doi: 10.1111/bjd.15509.
    PubMed     Text format     Abstract available


  457. DE RISI-PUGLIESE T, Servy A, Decousser JW, Nebbad B, et al
    Skin biopsy PCR for rapid microbiological diagnosis in patients with purpura fulminans.
    Br J Dermatol. 2017 Mar 30. doi: 10.1111/bjd.15503.
    PubMed     Text format     Abstract available


  458. CHANG J, Tran DC, Zhu GA, Li R, et al
    Initial in vitro functional characterization of serum exosomal microRNAs from patients with metastatic basal cell carcinoma.
    Br J Dermatol. 2017 Mar 30. doi: 10.1111/bjd.15508.
    PubMed     Text format     Abstract available


  459. LOTT JP, Wang Q, Titus LJ, Onega T, et al
    Temporal Trends in Healthcare Utilization following Primary Melanoma Diagnosis among Medicare Beneficiaries.
    Br J Dermatol. 2017 Mar 30. doi: 10.1111/bjd.15530.
    PubMed     Text format     Abstract available


  460. POLUBOTHU S, Scott RH, Vabres P, Kinsler VA, et al
    Atypical dermal melanocytosis: diagnostic clue in constitutional mismatch repair deficiency syndrome.
    Br J Dermatol. 2017 Mar 30. doi: 10.1111/bjd.15532.
    PubMed     Text format     Abstract available


  461. OVEJERO-BENITO MC, Cabaleiro T, Sanz-Garcia A, Llamas-Velasco M, et al
    Epigenetic biomarkers associated with anti-TNF drugs response in moderate-to- severe psoriasis.
    Br J Dermatol. 2017 Mar 30. doi: 10.1111/bjd.15504.
    PubMed     Text format     Abstract available


  462. KARIMKHANI C, Green AC, Nijsten T, Weinstock MA, et al
    The Global Burden of Melanoma: Results from Global Burden of Disease Study 2015.
    Br J Dermatol. 2017 Mar 30. doi: 10.1111/bjd.15510.
    PubMed     Text format     Abstract available


  463. ISKANDAR IY, Ashcroft DM, Warren RB, Lunt M, et al
    Comparative effectiveness of biologic therapies on improvements in quality of life in patients with psoriasis.
    Br J Dermatol. 2017 Mar 30. doi: 10.1111/bjd.15531.
    PubMed     Text format     Abstract available


  464. KOGUCHI-YOSHIOKA H, Okiyama N, Iwamoto K, Matsumura Y, et al
    Intravenous immunoglobulin contributes to control anti-melanoma differentiation-associated protein 5 (MDA5) antibody-associated dermatomyositis with palmar violaceous macules/papules.
    Br J Dermatol. 2017 Mar 27. doi: 10.1111/bjd.15499.
    PubMed     Text format     Abstract available


  465. AL-JEFRI K, Newbury-Birch D, Muirhead CR, Gilvarry E, et al
    High prevalence of alcohol use disorders in patients with inflammatory skin diseases.
    Br J Dermatol. 2017 Mar 27. doi: 10.1111/bjd.15497.
    PubMed     Text format     Abstract available


  466. SAEKI H, Kabashima K, Tokura Y, Murata Y, et al
    Efficacy and Safety of Ustekinumab in Japanese Patients with Severe Atopic Dermatitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Study.
    Br J Dermatol. 2017 Mar 24. doi: 10.1111/bjd.15493.
    PubMed     Text format     Abstract available


  467. ANDOH T, Shimizu T
    Increase in sensory sensitivity around, but not in the central part of, the hyperkeratotic papule in lichen amyloidosis.
    Br J Dermatol. 2017 Mar 23. doi: 10.1111/bjd.15488.
    PubMed     Text format     Abstract available


  468. ANDERSEN YM, Egeberg A, Gislason GH, Skov L, et al
    Burden of respiratory comorbidities in patients with atopic dermatitis and psoriasis.
    Br J Dermatol. 2017 Mar 23. doi: 10.1111/bjd.15489.
    PubMed     Text format     Abstract available


  469. HENRY AL, Kyle SD, Chisholm A, Griffiths CE, et al
    A cross-sectional survey of the nature and correlates of sleep disturbance in people with psoriasis.
    Br J Dermatol. 2017 Mar 17. doi: 10.1111/bjd.15469.
    PubMed     Text format     Abstract available


  470. CHAN BC, Stefanato CM, Moonim MT, Morris SL, et al
    Diffuse large B-Cell lymphoma developing in erythrodermic cutaneous T-cell lymphoma: a case series.
    Br J Dermatol. 2017 Mar 16. doi: 10.1111/bjd.15460.
    PubMed     Text format     Abstract available


  471. TEO Y, Walsh S, Creamer D
    Cutaneous Adverse Drug Reactions Referrals to a Liaison Dermatology Service.
    Br J Dermatol. 2017 Mar 16. doi: 10.1111/bjd.15461.
    PubMed     Text format     Abstract available


  472. BLAUVELT A, Griffiths CE, Lebwohl M, Mrowietz U, et al
    Reaching complete or near complete resolution of psoriasis: benefit and risk considerations.
    Br J Dermatol. 2017 Mar 16. doi: 10.1111/bjd.15463.
    PubMed     Text format     Abstract available


  473. INZELBERG R, Friedman E, Azizi E
    Cutaneous squamous cell carcinoma and the PARK2 gene.
    Br J Dermatol. 2017 Mar 16. doi: 10.1111/bjd.15465.
    PubMed     Text format     Abstract available


  474. REICH K, Zschocke I, Bachelez H, de Jong EM, et al
    A Topical Treatment Optimisation Programme (TTOP) improves clinical outcome to calcipotriol/betamethasone gel in psoriasis: Results of the 64-week, multinational, randomized, phase IV study in 1790 patients (PSO-TOP).
    Br J Dermatol. 2017 Mar 16. doi: 10.1111/bjd.15466.
    PubMed     Text format     Abstract available


  475. ATWAN A, Piguet V, Finlay AY, Francis NA, et al
    Dermatology Life Quality Index (DLQI) as a psoriasis referral triage tool.
    Br J Dermatol. 2017 Mar 10. doi: 10.1111/bjd.15446.
    PubMed     Text format     Abstract available


  476. LICCIARDELLO M, T Giura M, Rozzo G, Marra E, et al
    Arrhythmias in metastatic melanoma patient treated with targeted therapy and ICD implant.
    Br J Dermatol. 2017 Mar 10. doi: 10.1111/bjd.15447.
    PubMed     Text format     Abstract available


  477. NABIL R, Bergman W, Kukutsch NA
    Poor agreement between a mobile phone application for the analysis of skin lesions and the clinical diagnosis of the dermatologist, a pilot study.
    Br J Dermatol. 2017 Mar 10. doi: 10.1111/bjd.15443.
    PubMed     Text format     Abstract available


  478. TAKEICHI T, Kobayashi A, Ogawa E, Okuno Y, et al
    Autosomal dominant familial generalized pustular psoriasis caused by a CARD14 mutation.
    Br J Dermatol. 2017 Mar 10. doi: 10.1111/bjd.15442.
    PubMed     Text format     Abstract available


  479. RICHTIG G, Hoeller C, Kashofer K, Aigelsreiter A, et al
    Beyond the BRAFV600E hotspot - Biology and clinical implications of rare BRAF gene mutations in melanoma patients.
    Br J Dermatol. 2017 Mar 9. doi: 10.1111/bjd.15436.
    PubMed     Text format     Abstract available


  480. WOLK K, Wenzel J, Tsaousi A, Witte-Handel E, et al
    Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa / hidradenitis suppurativa.
    Br J Dermatol. 2017 Mar 3. doi: 10.1111/bjd.15424.
    PubMed     Text format     Abstract available


  481. ADLER NR, Aung AK, Ergen EN, Trubiano J, et al
    Recent advances in the understanding of severe cutaneous adverse reactions.
    Br J Dermatol. 2017 Mar 3. doi: 10.1111/bjd.15423.
    PubMed     Text format     Abstract available


  482. REICH A
    Interleukin-17 blockade in generalized pustular psoriasis - new hope for severely ill patients.
    Br J Dermatol. 2017;176:572-573.
    PubMed     Text format    


  483. GRIFFITHS CE
    Systems medicine and psoriasis.
    Br J Dermatol. 2017;176:560-562.
    PubMed     Text format    


  484. CUST AE, Murrell DF
    Increasing prevalence but not incidence of psoriasis in the U.K.
    Br J Dermatol. 2017;176:568-569.
    PubMed     Text format    


  485. TRABANELLI S
    Indoleamine 2,3-dioxygenase in psoriasis: a defective mechanism.
    Br J Dermatol. 2017;176:570-572.
    PubMed     Text format    


  486. GISONDI P
    Could maternal stress increase the risk of developing psoriasis in the offspring?
    Br J Dermatol. 2017;176:569-570.
    PubMed     Text format    


  487. YIU ZZ
    Disease-specific treatment registries for research: psoriasis as an exemplar.
    Br J Dermatol. 2017;176:794-796.
    PubMed     Text format    


  488. YIU ZZ
    Psoriasis and increased drug utilization: a true burden of psoriasis or potential surveillance bias of comorbidities?
    Br J Dermatol. 2017;176:566-567.
    PubMed     Text format    


  489. YAN J
    Identifying biomarkers in human psoriasis: revealed by a systems metabolomics approach.
    Br J Dermatol. 2017;176:555-557.
    PubMed     Text format    


  490. ZHENG J
    Absolute Psoriasis Area and Severity Index: an additional evaluation for clinical practice.
    Br J Dermatol. 2017;176:576.
    PubMed     Text format    


  491. KIVELEVITCH D, Michel P, Menter A
    Quality of life instruments in psoriasis clinical trials.
    Br J Dermatol. 2017;176:563.
    PubMed     Text format    


  492. BURDEN AD
    Etanercept or infliximab for psoriasis? An independent randomized clinical trial.
    Br J Dermatol. 2017;176:565.
    PubMed     Text format    


  493. COATES LC
    Patient education and screening for psoriatic arthritis is key in the care of patients with psoriasis, whichever method is chosen.
    Br J Dermatol. 2017;176:574-575.
    PubMed     Text format    


  494. FINLAY AY
    Every dermatology consultation: think adherence.
    Br J Dermatol. 2017;176:558-559.
    PubMed     Text format    


  495. MAKRYGEORGOU A
    Secukinumab shows reassuring low immunogenicity.
    Br J Dermatol. 2017;176:573-574.
    PubMed     Text format    


    February 2017
  496. LI S, Villarreal M, Stewart S, Choi J, et al
    Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in Atopic Dermatitis.
    Br J Dermatol. 2017 Feb 28. doi: 10.1111/bjd.15409.
    PubMed     Text format     Abstract available


  497. ERIKSSON S, van der Plas MJ, Morgelin M, Sonesson A, et al
    Antibacterial and anti-biofilm effects of sodium hypochlorite against Staphylococcus aureus isolates derived from patients with atopic dermatitis.
    Br J Dermatol. 2017 Feb 26. doi: 10.1111/bjd.15410.
    PubMed     Text format     Abstract available


  498. CHANG J, Bilker WB, Hoffstad O, Margolis DJ, et al
    Cross-Sectional Comparisons of Patient-Reported Disease Control, Disease Severity, and Symptom Frequency in Children with Atopic Dermatitis.
    Br J Dermatol. 2017 Feb 24. doi: 10.1111/bjd.15403.
    PubMed     Text format     Abstract available


  499. DICK A, Tantcheva-Poor I, Oji V, Giehl KA, et al
    Diminished Protein-Bound omega-Hydroxylated Ceramides In The Skin Of Ichthyosis Patients With 12r-Lox Or Elox-3 Deficiency.
    Br J Dermatol. 2017 Feb 24. doi: 10.1111/bjd.15406.
    PubMed     Text format     Abstract available


  500. CORR M, Roulston G, King N, Dornan T, et al
    Living with 'melanoma'...for a day: a phenomenological analysis of medical students' simulated experiences.
    Br J Dermatol. 2017 Feb 23. doi: 10.1111/bjd.15402.
    PubMed     Text format     Abstract available


  501. TSAI S, Scott JF, Keller JJ, Gerstenblith MR, et al
    Cutaneous malignancies identified on an inpatient Dermatology consult service.
    Br J Dermatol. 2017 Feb 23. doi: 10.1111/bjd.15401.
    PubMed     Text format     Abstract available


  502. PRIETO-BARRIOS M, Velasco-Tamariz V, Tous-Romero F, Burillo-Martinez S, et al
    Linear Immunoglobulin A dermatosis mimicking Toxic Epidermal Necrolysis: a case report of etanercept treatment.
    Br J Dermatol. 2017 Feb 21. doi: 10.1111/bjd.15400.
    PubMed     Text format     Abstract available


  503. VERKOUTEREN JA, Ramdas KH, Wakkee M, Nijsten T, et al
    Epidemiology of basal cell carcinoma: scholarly review.
    Br J Dermatol. 2017 Feb 20. doi: 10.1111/bjd.15321.
    PubMed     Text format     Abstract available


  504. DYBBOE R, Bandier J, Skov L, Engstrand L, et al
    The Role of the Skin Microbiome in Atopic Dermatitis: A Systematic Review.
    Br J Dermatol. 2017 Feb 16. doi: 10.1111/bjd.15390.
    PubMed     Text format     Abstract available


  505. GREEN AC, Olsen CM
    Cutaneous squamous cell carcinoma: an epidemiological review.
    Br J Dermatol. 2017 Feb 16. doi: 10.1111/bjd.15324.
    PubMed     Text format     Abstract available


  506. QIN Z, Balimunkwe RM, Quan T
    Age-related reduction of dermal fibroblast size up-regulates multiple matrix metalloproteinases as observed in aged human skin in vivo.
    Br J Dermatol. 2017 Feb 14. doi: 10.1111/bjd.15379.
    PubMed     Text format     Abstract available


  507. SANTONJA C, Santos-Briz A, Palmedo G, Kutzner H, et al
    Detection of human parvovirus B19 DNA in 22% of 1,815 cutaneous biopsies of a wide variety of dermatologic conditions suggests viral persistence after primary infection and casts doubts on its pathogenic significance.
    Br J Dermatol. 2017 Feb 14. doi: 10.1111/bjd.15382.
    PubMed     Text format     Abstract available


  508. BAGEL J, Tyring S, Rice KC, Collier DH, et al
    Open-label study of etanercept treatment in patients with moderate to severe plaque psoriasis who lost a satisfactory response to adalimumab.
    Br J Dermatol. 2017 Feb 14. doi: 10.1111/bjd.15381.
    PubMed     Text format     Abstract available


  509. GOMEZ-GARCIA F, Ruano J, Aguilar-Luque M, Gay-Mimbrera J, et al
    Systematic reviews and meta-analyses on psoriasis: role of funding sources, conflict of interest, and bibliometric indices as predictors of methodological quality.
    Br J Dermatol. 2017 Feb 13. doi: 10.1111/bjd.15380.
    PubMed     Text format     Abstract available


  510. VAZQUEZ-OSORIO I, Chmel N, Rodriguez-Diaz E, Gonzalvo-Rodriguez P, et al
    A case of mosaicism in ectodermal dysplasia - skin fragility syndrome.
    Br J Dermatol. 2017 Feb 9. doi: 10.1111/bjd.15374.
    PubMed     Text format     Abstract available


  511. SKOIE IM, Dalen I 1st, Ternowitz T, Jonsson G, et al
    Fatigue in psoriasis - a controlled study.
    Br J Dermatol. 2017 Feb 9. doi: 10.1111/bjd.15375.
    PubMed     Text format     Abstract available


  512. SU JC, Dailey R, Zallmann M, Leins E, et al
    Determining Effects of Superfine Sheep wool in INfantile Eczema (DESSINE): a randomized paediatric cross over study.
    Br J Dermatol. 2017 Feb 9. doi: 10.1111/bjd.15376.
    PubMed     Text format     Abstract available


  513. NG CY, Huang YH, Chu CF, Wu TC, et al
    Risks for Staphylococcus aureus Colonization in Psoriasis Patients: A Systematic Review and Meta-Analysis.
    Br J Dermatol. 2017 Feb 3. doi: 10.1111/bjd.15366.
    PubMed     Text format     Abstract available


  514. GALIMOVA E, Khusnutdinova E, Ratsep R, Traks T, et al
    Interleukin-10 family cytokines pathway: genetic variants and psoriasis.
    Br J Dermatol. 2017 Feb 2. doi: 10.1111/bjd.15363.
    PubMed     Text format     Abstract available


  515. LEE HY, Walsh SA, Creamer D
    Long term complications of Stevens-Johnson syndrome / Toxic epidermal necrolysis: The spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multi-disciplinary follow up.
    Br J Dermatol. 2017 Feb 1. doi: 10.1111/bjd.15360.
    PubMed     Text format     Abstract available


  516. BREMBILLA NC, Stalder R, Senra L, Bohencke WH, et al
    IL-17A localizes in the exocytic compartment of mast cells in psoriatic skin.
    Br J Dermatol. 2017 Feb 1. doi: 10.1111/bjd.15358.
    PubMed     Text format     Abstract available


  517. KING L
    A criteria-validated sun-exposure questionnaire to evaluate skin cancer prevention campaigns.
    Br J Dermatol. 2017;176:298-299.
    PubMed     Text format    


  518. KURTZMAN DJ, Vleugels RA
    Expanding the use of the Cutaneous Dermatomyositis Area and Severity Index (CDASI) to nondermatologists.
    Br J Dermatol. 2017;176:296-297.
    PubMed     Text format    


  519. JOHNSTON GA, Exton LS, Mohd Mustapa MF, Slack JA, et al
    British Association of Dermatologists' guidelines for the management of contact dermatitis 2017.
    Br J Dermatol. 2017;176:317-329.
    PubMed     Text format    


  520. JORDAN M, Ghoreschi K
    Anti-melanoma differentiation-associated protein 5 autoantibodies as a marker for dermatomyositis-associated interstitial lung disease.
    Br J Dermatol. 2017;176:294-295.
    PubMed     Text format    


  521. CHOI JW, Na SY
    Image Gallery: Myoepithelial carcinoma involving the skin.
    Br J Dermatol. 2017;176:e12.
    PubMed     Text format    


  522. MASHAYEKHI S, Flohr C, Lewis FM
    The treatment of vulval lichen sclerosus in prepubertal girls: a critically appraised topic.
    Br J Dermatol. 2017;176:307-316.
    PubMed     Text format     Abstract available


  523. CHOPRA S, Downs A, Perris R
    Intense pulsed light combined with methyl aminolaevulinate for treating actinic keratoses and photoaged skin of the dorsal hands has considerable advantages. However, is it worth the extra expense?
    Br J Dermatol. 2017;176:290-291.
    PubMed     Text format    


  524. LINDBERG M, Soderquist B
    Atopic dermatitis and gut microbiota.
    Br J Dermatol. 2017;176:297-298.
    PubMed     Text format    


  525. LINOS E, Bhatia S, Chren MM
    More than skin-deep: is basal cell carcinoma a marker for a cancer-prone phenotype?
    Br J Dermatol. 2017;176:305-306.
    PubMed     Text format    


  526. KUHN A, Landmann A, Bonsmann G
    Fumaric acid esters: a new therapeutic option for skin manifestations in lupus erythematosus?
    Br J Dermatol. 2017;176:301-302.
    PubMed     Text format    


  527. PARK J, Yun SK, Kim HU
    Image Gallery: Heel-line band of infancy: postinflammatory skin change associated with tight socks.
    Br J Dermatol. 2017;176:e15.
    PubMed     Text format    


  528. DRUCKER AM
    Taking steps to improve the assessment and management of rosacea.
    Br J Dermatol. 2017;176:283-284.
    PubMed     Text format    


  529. WEISSHAAR E
    Outcome measures in patients with chronic pruritus: moving forward but still a long way to go.
    Br J Dermatol. 2017;176:291-292.
    PubMed     Text format    


  530. FOLSTER-HOLST R
    Severe systemic juvenile xanthogranuloma is an indication for systemic therapy.
    Br J Dermatol. 2017;176:302-304.
    PubMed     Text format    


  531. FLETCHER J, Haniffa M
    Mechanisms of immune evasion in extramammary Paget disease.
    Br J Dermatol. 2017;176:293-294.
    PubMed     Text format    


  532. HASHIMOTO T
    Induced autoimmune bullous diseases.
    Br J Dermatol. 2017;176:304-305.
    PubMed     Text format    


  533. EGEBERG A
    Evidence-based management of rosacea.
    Br J Dermatol. 2017;176:300-301.
    PubMed     Text format    


  534. INGRAM JR, Burton T
    NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?
    Br J Dermatol. 2017;176:281-282.
    PubMed     Text format    


  535. SAKAI A, Shimomura Y, Ansai O, Saito Y, et al
    Linagliptin-associated bullous pemphigoid that was most likely caused by IgG autoantibodies against the midportion of BP180.
    Br J Dermatol. 2017;176:541-543.
    PubMed     Text format    


    January 2017
  536. WOLNER ZJ, Marghoob AA, Pulitzer MP, Postow MA, et al
    A case report of disappearing pigmented skin lesions associated with pembrolizumab treatment for metastatic melanoma.
    Br J Dermatol. 2017 Jan 28. doi: 10.1111/bjd.15354.
    PubMed     Text format     Abstract available


  537. LANGTON AK, Graham HK, McConnell JC, Sherratt MJ, et al
    Organisation of the dermal matrix impacts the biomechanical properties of skin.
    Br J Dermatol. 2017 Jan 28. doi: 10.1111/bjd.15353.
    PubMed     Text format     Abstract available


  538. VAN SANTEN S, van Doorn R, Neelis KJ, Daniels LA, et al
    Recommendations for treatment in Folliculotropic Mycosis Fungoides: Report of the Dutch Cutaneous Lymphoma Group.
    Br J Dermatol. 2017 Jan 28. doi: 10.1111/bjd.15355.
    PubMed     Text format     Abstract available


  539. CHOI CW, Kim BR, Seo E, Youn SW, et al
    The objective Psoriasis Area Severity Index: A randomised controlled pilot study comparing the effectiveness of cyclosporine and methotrexate using an objective PASI (oPASI).
    Br J Dermatol. 2017 Jan 27. doi: 10.1111/bjd.15350.
    PubMed     Text format     Abstract available


  540. WU JH, Cohen DN, Rady PL, Tyring SK, et al
    BRAF inhibitor-associated cutaneous squamous cell carcinoma: new mechanistic insight, emerging evidence for a viral involvement, and perspectives on clinical management.
    Br J Dermatol. 2017 Jan 27. doi: 10.1111/bjd.15348.
    PubMed     Text format     Abstract available


  541. VANHAECKE C, Deilhes F, Chanal J, Regnier-Rosencher E, et al
    BRAFV600 inhibitor discontinuation after complete response in advanced melanoma. A retrospective analysis of 16 patients.
    Br J Dermatol. 2017 Jan 27. doi: 10.1111/bjd.15345.
    PubMed     Text format     Abstract available


  542. KOGAME T, Nomura T, Kataoka T, Hirata M, et al
    Possible inducible skin-associated lymphoid tissues (iSALT)-like structures with CXCL13+ fibroblast-like cells in secondary syphilis.
    Br J Dermatol. 2017 Jan 27. doi: 10.1111/bjd.15349.
    PubMed     Text format     Abstract available


  543. KUNTE C, Letule V, Gehl J, Dahlstroem K, et al
    Electrochemotherapy in the treatment of metastatic malignant melanoma: A prospective cohort study by InspECT.
    Br J Dermatol. 2017 Jan 24. doi: 10.1111/bjd.15340.
    PubMed     Text format     Abstract available


  544. HAGFORSEN E, Lampinen M, Paivandy A, Westrom S, et al
    Siramesine causes preferential apoptosis of mast cells in skin biopsies from psoriatic lesions.
    Br J Dermatol. 2017 Jan 24. doi: 10.1111/bjd.15336.
    PubMed     Text format     Abstract available


  545. MINAGAWA A, Omodaka T, Koga H, Yokokawa Y, et al
    Nail apparatus melanoma thickness is associated with side and age.
    Br J Dermatol. 2017 Jan 24. doi: 10.1111/bjd.15318.
    PubMed     Text format     Abstract available


  546. CHASSET F, Bouaziz JD, Costedoat-Chalumeau N, Frances C, et al
    Efficacy and comparison of antimalarials in cutaneous lupus erythematosus subtypes: a systematic review and meta-analysis.
    Br J Dermatol. 2017 Jan 23. doi: 10.1111/bjd.15312.
    PubMed     Text format     Abstract available


  547. ZHOU H, Shi HJ, Yang J, Chen WG, et al
    Efficacy and relapse-suppression of severe plaque psoriasis by oxymatrine: Results from a single blinded randomized controlled clinical trial.
    Br J Dermatol. 2017 Jan 23. doi: 10.1111/bjd.15316.
    PubMed     Text format     Abstract available


  548. VAN DEN REEK JM, Menting SP, Janssen WW, Dhaliwal R, et al
    PIIINP measurements for the detection of liver fibrosis in methotrexate treated psoriasis patients: Daily practice use and clinical implications.
    Br J Dermatol. 2017 Jan 23. doi: 10.1111/bjd.15313.
    PubMed     Text format     Abstract available


  549. TAKEICHI T, Nomura T, Takama H, Kono M, et al
    Deficient stratum corneum intercellular lipid in a Japanese patient with lamellar ichthyosis by a homozygous deletion mutation in SDR9C7.
    Br J Dermatol. 2017 Jan 23. doi: 10.1111/bjd.15315.
    PubMed     Text format     Abstract available


  550. WAALBOER-SPUIJ R, Hollestein LM, van de Poll-Franse LV, Nijsten TE, et al
    Histological diagnosis of basal cell carcinoma is not associated with life expectancy in elderly Dutch people; a population-based cohort study.
    Br J Dermatol. 2017 Jan 23. doi: 10.1111/bjd.15310.
    PubMed     Text format     Abstract available


  551. ZIMMER AD, Kim GJ, Hotz A, Bourrat E, et al
    16 novel mutations in PNPLA1 in patients with autosomal recessive congenital ichthyosis reveal the importance of an extended patatin domain in PNPLA1 that is essential for proper human skin barrier function.
    Br J Dermatol. 2017 Jan 17. doi: 10.1111/bjd.15308.
    PubMed     Text format     Abstract available


  552. SIMPSON JK, Wilson M, Ahmed AA, Mizara A, et al
    An exploratory study to investigate health-seeking behaviour in patients with psoriasis using framework analysis.
    Br J Dermatol. 2017 Jan 13. doi: 10.1111/bjd.15307.
    PubMed     Text format     Abstract available


  553. OTERO M, van den Reek J, Seyger M, Van Der Kerkhof P, et al
    Determinants for drug survival of Methotrexate in patients with psoriasis, split for different reasons of discontinuation - Results of the prospective MTX-CAPTURE.
    Br J Dermatol. 2017 Jan 12. doi: 10.1111/bjd.15305.
    PubMed     Text format     Abstract available


  554. KINSLER VA, O'Hare P, Bulstrode N, Calonje JE, et al
    Melanoma in congenital melanocytic naevi.
    Br J Dermatol. 2017 Jan 12. doi: 10.1111/bjd.15301.
    PubMed     Text format     Abstract available


  555. SU HH, Wu W, Guo Y, Chen HD, et al
    Pediatric Erdheim-Chester disease with aggressive skin manifestations.
    Br J Dermatol. 2017 Jan 12. doi: 10.1111/bjd.15306.
    PubMed     Text format     Abstract available


  556. RAZMI T M, Mahajan R, Agrawal P
    Image Gallery: Cutaneous botryomycosis at an unusual site in an immunocompetent patient.
    Br J Dermatol. 2017;176:e3.
    PubMed     Text format    


  557. BARZILAI A, Cohen AD
    Expanding the skin and histopathology manifestations of autoinflammatory diseases.
    Br J Dermatol. 2017;176:18-19.
    PubMed     Text format    


  558. TSURUTA D
    Intercellular IgA dermatosis.
    Br J Dermatol. 2017;176:13-14.
    PubMed     Text format    


  559. BRATTSAND M
    Missing factors in human skin equivalent models?
    Br J Dermatol. 2017;176:11-12.
    PubMed     Text format    


  560. MARIA-ENGLER SS
    Assessing the effects of advanced glycation end products in the skin.
    Br J Dermatol. 2017;176:12-13.
    PubMed     Text format    


  561. CHONG BF
    Patient-reported outcomes in patients with cutaneous lupus.
    Br J Dermatol. 2017;176:7.
    PubMed     Text format    


  562. FOERSTER J
    Rare diseases and costly treatments: the role of IL-1beta in pustular psoriasis.
    Br J Dermatol. 2017;176:17-18.
    PubMed     Text format    


  563. HAS C
    Mosaicism in the skin: lumping or splitting?
    Br J Dermatol. 2017;176:15-16.
    PubMed     Text format    


  564. DE BERKER D, McGregor JM, Mohd Mustapa MF, Exton LS, et al
    British Association of Dermatologists' guidelines for the care of patients with actinic keratosis 2017.
    Br J Dermatol. 2017;176:20-43.
    PubMed     Text format    


  565. FLYNN A, Molony P, Keeting C, Cullen J, et al
    Image Gallery: Systemic sarcoidosis presenting within the black pigment of a cosmetic tattoo.
    Br J Dermatol. 2017;176:e2.
    PubMed     Text format    


  566. TAN J, Steinhoff M, Berg M, Del Rosso J, et al
    Shortcomings in rosacea diagnosis and classification.
    Br J Dermatol. 2017;176:197-199.
    PubMed     Text format    


  567. TANG JQ, Ran X, Ran YP
    Cover Image: Dermoscopy in vivo for the life cycle of Phthirus pubis.
    Br J Dermatol. 2017;176:279.
    PubMed     Text format    


  568. INGRAM JR, Anstey A
    The evolution of clinical guidelines for dermatologists: GRADE, AGREE and occasionally consensus by experts.
    Br J Dermatol. 2017;176:3-4.
    PubMed     Text format    


    December 2016
  569. KHOURY LR, Skov L, Moller T
    Facing the dilemma of patient-centred psoriasis care: a qualitative study identifying patient needs in dermatological outpatient clinics.
    Br J Dermatol. 2016 Dec 29. doi: 10.1111/bjd.15292.
    PubMed     Text format     Abstract available


  570. BALIEVA F, Kupfer J, Lien L, Gieler U, et al
    The Burden of Common Skin Diseases Assessed with the EQ5D: a European Multi-centre Study in 13 Countries.
    Br J Dermatol. 2016 Dec 29. doi: 10.1111/bjd.15280.
    PubMed     Text format     Abstract available


  571. HAMBLY R, Mansoor N, Quinlan C, Shah Z, et al
    Topical Photodynamic Therapy for Primary Bowen's Disease and Basal Cell Carcinoma - Optimising Patient Selection.
    Br J Dermatol. 2016 Dec 27. doi: 10.1111/bjd.15281.
    PubMed     Text format     Abstract available


  572. ZHAO CY, Hao EY, Oh DD, Daniel BS, et al
    A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate to dark skin patients.
    Br J Dermatol. 2016 Dec 23. doi: 10.1111/bjd.15271.
    PubMed     Text format     Abstract available


  573. OH CC, Hofbauer GF, Serra AL, Harwood CA, et al
    Painful skin lesions and squamous cell carcinoma predict overall mortality risk in organ transplant recipients: A cohort study.
    Br J Dermatol. 2016 Dec 23. doi: 10.1111/bjd.15269.
    PubMed     Text format     Abstract available


  574. NEITTAANMAKI N, Salmivuori M, Polonen I, Jeskanen L, et al
    Hyperspectral imaging in detecting dermal invasion in lentigo maligna melanoma.
    Br J Dermatol. 2016 Dec 23. doi: 10.1111/bjd.15267.
    PubMed     Text format     Abstract available


  575. SCHAEFER C, Mamolo C, Cappelleri JC, Daniel S, et al
    Treatment Patterns and Outcomes among Adults Admitted to Hospital in the United Kingdom (UK) due to Plaque or Erythrodermic Psoriasis.
    Br J Dermatol. 2016 Dec 23. doi: 10.1111/bjd.15270.
    PubMed     Text format     Abstract available


  576. USHER-SMITH JA, Kassianos AP, Emery JD, Abel GA, et al
    Identifying people at higher risk of melanoma across the U.K.: a primary-care-based electronic survey.
    Br J Dermatol. 2016 Dec 23. doi: 10.1111/bjd.15181.
    PubMed     Text format     Abstract available


  577. BENSEFA-COLAS L, Stocks SJ, McNamee R, Faye S, et al
    Effectiveness of the European Chromium VI Directive for cement implementation on occupational allergic contact dermatitis occurrence: Assessment in France and UK.
    Br J Dermatol. 2016 Dec 23. doi: 10.1111/bjd.15261.
    PubMed     Text format     Abstract available


  578. TOBIN AM, Sadlier M, Collins P, Rogers S, et al
    Fatigue as a symptom in psoriasis and psoriatic arthritis: an observational study.
    Br J Dermatol. 2016 Dec 22. doi: 10.1111/bjd.15258.
    PubMed     Text format     Abstract available


  579. NIC DHONNCHA E, Clowry J, Dunphy M, Buckley C, et al
    Treatment of severe atopic dermatitis with ustekinumab: a case series of 10 patients.
    Br J Dermatol. 2016 Dec 22. doi: 10.1111/bjd.15262.
    PubMed     Text format     Abstract available


  580. HERMS F, Franck N, Kramkimel N, Fichel F, et al
    Neutrophilic eccrine hidradenitis in 2 patients treated with BRAF inhibitors: a new cutaneous adverse event.
    Br J Dermatol. 2016 Dec 22. doi: 10.1111/bjd.15259.
    PubMed     Text format     Abstract available


  581. GOTTLIEB J, Ingen-Housz-Oro S, Alexandre M, Grootenboer-Mignot S, et al
    Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case-series of 72 adults.
    Br J Dermatol. 2016 Dec 20. doi: 10.1111/bjd.15244.
    PubMed     Text format     Abstract available


  582. SAMPOGNA F, Puig L, Spuls P, Girolomoni G, et al
    Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study.
    Br J Dermatol. 2016 Dec 20. doi: 10.1111/bjd.15243.
    PubMed     Text format     Abstract available


  583. HELANDER A, Bradley M, Hasselblad A, Norlen L, et al
    Acute skin and hair symptoms followed by severe, delayed eye complications in subjects using the synthetic opioid MT-45.
    Br J Dermatol. 2016 Dec 14. doi: 10.1111/bjd.15174.
    PubMed     Text format     Abstract available


  584. NALDI L, Cazzaniga S, di Mercurio M, Grossi E, et al
    Inequalities in access to biological treatments for psoriasis: Results from the Italian Psocare Registry.
    Br J Dermatol. 2016 Dec 14. doi: 10.1111/bjd.15234.
    PubMed     Text format     Abstract available


  585. CANUETO J, Cardenoso-Alvarez E, Garcia-Hernandez JL, Galindo-Villardon P, et al
    miR-203 and miR-205 expression patterns identify subgroups of prognosis in cutaneous squamous cell carcinoma.
    Br J Dermatol. 2016 Dec 11. doi: 10.1111/bjd.15236.
    PubMed     Text format     Abstract available


  586. OHATA C, Ishii N, Koga H, Nakama T, et al
    A clinical and serological study of linear IgA bullous dermatosis without linear immunoglobulin deposition other than IgA at the basement membrane zone in direct immunofluorescence.
    Br J Dermatol. 2016 Dec 11. doi: 10.1111/bjd.15232.
    PubMed     Text format     Abstract available


  587. CHANG Y, Anolik R, Cabral H, Bhawan J, et al
    Frequency of Squamous Cell Carcinoma In Situ and Squamous Cell Carcinoma in Re-Excisions of Biopsy-Proven Cutaneous Squamous Cell Carcinoma In Situ.
    Br J Dermatol. 2016 Dec 11. doi: 10.1111/bjd.15230.
    PubMed     Text format     Abstract available


  588. MARTINEZ-MERA C, Camarero-Mulas C, Sanz-Sanchez T, Dauden E, et al
    Combination therapy of infliximab and cyclosporin in the treatment of recalcitrant psoriasis. A case series.
    Br J Dermatol. 2016 Dec 11. doi: 10.1111/bjd.15229.
    PubMed     Text format     Abstract available


  589. VAN DER VOORT EA, Wakkee M, Veldt-Kok P, Darwish Murad S, et al
    Enhanced liver fibrosis test (ELF) in psoriasis, psoriatic arthritis and rheumatoid arthritis patients: a cross-sectional comparison with procollagen-3 N-terminal peptide (P3NP).
    Br J Dermatol. 2016 Dec 7. doi: 10.1111/bjd.15220.
    PubMed     Text format     Abstract available


  590. LIU X, Chen J, Olsen J, Schlunssen V, et al
    Prenatal exposure to maternal bereavement and offspring psoriasis: a Danish nationwide cohort study.
    Br J Dermatol. 2016 Dec 7. doi: 10.1111/bjd.15224.
    PubMed     Text format     Abstract available


  591. RICHTIG G, Richtig E, Kashofer K, Koch L, et al
    Testing and clinical implications for non-V600 BRAF mutations in metastatic NRASmt melanoma.
    Br J Dermatol. 2016 Dec 7. doi: 10.1111/bjd.15222.
    PubMed     Text format     Abstract available


  592. LINOS E, Li WQ, Han J, Li T, et al
    Lifetime UV exposure and Lentigo Maligna Melanoma.
    Br J Dermatol. 2016 Dec 7. doi: 10.1111/bjd.15218.
    PubMed     Text format     Abstract available


  593. SPENDER LC, Inman GJ
    Fatal attractions? Correlations of CXCL12-CXCR4-CXCR7 expression with disease progression in melanoma and Kaposi sarcoma.
    Br J Dermatol. 2016;175:1140-1141.
    PubMed     Text format    


  594. SHIIYA C, Watanabe K, Ota M
    Image Gallery: Lichen amyloidosis on the external auditory canal.
    Br J Dermatol. 2016;175:e149.
    PubMed     Text format    


  595. YELAMOS O, Nehal KS
    Integrating clinical information, dermoscopy and reflectance confocal microscopy to improve the diagnostic accuracy and confidence of amelanotic and lightly pigmented melanomas.
    Br J Dermatol. 2016;175:1147-1148.
    PubMed     Text format    


  596. HAASS NK
    JNK-ERK signalling in melanoma: rewired or entangled?
    Br J Dermatol. 2016;175:1139-1140.
    PubMed     Text format    


  597. NAMIKI T, Tokoro S, Hanafusa T, Yokozeki H, et al
    Image Gallery: Periorbital and temporal dermal melanocytosis of hypohidrotic ectodermal dysplasia.
    Br J Dermatol. 2016;175:e146-e147.
    PubMed     Text format    


  598. ULRICH M
    Optical coherence tomography for diagnosis of basal cell carcinoma: essentials and perspectives.
    Br J Dermatol. 2016;175:1145-1146.
    PubMed     Text format    


  599. DIXON A, Steinman H, Anderson S, Nirenberg A, et al
    Routine usage of sentinel node biopsy in melanoma management must cease.
    Br J Dermatol. 2016;175:1340-1341.
    PubMed     Text format    


  600. SOURA E, Chasapi V, Stratigos AJ
    Programmed cell death protein-1 inhibitors for immunotherapy of advanced nonmelanoma skin cancer: showing early promise.
    Br J Dermatol. 2016;175:1150-1151.
    PubMed     Text format    


  601. YANIK EL
    Skin cancer in the end-stage renal disease population: unique risk factors for patients on dialysis.
    Br J Dermatol. 2016;175:1136-1137.
    PubMed     Text format    


    November 2016
  602. DAMIAN DL, Martin AJ, Scolyer RA, Chen AC, et al
    Reply to 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients': reply from the authors.
    Br J Dermatol. 2016 Nov 28. doi: 10.1111/bjd.15204.
    PubMed     Text format     Abstract available


  603. DURAN J, Morgan FC, Karia PS, Schmults CD, et al
    An evaluation of high-stage cutaneous squamous cell carcinoma outcomes by gender.
    Br J Dermatol. 2016 Nov 28. doi: 10.1111/bjd.15208.
    PubMed     Text format     Abstract available


  604. YELAMOS O, Halpern AC, Weinstock MA
    Reply to: A Phase 2 Randomised Controlled Trial of Nicotinamide for Skin Cancer Chemoprevention in Renal Transplant Recipients.
    Br J Dermatol. 2016 Nov 23. doi: 10.1111/bjd.15203.
    PubMed     Text format     Abstract available


  605. DHANA A, Gumedze F, Khumalo N
    Regarding "Frontal fibrosing alopecia: possible association with leave-on facial skin care products and sunscreens; a questionnaire study".
    Br J Dermatol. 2016 Nov 22. doi: 10.1111/bjd.15197.
    PubMed     Text format     Abstract available


  606. SPEIGL L, Janssen N, Weide B, Pawelec G, et al
    Prognostic impact of the putative cancer stem cell markers ABCG2, CD133, ALDH1A1 and CD44V7/8 in metastatic melanoma.
    Br J Dermatol. 2016 Nov 21. doi: 10.1111/bjd.15194.
    PubMed     Text format     Abstract available


  607. ROEKEVISCH E, Leeflang MM, Schram ME, Campbell LE, et al
    Atopic dermatitis patients with filaggrin loss-of-function mutations show good but lower responses to immunosuppressive treatment.
    Br J Dermatol. 2016 Nov 19. doi: 10.1111/bjd.15191.
    PubMed     Text format     Abstract available


  608. HART VA
    Response to ' A functional mechanistic study of the effect of emollients on the structure and function of the skin barrier'.
    Br J Dermatol. 2016 Nov 19. doi: 10.1111/bjd.15184.
    PubMed     Text format     Abstract available


  609. KORKMAZ S, Korkmaz H
    Effect of Alterations in Apoptotic pathway on Development of Metabolic Syndrome in Patients with Psoriasis Vulgaris.
    Br J Dermatol. 2016 Nov 18. doi: 10.1111/bjd.15185.
    PubMed     Text format     Abstract available


  610. WOBSER M, Maurus K, Roth S, Appenzeller S, et al
    MYD88 mutations in a distinct type of cutaneous marginal zone lymphoma with a non-class switched IgM-immunophenotype.
    Br J Dermatol. 2016 Nov 18. doi: 10.1111/bjd.15183.
    PubMed     Text format     Abstract available


  611. MAHER NG, Blumetti TP, Gomes EE, Cheng HM, et al
    Melanoma diagnosis may be a pitfall for optical coherence tomography assessment of equivocal amelanotic or hypomelanotic skin lesions.
    Br J Dermatol. 2016 Nov 18. doi: 10.1111/bjd.15187.
    PubMed     Text format     Abstract available


  612. DESCAMPS V, Claessens YE, Doumenc B
    Skin manifestations in ultra-marathon runners: experience in the Marathon des Sables 2014.
    Br J Dermatol. 2016 Nov 18. doi: 10.1111/bjd.15182.
    PubMed     Text format     Abstract available


  613. POLESIE S, Gillstedt M, Sonnergren HH, Osmancevic A, et al
    Methotrexate Treatment and Risk for Cutaneous Malignant Melanoma - a Retrospective Comparative Registry-based Cohort Study.
    Br J Dermatol. 2016 Nov 10. doi: 10.1111/bjd.15170.
    PubMed     Text format     Abstract available


  614. GONZALEZ-LOPEZ G, Ceballos-Rodriguez RM, Gonzalez-Lopez JJ, Feito Rodriguez M, et al
    Efficacy and safety of wet wrap therapy for patients with atopic dermatitis: a systematic review and meta-analysis.
    Br J Dermatol. 2016 Nov 8. doi: 10.1111/bjd.15165.
    PubMed     Text format     Abstract available


  615. KOPPES SA, Ljubojevic Hadzavdic S, Jakasa I, Franceschi N, et al
    Stratum corneum profiles of inflammatory mediators in patch test reactions to common contact allergens and sodium lauryl sulfate.
    Br J Dermatol. 2016 Nov 4. doi: 10.1111/bjd.15163.
    PubMed     Text format     Abstract available


  616. BERENTS TL, Lodrup Carlsen KC, Mowinckel P, Skjerven HO, et al
    Transepidermal water loss in infancy associated with atopic eczema at 2 years: a population-based cohort study.
    Br J Dermatol. 2016 Nov 3. doi: 10.1111/bjd.15157.
    PubMed     Text format     Abstract available


  617. DAMSKY W, King BA
    STATing the obvious: it's time for new treatments in atopic dermatitis.
    Br J Dermatol. 2016;175:861-862.
    PubMed     Text format    


  618. PUIG L
    Interleukin-17 in skin: psoriasis and yonder.
    Br J Dermatol. 2016;175:859-860.
    PubMed     Text format    


  619. EDWARDS C
    Measurements of structure and function of skin: emollient effects on atopic dermatitis.
    Br J Dermatol. 2016;175:868-869.
    PubMed     Text format    


  620. VASAITIS L
    Metal dust as a possible inducer of immunoglobulin G4-related skin nodules.
    Br J Dermatol. 2016;175:871.
    PubMed     Text format    


  621. BARRETT JH
    Telomere length and melanoma - is there a straightforward relationship?
    Br J Dermatol. 2016;175:865-866.
    PubMed     Text format    


  622. ELLIKER KR, Williams HC
    Detection of skin cancer odours using dogs: a step forward in melanoma detection training and research methodologies.
    Br J Dermatol. 2016;175:851-852.
    PubMed     Text format    


  623. EISEMANN N
    Routine health data in skin cancer screening evaluation.
    Br J Dermatol. 2016;175:862.
    PubMed     Text format    


  624. EGEBERG A
    Fumarates for treatment of psoriasis.
    Br J Dermatol. 2016;175:857.
    PubMed     Text format    


  625. SCHOFIELD JK, Linos E, Callander J
    Management of skin cancer in the frail elderly: time for a rethink?
    Br J Dermatol. 2016;175:855-856.
    PubMed     Text format    


  626. KIRBY B
    Is late-onset psoriasis a distinct subtype of chronic plaque psoriasis?
    Br J Dermatol. 2016;175:869-870.
    PubMed     Text format    


  627. KIMURA Y, Shimada-Omori R, Takahashi T, Tsuchiyama K, et al
    Therapeutic drug monitoring of patients with psoriasis during tumour necrosis factor (TNF)-alpha antagonist treatment using a novel interleukin-8 reporter cell line.
    Br J Dermatol. 2016;175:979-987.
    PubMed     Text format     Abstract available


  628. STROM MA, Fishbein AB, Paller AS, Silverberg JI, et al
    Association between atopic dermatitis and attention deficit hyperactivity disorder in U.S. children and adults.
    Br J Dermatol. 2016;175:920-929.
    PubMed     Text format     Abstract available


  629. TOMIDA E, Kato Y, Ozawa H, Hasegawa H, et al
    Causative drug detection by drug-induced lymphocyte stimulation test in drug-induced linear IgA bullous dermatosis.
    Br J Dermatol. 2016;175:1106-1108.
    PubMed     Text format    


  630. WEILER L, Poulalhon N, Slama A, Guillaud-Bataille M, et al
    Isolated cutaneous leiomyosarcoma revealing a novel germline mutation of the fumarate hydratase gene.
    Br J Dermatol. 2016;175:1104-1106.
    PubMed     Text format    


  631. GYLDENLOVE M, Vilsboll T, Holst JJ, Zachariae C, et al
    Disturbed postprandial glucose metabolism and gut hormone responses in non-diabetic patients with psoriasis.
    Br J Dermatol. 2016;175:1085-1088.
    PubMed     Text format    


  632. HUNTER HJ, Hinz R, Gerhard A, Talbot PS, et al
    Brain inflammation and psoriasis: a [11 C]-(R)-PK11195 positron emission tomography study.
    Br J Dermatol. 2016;175:1082-1084.
    PubMed     Text format    


    October 2016
  633. GRIFFITHS CE, Thaci D, Gerdes S, Arenberger P, et al
    The EGALITY study: A confirmatory, randomised, double-blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, versus the originator product in patients with moderate to severe chronic plaque-type psor
    Br J Dermatol. 2016 Oct 27. doi: 10.1111/bjd.15152.
    PubMed     Text format     Abstract available


  634. HJULER KF, Gormsen L, Vendelbo MH, Egeberg A, et al
    Increased global arterial and subcutaneous adipose tissue inflammation in patients with moderate-to-severe psoriasis.
    Br J Dermatol. 2016 Oct 27. doi: 10.1111/bjd.15149.
    PubMed     Text format     Abstract available


  635. KIM JY, Lee EJ, Seo J, Oh SH, et al
    Impact of HMGB1 on melanocytic survival and its involvement in the pathogenesis of vitiligo.
    Br J Dermatol. 2016 Oct 27. doi: 10.1111/bjd.15151.
    PubMed     Text format     Abstract available


  636. HEPBURN L, Hijnen DJ, Sellman BR, Mustelin T, et al
    The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies.
    Br J Dermatol. 2016 Oct 25. doi: 10.1111/bjd.15139.
    PubMed     Text format     Abstract available


  637. BATH-HEXTALL F, Nalubega S, Evans C
    The needs and experiences of skin cancer patients: a qualitative systematic review with meta-synthesis.
    Br J Dermatol. 2016 Oct 24. doi: 10.1111/bjd.15148.
    PubMed     Text format     Abstract available


  638. TIAO J, Feng R, Bird S, Choi JK, et al
    The reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) among dermatologists, rheumatologists and neurologists.
    Br J Dermatol. 2016 Oct 19. doi: 10.1111/bjd.15140.
    PubMed     Text format     Abstract available


  639. RICHTIG G, Byrom L, Kupsa R, Schaider H, et al
    Pregnancy as driver for melanoma.
    Br J Dermatol. 2016 Oct 8. doi: 10.1111/bjd.15124.
    PubMed     Text format     Abstract available


  640. LARESE FILON F, Plazzotta S, Rui F, Mauro M, et al
    Ten years incidence of contact dermatitis in a prospective cohort of health care workers in Trieste Hospitals (North East of Italy) 2004-2013.
    Br J Dermatol. 2016 Oct 8. doi: 10.1111/bjd.15118.
    PubMed     Text format     Abstract available


  641. VAN GEEL MJ, Otero ME, de Jong EM, van de Kerkhof PC, et al
    Validation of the Simplified Psoriasis Index (SPI) in Dutch children and adolescents with plaque psoriasis.
    Br J Dermatol. 2016 Oct 8. doi: 10.1111/bjd.15120.
    PubMed     Text format     Abstract available


  642. MODALSLI EH, Asvold BO, Romundstad PR, Langhammer A, et al
    Psoriasis, fracture risk and bone mineral density: The HUNT Study, Norway.
    Br J Dermatol. 2016 Oct 8. doi: 10.1111/bjd.15123.
    PubMed     Text format     Abstract available


  643. MAIQUES O, Macia A, Moreno S, Barcelo C, et al
    Immunohistochemical analysis of T-type calcium channels in acquired melanocytic nevi and melanoma.
    Br J Dermatol. 2016 Oct 8. doi: 10.1111/bjd.15121.
    PubMed     Text format     Abstract available


  644. VAN CRANENBURGH OD, Nijland SB, Lindeboom R, de Korte J, et al
    Patients with lichen sclerosus experience moderate satisfaction with treatment and impairment of quality of life: results of a cross-sectional study.
    Br J Dermatol. 2016 Oct 8. doi: 10.1111/bjd.15125.
    PubMed     Text format     Abstract available


  645. HOORENS I, Brochez L
    Chemoprevention of basal cell carcinoma: reply from authors.
    Br J Dermatol. 2016 Oct 7. doi: 10.1111/bjd.15055.
    PubMed     Text format    


  646. GOON PK, Greenberg DC, Igali L, Levell NJ, et al
    Predicted cases of UK skin SCC and BCC in 2020 and 2025: Horizon planning for NHS Dermatology and Dermatopathology.
    Br J Dermatol. 2016 Oct 7. doi: 10.1111/bjd.15110.
    PubMed     Text format     Abstract available


  647. RUSSO T, Piccolo V, Staibano S, Alfano R, et al
    Image Gallery: Segmental cutaneous leiomyomas in a patient with Reed syndrome.
    Br J Dermatol. 2016;175:e123.
    PubMed     Text format    


  648. SIMONSEN S, Vera Casano A, Gomez Moyano E, Sanz Trelles A, et al
    Image Gallery: Complete remission of aggressive desmoid-type fibromatosis after low-dose methotrexate for 2 weeks in a child with psoriasis.
    Br J Dermatol. 2016;175:e122.
    PubMed     Text format    


  649. LALLAS A, Argenziano G, Ioannides D
    Dermoscopy for basal cell carcinoma subtype prediction.
    Br J Dermatol. 2016;175:674-5.
    PubMed     Text format    


  650. STAMATAS GN
    Neonatal skin barrier.
    Br J Dermatol. 2016;175:670-1.
    PubMed     Text format    



  651. British Skin Foundation, Skin Deep - 20 Years of Research, 20th Anniversary Conference, 13th October 2016, Royal College of Physicians, London, U.K.
    Br J Dermatol. 2016;175 Suppl 2:35-69.
    PubMed     Text format    


  652. O'SHEA SJ, Davies JR, Newton-Bishop JA
    Vitamin D, vitamin A, the primary melanoma transcriptome and survival.
    Br J Dermatol. 2016;175 Suppl 2:30-34.
    PubMed     Text format     Abstract available


  653. JARRETT R, Ogg G
    Lipid-specific T cells and the skin.
    Br J Dermatol. 2016;175 Suppl 2:19-25.
    PubMed     Text format     Abstract available


  654. MARRS T, Flohr C
    The role of skin and gut microbiota in the development of atopic eczema.
    Br J Dermatol. 2016;175 Suppl 2:13-18.
    PubMed     Text format     Abstract available


  655. MCLEAN WH
    Filaggrin failure - from ichthyosis vulgaris to atopic eczema and beyond.
    Br J Dermatol. 2016;175 Suppl 2:4-7.
    PubMed     Text format     Abstract available


  656. GRAHAM-BROWN R
    Felix Natalis, O BSF The British Skin Foundation 20th Anniversary: an introduction.
    Br J Dermatol. 2016;175 Suppl 2:3.
    PubMed     Text format    


    September 2016
  657. ANJUM N, Robson A, Craythorne E, Mallipeddi R, et al
    Follicular Proliferation or Basal Cell Carcinoma? The first prospective UK study of this histological challenge during Mohs Surgery.
    Br J Dermatol. 2016 Sep 28. doi: 10.1111/bjd.15096.
    PubMed     Text format     Abstract available


  658. TODBERG T, Egeberg A, Jensen P, Gislason G, et al
    Psychiatric comorbidities in children and adolescents with psoriasis - a population-based cohort study.
    Br J Dermatol. 2016 Sep 28. doi: 10.1111/bjd.15095.
    PubMed     Text format     Abstract available


  659. PIZZICHETTA MA, Kittler H, Stanganelli I, Ghigliotti G, et al
    Dermoscopic diagnosis of amelanotic/hypomelanotic melanoma.
    Br J Dermatol. 2016 Sep 28. doi: 10.1111/bjd.15093.
    PubMed     Text format     Abstract available


  660. LICHTER J, Bock U, Lotz C, Groeber F, et al
    Functional expression of N-acetyltransferase 1 (NAT1) in differentiated human skin keratinocytes.
    Br J Dermatol. 2016 Sep 28. doi: 10.1111/bjd.15091.
    PubMed     Text format     Abstract available


  661. BURDEN-TEH E, Thomas KS, Rangaraj S, Murphy R, et al
    Interviews with paediatric rheumatologists about psoriasis and psoriatic arthritis in children: How can specialties learn from each other?
    Br J Dermatol. 2016 Sep 28. doi: 10.1111/bjd.15090.
    PubMed     Text format     Abstract available


  662. HIGGINS CA, Roger M, Hill R, Ali-Khan AS, et al
    Multifaceted role of hair follicle dermal cells in bioengineered skins.
    Br J Dermatol. 2016 Sep 28. doi: 10.1111/bjd.15087.
    PubMed     Text format     Abstract available


  663. ALINIA H, Moradi Tuchayi S, Smith JA, Richardson IM, et al
    Long-term adherence to topical psoriasis treatment can be abysmal: A one-year randomized intervention study using objective electronic adherence monitoring.
    Br J Dermatol. 2016 Sep 24. doi: 10.1111/bjd.15085.
    PubMed     Text format     Abstract available


  664. THORNELOE RJ, Bundy C, Griffiths CE, Ashcroft DM, et al
    Non-adherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis.
    Br J Dermatol. 2016 Sep 24. doi: 10.1111/bjd.15086.
    PubMed     Text format     Abstract available


  665. GRETHER-BECK S, Marini A, Jaenicke T, Stahl W, et al
    Molecular evidence that oral supplementation with lycopene or lutein protects human skin against ultraviolet radiation: Results from a double-blinded, placebo-controlled, cross-over study.
    Br J Dermatol. 2016 Sep 23. doi: 10.1111/bjd.15080.
    PubMed     Text format     Abstract available


  666. CHAN SA, Shah F, Chiganti S, Stevens A, et al
    Primary Cutaneous B-Cell Lymphoma - Systemic spread is rare whilst cutaneous relapses and secondary malignancies are frequent.
    Br J Dermatol. 2016 Sep 19. doi: 10.1111/bjd.15071.
    PubMed     Text format     Abstract available


  667. WEINSTOCK MA, Lott JP, Wang Q, Titus LJ, et al
    Skin Biopsy Utilization and Melanoma Incidence among Medicare Beneficiaries.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15077.
    PubMed     Text format     Abstract available


  668. SHAHBAZ A, Qiang J, Marinas JE, Kim WB, et al
    Efficacies Of Biologic Therapies at week 12 in patients with Plaque Psoriasis in Real World Academic Clinical Practice: A Canadian Multicentre Retrospective Study.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15069.
    PubMed     Text format     Abstract available


  669. HALLING-OVERGAARD AS, Kezic S, Jakasa I, Engebretsen KA, et al
    Skin absorption through atopic dermatitis skin: a systematic review.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15065.
    PubMed     Text format     Abstract available


  670. LO MC, Maraka J, Garioch J, John WG, et al
    Monitoring vitamin D in the melanoma patient - impact of sun avoidance on vitamin D levels of melanoma patients at a tertiary UK referral melanoma service.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15062.
    PubMed     Text format     Abstract available


  671. TAN W, Zakka LR, Gao L, Wang J, et al
    Pathological Alterations Involve the Entire Skin Physiological Milieu in Infantile and Early Childhood Port Wine Stain.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15068.
    PubMed     Text format     Abstract available


  672. BLAUVELT A, Puig L, Chimenti S, Vender R, et al
    Biosimilars for Psoriasis: Clinical Studies to Determine Similarity.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15067.
    PubMed     Text format     Abstract available


  673. ORCIANI M, Campanati A, Caffarini M, Ganzetti G, et al
    Th1 -Th17 and Th2 imbalance in Mesenchymal Stem Cells of adult patients with atopic dermatitis: at the origin of the problem.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15078.
    PubMed     Text format     Abstract available


  674. SHIMODA Y, Sato Y, Hayashida Y, Yamazaki Y, et al
    Lichen amyloidosus as a sweat gland/duct-related disorder: Resolution associated with restoration of sweating disturbance.
    Br J Dermatol. 2016 Sep 15. doi: 10.1111/bjd.15060.
    PubMed     Text format     Abstract available


  675. PARK MK, Li W, Paek SY, Li X, et al
    Consumption of polyunsaturated fatty acids and risk of incident psoriasis and psoriatic arthritis from the Nurses' Health Study II.
    Br J Dermatol. 2016 Sep 15. doi: 10.1111/bjd.15059.
    PubMed     Text format     Abstract available


  676. ALDOORI N, Dobson K, Holden CR, McDonagh AJ, et al
    Statistical inaccuracies over use of facial skin care products and sunscreens in the aetiology of frontal fibrosing alopecia: reply from authors.
    Br J Dermatol. 2016 Sep 13. doi: 10.1111/bjd.15056.
    PubMed     Text format     Abstract available


  677. SEEGOBIN SD, Tziotzios C, Stefanato CM, Bhargava K, et al
    Statistical inaccuracies over use of facial skin care products and sunscreens in the aetiology of frontal fibrosing alopecia.
    Br J Dermatol. 2016 Sep 10. doi: 10.1111/bjd.15054.
    PubMed     Text format     Abstract available


  678. HEERFORDT IM, Wulf HC
    Protoporphyrin IX in the skin measured non-invasively predicts photosensitivity in patients with erythropoietic protoporphyria.
    Br J Dermatol. 2016 Sep 7. doi: 10.1111/bjd.15050.
    PubMed     Text format     Abstract available


  679. SCHUURMAN MS, de Waal AC, Thijs EJ, van Rossum MM, et al
    Risk factors for second primary melanoma among Dutch melanoma patients.
    Br J Dermatol. 2016 Sep 5. doi: 10.1111/bjd.15024.
    PubMed     Text format     Abstract available


  680. MOLLOY O, Foley CC, Lally A, Moriarty B, et al
    Progressive Multifocal Leucoencephalopathy and psoriasis.
    Br J Dermatol. 2016 Sep 2. doi: 10.1111/bjd.15028.
    PubMed     Text format     Abstract available


  681. ISKANDAR IY, Ashcroft DM, Warren RB, Evans I, et al
    Patterns of biologic therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
    Br J Dermatol. 2016 Sep 2. doi: 10.1111/bjd.15027.
    PubMed     Text format     Abstract available


  682. BALESTRI R, Rech G, Rossi E, Starace M, et al
    Natural history of isolated nail psoriasis and its role as a risk factor for the development of psoriatic arthritis: a single center cross sectional study.
    Br J Dermatol. 2016 Sep 2. doi: 10.1111/bjd.15026.
    PubMed     Text format     Abstract available


  683. FOX J
    A changing treatment paradigm: the role of palliative care in metastatic melanoma.
    Br J Dermatol. 2016;175:462-3.
    PubMed     Text format    


  684. NATSUGA K
    Stem cell markers of skin appendages in human skin tumours.
    Br J Dermatol. 2016;175:459.
    PubMed     Text format    


  685. SBIDIAN E
    Suicide and psoriasis: no longer an association.
    Br J Dermatol. 2016;175:456-7.
    PubMed     Text format    


  686. HENG M
    Protein kinases and phophodiesterases in psoriasis: time to refocus on biochemistry.
    Br J Dermatol. 2016;175:455-6.
    PubMed     Text format    


  687. SCHMITT-EGENOLF M
    Physical activity and lifestyle improvement in the management of psoriasis.
    Br J Dermatol. 2016;175:452-3.
    PubMed     Text format    


    August 2016
  688. SAUNTE DM, Mrowietz U, Puig L, Zachariae C, et al
    Candida infections in psoriasis and psoriatic arthritis patients treated with IL-17 inhibitors and their practical management.
    Br J Dermatol. 2016 Aug 31. doi: 10.1111/bjd.15015.
    PubMed     Text format     Abstract available


  689. ZWEEGERS J, Groenewoud JM, van den Reek JM, Otero ME, et al
    Comparison of the one and 5-years effectiveness of adalimumab, etanercept and ustekinumab in psoriasis patients in daily clinical practice: Results from the prospective BioCAPTURE registry.
    Br J Dermatol. 2016 Aug 31. doi: 10.1111/bjd.15023.
    PubMed     Text format     Abstract available


  690. SPRINGATE DA, Parisi R, Kontopantelis E, Reeves D, et al
    Incidence, prevalence and mortality of patients with psoriasis: a UK population-based cohort study.
    Br J Dermatol. 2016 Aug 31. doi: 10.1111/bjd.15021.
    PubMed     Text format     Abstract available


  691. DALY ML, Gordon PA, Creamer D
    Cutaneous Features of Dermatomyositis associated with Myositis Specific Antibodies.
    Br J Dermatol. 2016 Aug 31. doi: 10.1111/bjd.15020.
    PubMed     Text format     Abstract available


  692. VENABLES ZC, Bourke JF, Buckley DA, Campbell F, et al
    Has the epidemic of allergic contact dermatitis due to Methylisothiazolinone reached its peak?
    Br J Dermatol. 2016 Aug 31. doi: 10.1111/bjd.15016.
    PubMed     Text format     Abstract available


  693. LEE UH, Kim BE, Kim DJ, Cho YG, et al
    Atopic dermatitis is associated with reduced corneodesmosin expression: role of cytokine modulation and effects on viral penetration.
    Br J Dermatol. 2016 Aug 30. doi: 10.1111/bjd.15010.
    PubMed     Text format     Abstract available


  694. KANG H, Li X, Zhou Q, Quan S, et al
    Exploration of Candidate Biomarkers for Human Psoriasis Based on GC-MS Serum Metabolomics.
    Br J Dermatol. 2016 Aug 26. doi: 10.1111/bjd.15008.
    PubMed     Text format     Abstract available


  695. HUARD C, Gulla SV, Bennett DV, Coyle AJ, et al
    Correlation of Cutaneous Disease Activity with Type 1 Interferon Gene Signature and Interferon Beta in Dermatomyositis.
    Br J Dermatol. 2016 Aug 26. doi: 10.1111/bjd.15006.
    PubMed     Text format     Abstract available


  696. VAN DEN REEK JM, Coenen MJ, van de L'Isle Arias M, Zweegers J, et al
    Polymorphisms in CD84, IL12B and TNFAIP3 are associated with response to biologics in patients with psoriasis.
    Br J Dermatol. 2016 Aug 26. doi: 10.1111/bjd.15005.
    PubMed     Text format     Abstract available


  697. SALEM A, Rozov S, Al-Samadi A, Stegajev V, et al
    Histamine metabolism and transport are deranged in human keratinocytes in oral lichen planus.
    Br J Dermatol. 2016 Aug 20. doi: 10.1111/bjd.14995.
    PubMed     Text format     Abstract available


  698. JANSE IC, Blok JL, Diercks GF, Horvath B, et al
    Hidradenitis suppurativa: A disease of infundibular epidermis, rather than pilosebaceous units?
    Br J Dermatol. 2016 Aug 20. doi: 10.1111/bjd.14992.
    PubMed     Text format     Abstract available


  699. KOHL E, Popp C, Zeman F, Unger P, et al
    Photodynamic therapy using intense pulsed light for treating actinic keratoses and photoaged skin of the dorsal hands: a randomized placebo-controlled study.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14970.
    PubMed     Text format     Abstract available


  700. ORTEGA-RECALDE O, Silgado D, Fetiva C, Fonseca DJ, et al
    Transcriptome analysis of skin in a case of Ichthyosis Curth-Macklin caused by a KRT1 mutation.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14969.
    PubMed     Text format     Abstract available


  701. SZABO K, Erdei L, Bolla BS, Tax G, et al
    Factors shaping the composition of the cutaneous microbiota.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14967.
    PubMed     Text format     Abstract available


  702. REICH K, Blauvelt A, Armstrong A, Langley RG, et al
    Secukinumab, a Fully Human Anti-Interleukin-17A Monoclonal Antibody, Exhibits Minimal Immunogenicity in Subjects with Moderate to Severe Plaque Psoriasis.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14965.
    PubMed     Text format     Abstract available


  703. RUNGAPIROMNAN W, Yiu ZZ, Warren RB, Griffiths CE, et al
    Impact of Biologic Therapies on Risk of Major Adverse Cardiovascular Events in Patients with Psoriasis: Systematic Review and Meta-analysis of Randomised Controlled Trials.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14964.
    PubMed     Text format     Abstract available


  704. GREWAL SK, Wan J, Denburg MR, Shin DB, et al
    The risk of IgA nephropathy and glomerular disease in patients with psoriasis: A population based cohort study.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14961.
    PubMed     Text format     Abstract available


  705. CHIESA FUXENCH ZC, Troxel AB, Gelfand JM
    Validity of diagnosis codes for identifying cutaneous squamous cell carcinoma in The Health Improvement Network.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14957.
    PubMed     Text format     Abstract available


  706. SCHAPER K, Kother B, Hesse K, Satzger I, et al
    The Pattern and Clinicopathological Correlates of PD-L1 Expression in Cutaneous Squamous Cell Carcinoma.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14955.
    PubMed     Text format     Abstract available


  707. VON DEM BORNE PA, Jonkman MF, van Doorn R
    Complete remission of skin lesions in a patient with subcorneal pustular dermatosis (Sneddon-Wilkinson disease) treated with anti-myeloma therapy: association with disappearance of M-protein.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14954.
    PubMed     Text format     Abstract available


  708. RIBERO S, Marra E, Tomasini CF, Fierro MT, et al
    Confocal microscopy and dermoscopy for the monitoring of BRAF inhibitor therapy of melanoma skin metastases.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14951.
    PubMed     Text format     Abstract available


  709. MROWIETZ U, Szepietowski JC, Loewe R, Van de Kerkhof P, et al
    Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: A randomised, double-blind, Fumaderm(R) and placebo-controlled trial (BRIDGE).
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14947.
    PubMed     Text format     Abstract available


  710. LANGTON AK, Tsoureli-Nikita E, Griffiths CE, Antoniou C, et al
    Lysyl oxidase activity in human skin is increased by chronic UV-exposure and smoking.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14959.
    PubMed     Text format     Abstract available


  711. HOORENS I, Brochez L
    Chemoprevention of basal cell carcinoma: reply from authors.
    Br J Dermatol. 2016 Aug 11. doi: 10.1111/bjd.14945.
    PubMed     Text format     Abstract available


  712. BOCCARA O, Hadj-Rabia S, Bourrat E, Coulombe J, et al
    Lymphoedema is a potential sequela of Kaposiform haemangioendothelioma: reply from the authors.
    Br J Dermatol. 2016 Aug 11. doi: 10.1111/bjd.14817.
    PubMed     Text format    


  713. ALI FR, Craythorne EE, Al-Niaimi F
    Chemoprevention of basal cell carcinoma.
    Br J Dermatol. 2016 Aug 11. doi: 10.1111/bjd.14937.
    PubMed     Text format     Abstract available


  714. CANUETO J, Cardenoso E, Garcia JL, Santos-Briz A, et al
    EGFR expression is associated with poor outcome in cutaneous squamous cell carcinoma.
    Br J Dermatol. 2016 Aug 11. doi: 10.1111/bjd.14936.
    PubMed     Text format     Abstract available


  715. PAPO M, Valeyrie-Allanore L, Razazi K, Carteaux G, et al
    Renal replacement therapy during Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective observational study of 238 patients.
    Br J Dermatol. 2016 Aug 11. doi: 10.1111/bjd.14934.
    PubMed     Text format     Abstract available


  716. AMITAY-LAISH I, Tavallaee M, Kim J, Hoppe RT, et al
    Paediatric primary cutaneous marginal zone B-cell lymphoma: Does it differ from the adult counterpart?
    Br J Dermatol. 2016 Aug 8. doi: 10.1111/bjd.14932.
    PubMed     Text format     Abstract available


  717. MISHRA S, Kancharla H, Dogra S, Sharma A, et al
    Comparison of the Four Validated Psoriatic Arthritis Screening Tools in Diagnosing Psoriatic Arthritis in Patients with Psoriasis [COMPAQ Study].
    Br J Dermatol. 2016 Aug 8. doi: 10.1111/bjd.14929.
    PubMed     Text format     Abstract available


  718. LUBEEK SF, Borgonjen RJ, van Vugt LJ, Olde Rikkert MG, et al
    Improving the applicability of guidelines on nonmelanoma skin cancer in frail older adults: a multidisciplinary expert consensus and systematic review of current guidelines.
    Br J Dermatol. 2016 Aug 3. doi: 10.1111/bjd.14923.
    PubMed     Text format     Abstract available


  719. KUMARI V, Timm K, Kuhl AA, Heine G, et al
    Impact of systemic alitretinoin treatment on skin barrier gene and protein expression in patients with chronic hand eczema.
    Br J Dermatol. 2016 Aug 2. doi: 10.1111/bjd.14921.
    PubMed     Text format     Abstract available


  720. COIMBRA S, Oliveira H, Rocha-Pereira P, Figueiredo A, et al
    The crosstalk between renal function, inflammation and psoriasis vulgaris.
    Br J Dermatol. 2016 Aug 1. doi: 10.1111/bjd.14913.
    PubMed     Text format     Abstract available


  721. WEI T, Folkersen L, Biskup E, Xu N, et al
    USP2 as a potential link between miR-125b and psoriasis.
    Br J Dermatol. 2016 Aug 1. doi: 10.1111/bjd.14916.
    PubMed     Text format     Abstract available


  722. RIBERO S, Osella-Abate S, Reyes-Garcia D, Grulich A, et al
    Gender effects on naevi body distribution and melanoma risk in two melanoma case control studies at different latitudes.
    Br J Dermatol. 2016 Aug 1. doi: 10.1111/bjd.14915.
    PubMed     Text format     Abstract available


  723. KIM J, Han Y, Ahn JH, Kim SW, et al
    Airborne formaldehyde causes skin barrier dysfunction in atopic dermatitis.
    Br J Dermatol. 2016;175:357-63.
    PubMed     Text format     Abstract available


  724. KEMPF W
    TOX - what role does it play in cutaneous lymphomas?
    Br J Dermatol. 2016;175:248-9.
    PubMed     Text format    


  725. EGEBERG A
    Predictors of drug survival for tumour necrosis factor-alpha and interleukin 12/23 antagonists in psoriasis.
    Br J Dermatol. 2016;175:247-8.
    PubMed     Text format    


  726. ORTIZ-ROMERO PL
    Targeting KIR3DL2 in primary cutaneous anaplastic large cell lymphomas.
    Br J Dermatol. 2016;175:246-7.
    PubMed     Text format    


  727. DYRING-ANDERSEN B
    The evolving regulatory role of ubiquitin-editing enzyme A20 in psoriasis during calcipotriol treatment.
    Br J Dermatol. 2016;175:245-6.
    PubMed     Text format    


  728. ORMEROD AD
    Brodalumab established as an effective interleukin-17 receptor antagonist in psoriasis.
    Br J Dermatol. 2016;175:243-4.
    PubMed     Text format    


  729. WALSH S, Lew T, Lee HY
    Psychological sequelae of toxic epidermal necrolysis: further insights.
    Br J Dermatol. 2016;175:241.
    PubMed     Text format    


  730. WELZEL J
    Reflectance confocal microscopy: new micromorphological insights into inflammatory skin diseases.
    Br J Dermatol. 2016;175:239-40.
    PubMed     Text format    


    July 2016
  731. MANGAS C, Potrony M, Mainetti C, Bianchi E, et al
    Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF.
    Br J Dermatol. 2016 Jul 30. doi: 10.1111/bjd.14897.
    PubMed     Text format     Abstract available


  732. BLANCO I, Lipsker D, Lara B, Janciauskiene S, et al
    Neutrophilic panniculitis and autoinflammation: what's the link?: reply from authors.
    Br J Dermatol. 2016 Jul 27. doi: 10.1111/bjd.14614.
    PubMed     Text format    


  733. THEODORAKOPOULOU E, Yiu ZZ, Bundy C, Chularojanamontri L, et al
    Early and late onset psoriasis: a cross-sectional clinical and immunocytochemical investigation.
    Br J Dermatol. 2016 Jul 26. doi: 10.1111/bjd.14886.
    PubMed     Text format     Abstract available


  734. ZWEEGERS J, Roosenboom B, van de Kerkhof PC, van den Reek JM, et al
    Frequency of and predictors for a high clinical response in psoriasis patients on biologic therapy in daily practice.
    Br J Dermatol. 2016 Jul 25. doi: 10.1111/bjd.14888.
    PubMed     Text format     Abstract available


  735. WILLIS CM, Britton LE, Swindells MA, Jones EM, et al
    Invasive melanoma in-vivo can be distinguished from basal cell carcinoma, benign naevi and healthy skin by canine olfaction: a proof of principle study of differential volatile organic compound emission.
    Br J Dermatol. 2016 Jul 25. doi: 10.1111/bjd.14887.
    PubMed     Text format     Abstract available


  736. GRUBER R, Rainer G, Weiss A, Udvardi A, et al
    Morphological alterations in two siblings with autosomal recessive congenital ichthyosis associated with CYP4F22 mutations.
    Br J Dermatol. 2016 Jul 23. doi: 10.1111/bjd.14860.
    PubMed     Text format     Abstract available


  737. MCGOVERN JA, Meinert C, de Veer SJ, Hollier BG, et al
    Attenuated kallikrein-related peptidase activity disrupts desquamation and leads to stratum corneum thickening in human skin equivalent models.
    Br J Dermatol. 2016 Jul 21. doi: 10.1111/bjd.14879.
    PubMed     Text format     Abstract available


  738. LEE E, Choi SY, Bin BH, Kim NH, et al
    ITAC induces the melanocytic migration and hypopigmentation through destabilizing p53 via HDAC5: A possible role of ITAC in pigment-related disorders.
    Br J Dermatol. 2016 Jul 20. doi: 10.1111/bjd.14878.
    PubMed     Text format     Abstract available


  739. VAN BEUGEN S, van Middendorp H, Ferwerda M, Smit JV, et al
    Predictors of perceived stigmatization in patients with psoriasis.
    Br J Dermatol. 2016 Jul 20. doi: 10.1111/bjd.14875.
    PubMed     Text format     Abstract available


  740. CHALMERS JR, Simpson E, Apfelbacher CJ, Thomas KS, et al
    Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
    Br J Dermatol. 2016 Jul 19. doi: 10.1111/bjd.14773.
    PubMed     Text format     Abstract available


  741. BISSONNETTE R, Papp KA, Poulin Y, Gooderham M, et al
    Topical tofacitinib for atopic dermatitis: A Phase 2a randomised trial.
    Br J Dermatol. 2016 Jul 16. doi: 10.1111/bjd.14871.
    PubMed     Text format     Abstract available


  742. GRANT WB
    Increased risk of non-cutaneous malignancy after diagnosis of non-melanoma skin cancer may be due to sun avoidance.
    Br J Dermatol. 2016 Jul 15. doi: 10.1111/bjd.14862.
    PubMed     Text format     Abstract available


  743. OGUNSANYA ME, Kalb SJ, Kabaria A, Chen S, et al
    A Systematic Review of Patient-Reported Outcomes (PROs) in Patients with Cutaneous Lupus Erythematosus (CLE).
    Br J Dermatol. 2016 Jul 15. doi: 10.1111/bjd.14868.
    PubMed     Text format     Abstract available


  744. DE VRIES AC, Thio HB, de Kort WJ, Opmeer BC, et al
    A prospective randomised controlled trial comparing infliximab and etanercept in patients with moderate to severe chronic plaque type psoriasis Psoriasis Infliximab versus Etanercept Comparison Evaluation, the PIECE study.
    Br J Dermatol. 2016 Jul 15. doi: 10.1111/bjd.14867.
    PubMed     Text format     Abstract available


  745. FELTON SJ, Cooke MS, Kift R, Berry JL, et al
    Concurrent beneficial (vitamin D production) and hazardous (cutaneous DNA damage) impact of repeated low-level summer sunlight exposures.
    Br J Dermatol. 2016 Jul 14. doi: 10.1111/bjd.14863.
    PubMed     Text format     Abstract available


  746. BATTISTELLA M, Salle de Chou C, de Bazelaire C, Cayuela JM, et al
    Lymph node image-guided core-needle biopsy for cutaneous T-cell lymphoma staging.
    Br J Dermatol. 2016 Jul 5. doi: 10.1111/bjd.14850.
    PubMed     Text format     Abstract available


  747. PARDO LM, van der Leest RJ, de Vries E, Soerjomataram I, et al
    Comparing survival of patients with single or multiple primary melanoma in The Netherlands: 1994-2009.
    Br J Dermatol. 2016 Jul 5. doi: 10.1111/bjd.14846.
    PubMed     Text format     Abstract available


  748. CHONG HT, Yang GN, Sidhu S, Ibbetson J, et al
    Reducing Flightless I expression decreases severity of psoriasis in an imiquimod-induced murine model of psoriasiform dermatitis.
    Br J Dermatol. 2016 Jul 4. doi: 10.1111/bjd.14842.
    PubMed     Text format     Abstract available


  749. CHISHOLM A, Nelson PA, Pearce CJ, Littlewood AJ, et al
    Motivational interviewing-based training enhances clinicians' skills and knowledge in psoriasis: findings from the Pso Well(R) study.
    Br J Dermatol. 2016 Jul 4. doi: 10.1111/bjd.14837.
    PubMed     Text format     Abstract available


  750. LAMB RC, Matcham F, Turner M, Rayner L, et al
    Screening for Anxiety and Depression in people with psoriasis: a cross sectional study in a tertiary referral setting.
    Br J Dermatol. 2016 Jul 1. doi: 10.1111/bjd.14833.
    PubMed     Text format     Abstract available


  751. LEE KH, Ng YP, Cheah PS, Lim CK, et al
    Molecular characterization of glycation-associated skin ageing: An alternative skin model to study topical anti-glycation activity in vitro of a cosmeceutical and pharmaceutical formulation.
    Br J Dermatol. 2016 Jul 1. doi: 10.1111/bjd.14832.
    PubMed     Text format     Abstract available


  752. KIRBY LC, Banerjee A, Augustine T, Douglas JF, et al
    An ethical dilemma: malignant melanoma in a 51-year-old patient awaiting simultaneous kidney and pancreas transplantation for type 1 diabetes.
    Br J Dermatol. 2016;175:172-4.
    PubMed     Text format     Abstract available


  753. WARREN RB, Weatherhead SC, Smith CH, Exton LS, et al
    British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016.
    Br J Dermatol. 2016;175:23-44.
    PubMed     Text format    


  754. MOLIN S
    Deciphering the lipidomic profile of irritant contact dermatitis.
    Br J Dermatol. 2016;175:20-1.
    PubMed     Text format    


  755. RYAN C, Menter A
    Discordance between physician assessment of psoriasis and patient self-assessment: the importance of itch.
    Br J Dermatol. 2016;175:19-20.
    PubMed     Text format    


  756. WU KC, Reynolds NJ
    CARD14 mutations may predict response to antitumour necrosis factor-alpha therapy in psoriasis: a potential further step towards personalized medicine.
    Br J Dermatol. 2016;175:17-8.
    PubMed     Text format    


  757. HEERINGA JJ, van Zelm MC
    Is there a pathogenic role for IgE in psoriasis?
    Br J Dermatol. 2016;175:16-7.
    PubMed     Text format    


  758. SCARISBRICK JJ
    Cutaneous T-cell lymphomas: an urgent need for more improved therapies.
    Br J Dermatol. 2016;175:14-5.
    PubMed     Text format    


  759. CHALMERS RJ
    The expanding role of methotrexate for treating skin disease.
    Br J Dermatol. 2016;175:9-10.
    PubMed     Text format    


    June 2016
  760. BANNER A, Dinsey M, Ezzedine K, Dadzie OE, et al
    The Spectrum of Skin Diseases Occurring in a Multi-Ethnic Population in Northwest London, UK; Findings of a Cross-Sectional Descriptive Study.
    Br J Dermatol. 2016 Jun 25. doi: 10.1111/bjd.14824.
    PubMed     Text format     Abstract available


  761. SCHLAGER JG, Rosumeck S, Werner RN, Jacobs A, et al
    Topical treatments for scalp psoriasis - summary of a Cochrane Systematic Review.
    Br J Dermatol. 2016 Jun 17. doi: 10.1111/bjd.14811.
    PubMed     Text format     Abstract available


  762. TEY HL, Nattkemper LA, Cao T, Pramono ZA, et al
    Interleukin-31 receptor and pruritus associated with primary localized cutaneous amyloidosis: reply from the authors.
    Br J Dermatol. 2016 Jun 17. doi: 10.1111/bjd.14774.
    PubMed     Text format    


  763. SHITARA D, Tell-Marti G, Badenas C, Enokihara MM, et al
    Discrepant mutational status between naevi and melanomas in naevus-associated melanomas: about mutation-specific immunohistochemistry: reply from the authors.
    Br J Dermatol. 2016 Jun 16. doi: 10.1111/bjd.14613.
    PubMed     Text format    


  764. DODIUK-GAD RP, Olteanu C, Feinstein A, Hashimoto R, et al
    Major psychological complications and decreased health related quality of life among survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Br J Dermatol. 2016 Jun 13. doi: 10.1111/bjd.14799.
    PubMed     Text format     Abstract available


  765. GOMEZ-GARCIA F, Epstein D, Isla-Tejera B, Lorente A, et al
    Short-term efficacy and safety of new biologic agents targeting IL-23/Th17 pathway for moderate to severe plaque psoriasis: a systematic review and network meta-analysis.
    Br J Dermatol. 2016 Jun 13. doi: 10.1111/bjd.14814.
    PubMed     Text format     Abstract available


  766. GONZALEZ JM, Johnson FR, McAteer H, Posner J, et al
    Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the UK: results from a discrete-choice experiment.
    Br J Dermatol. 2016 Jun 13. doi: 10.1111/bjd.14798.
    PubMed     Text format     Abstract available


  767. BISSONNETTE R, Cademartiti F, Maffei E, Tardif JC, et al
    Increase in coronary atherosclerosis severity and the prevalence of coronary artery mixed plaques in patients with psoriasis.
    Br J Dermatol. 2016 Jun 13. doi: 10.1111/bjd.14797.
    PubMed     Text format     Abstract available


  768. HAMMILL A, Mobberley-Schuman P, Adams D
    Lymphoedema is a potential sequela of Kaposiform Hemangioendothelioma.
    Br J Dermatol. 2016 Jun 13. doi: 10.1111/bjd.14810.
    PubMed     Text format     Abstract available


  769. SAITO R, Boyce A, Hsu CK, Rashidghamat E, et al
    Predictive phenotyping of inherited ichthyosis by next generation DNA sequencing.
    Br J Dermatol. 2016 Jun 13. doi: 10.1111/bjd.14807.
    PubMed     Text format     Abstract available


  770. LYNCH MD, White JM, McFadden JP, Wang Y, et al
    A dynamic landscape of allergen associations in delayed-type cutaneous hypersensitivity.
    Br J Dermatol. 2016 Jun 10. doi: 10.1111/bjd.14793.
    PubMed     Text format     Abstract available


  771. MARTINS DA SILVA V, Kinsler V
    Infantile haemangiomas do not occur more frequently in children with congenital melanocytic naevi.
    Br J Dermatol. 2016 Jun 8. doi: 10.1111/bjd.14791.
    PubMed     Text format     Abstract available


  772. TEULINGS HE, Lommerts JE, Wolkerstorfer A, Nieuweboer-Krobotova L, et al
    Vitiligo-like depigmentations as first sign of melanoma; a retrospective case series from a tertiary vitiligo centre.
    Br J Dermatol. 2016 Jun 7. doi: 10.1111/bjd.14790.
    PubMed     Text format     Abstract available


  773. WANG CC, Tang CH, Wang CY, Huang SY, et al
    Risk of skin cancer in chronic haemodialysis patients: a nationwide, population-based study in Taiwan.
    Br J Dermatol. 2016 Jun 7. doi: 10.1111/bjd.14789.
    PubMed     Text format     Abstract available


  774. ALI FM, Cueva AC, Vyas J, Atwan AA, et al
    A systematic review of the use of quality of life instruments in randomised controlled trials of psoriasis.
    Br J Dermatol. 2016 Jun 7. doi: 10.1111/bjd.14788.
    PubMed     Text format     Abstract available


  775. HASHIMOTO T, Teye K, Ishii N
    Clinical and immunological studies of 49 cases of various types of intercellular IgA dermatosis and 13 cases of classical subcorneal pustular dermatosis examined at Kurume University.
    Br J Dermatol. 2016 Jun 3. doi: 10.1111/bjd.14780.
    PubMed     Text format     Abstract available


  776. LLAMAS-VELASCO M, Bonay P, Jose Concha-Garzon M, Corvo-Villen L, et al
    Immune cells from Psoriasis patients are defective to induce Indoleamine 2,3-dioxygenase expression in response to inflammatory stimuli.
    Br J Dermatol. 2016 Jun 3. doi: 10.1111/bjd.14779.
    PubMed     Text format     Abstract available


  777. GARCIA-DOVAL I, Hernandez MV, Vanaclocha F, Sellas A, et al
    Should TNF-antagonists safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis Biobadaser and psoriasis Biobadaderm cohorts.
    Br J Dermatol. 2016 Jun 3. doi: 10.1111/bjd.14776.
    PubMed     Text format     Abstract available


  778. HUGUEN J, Bonsang B, Lemasson G, Misery L, et al
    Image Gallery: Acroangiodermatitis or pseudo-Kaposi sarcoma: two cases in patients with paralyzed legs.
    Br J Dermatol. 2016;174:e84.
    PubMed     Text format    


  779. HUANG YT, Liao CH, Hsueh PR
    Image Gallery: Cutaneous infections caused by Alternaria alternata and Mucor irregularis 1 year apart in a patient with iatrogenic Cushing syndrome.
    Br J Dermatol. 2016;174:e82.
    PubMed     Text format    


  780. CREAMER D, Walsh SA, Dziewulski P, Exton LS, et al
    U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.
    Br J Dermatol. 2016;174:1194-227.
    PubMed     Text format    


  781. YAMANAKA K, Mizutani H
    A new biomarker for psoriasis.
    Br J Dermatol. 2016;174:1191-2.
    PubMed     Text format    


  782. STEFANAKI I, Stratigos AJ
    Inherited susceptibility to melanoma: insights from a high-risk Austrian cohort.
    Br J Dermatol. 2016;174:1188-90.
    PubMed     Text format    


  783. MELNIK BC
    Acne vulgaris: an inflammasomopathy of the sebaceous follicle induced by deviated FoxO1/mTORC1 signalling.
    Br J Dermatol. 2016;174:1186-8.
    PubMed     Text format    


  784. ALBRECHT J, Gerdes S
    A new option on the horizon for the treatment of psoriasis: it is needed, but not at any price.
    Br J Dermatol. 2016;174:1183-4.
    PubMed     Text format    


  785. WISCO OJ, Adelson D
    Basal cell carcinoma screening drives a comprehensive approach to skin cancer.
    Br J Dermatol. 2016;174:1182-3.
    PubMed     Text format    


  786. LINOS E, Chren MM
    Is screening for basal cell carcinoma worthwhile? Too soon to tell.
    Br J Dermatol. 2016;174:1181-2.
    PubMed     Text format    


  787. DOWLATSHAHI EA, Wakkee M
    Rising interest in the field of paediatric psoriasis.
    Br J Dermatol. 2016;174:1180-1.
    PubMed     Text format    


  788. BUNDY C
    Is education enough to improve quality of life in people with chronic inflammatory skin conditions?
    Br J Dermatol. 2016;174:1179.
    PubMed     Text format    


  789. COATES LC, Murphy R, Helliwell PS
    New GRAPPA recommendations for the management of psoriasis and psoriatic arthritis: process, challenges and implementation.
    Br J Dermatol. 2016;174:1174-8.
    PubMed     Text format    


  790. WOLKENSTEIN P, Wilson YT
    Toxic epidermal necrolysis: the past, the guidelines and challenges for the future.
    Br J Dermatol. 2016;174:1171-3.
    PubMed     Text format    


    May 2016
  791. PIRMEZ R, Duque-Estrada B, Donati A, Campos-do-Carmo G, et al
    Clinical and dermoscopic features of lichen planus pigmentosus in 37 patients with frontal fibrosing alopecia.
    Br J Dermatol. 2016 May 28. doi: 10.1111/bjd.14722.
    PubMed     Text format     Abstract available


  792. LUBEEK SF, Arnold WP
    A retrospective study on the effectiveness of curettage and electrodesiccation for clinically suspected primary nodular basal cell carcinoma.
    Br J Dermatol. 2016 May 27. doi: 10.1111/bjd.14770.
    PubMed     Text format     Abstract available


  793. RANSOHOFF KJ, Stefanick ML, Li S, Kurian AW, et al
    Association of non-melanoma skin cancer with second non-cutaneous malignancy in the Women's Health Initiative.
    Br J Dermatol. 2016 May 26. doi: 10.1111/bjd.14766.
    PubMed     Text format     Abstract available


  794. PETRELLI F, Borgonovo K, Cabiddu M, Coinu A, et al
    Antibiotic prophylaxis for skin toxicity induced by anti-EGFR agents: a systematic review and meta-analysis.
    Br J Dermatol. 2016 May 23. doi: 10.1111/bjd.14756.
    PubMed     Text format     Abstract available


  795. TRAUTMANN F, Meier F, Seidler A, Schmitt J, et al
    Effects of the German skin cancer screening program on melanoma incidence and indicators of disease severity.
    Br J Dermatol. 2016 May 20. doi: 10.1111/bjd.14758.
    PubMed     Text format     Abstract available


  796. DOWLATSHAHI EA, Hollestein LM, Herings RM, Nijsten T, et al
    Increased overall drug utilization in psoriasis patients: a case-control study based on Dutch general practitioner data.
    Br J Dermatol. 2016 May 20. doi: 10.1111/bjd.14754.
    PubMed     Text format     Abstract available


  797. GUITERA P, Menzies SW, Argenziano G, Longo C, et al
    Dermoscopy and in vivo confocal microscopy are complimentary techniques for the diagnosis of difficult amelanotic and light colored skin lesions.
    Br J Dermatol. 2016 May 13. doi: 10.1111/bjd.14749.
    PubMed     Text format     Abstract available


  798. DESNOYER A, Dupin N, Assoumou L, Carlotti A, et al
    Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi's sarcoma skin lesions.
    Br J Dermatol. 2016 May 13. doi: 10.1111/bjd.14748.
    PubMed     Text format     Abstract available


  799. THURNEYSEN S, Cheng PF, Nagel HW, Kunz M, et al
    An exploratory study investigating the metabolic activity and local cytokine profile in melanoma patients treated with pazopanib and paclitaxel.
    Br J Dermatol. 2016 May 11. doi: 10.1111/bjd.14727.
    PubMed     Text format     Abstract available


  800. NATHAN N, Burke K, Moss J, Darling TN, et al
    A diagnostic and management algorithm for individuals with an isolated skin finding suggestive of tuberous sclerosis complex.
    Br J Dermatol. 2016 May 11. doi: 10.1111/bjd.14724.
    PubMed     Text format     Abstract available


  801. MCCONNELL AT, Ellis R, Pathy B, Plummer R, et al
    The prognostic significance and impact of the CXCR4/CXCR7/CXCL12 axis in primary cutaneous melanoma.
    Br J Dermatol. 2016 May 11. doi: 10.1111/bjd.14720.
    PubMed     Text format     Abstract available


  802. CIZENSKI J, Griffin J, Menter A
    Image Gallery: Cutaneous T-cell lymphoma mimicking a gyrate erythema.
    Br J Dermatol. 2016;174:e42.
    PubMed     Text format    


  803. PIANA S, Moscarella E, Longo C
    Image Gallery: Brain? no, melanoma.
    Br J Dermatol. 2016;174:e41.
    PubMed     Text format    


  804. HARRIS AG, Choy C, Pigors M, Kelsell DP, et al
    Cover image: Unpeeling the layers of harlequin ichthyosis.
    Br J Dermatol. 2016;174:1160-1.
    PubMed     Text format    


  805. YOUN SW
    A prelude to a functional noninvasive in vivo diagnostic tool for skin diseases.
    Br J Dermatol. 2016;174:961.
    PubMed     Text format    


  806. BEWLEY AP
    Cutaneous lupus erythematosus is strongly associated with psychiatric disease.
    Br J Dermatol. 2016;174:958-9.
    PubMed     Text format    


  807. KURSCHUS F
    Of men and mice: analysing the action of an established drug using tumour necrosis factor-alpha-deficient mice in the imiquimod psoriasis model.
    Br J Dermatol. 2016;174:955-6.
    PubMed     Text format    


  808. SCHOFIELD JK, Robinson R, Reeken S, Jackson R, et al
    National Institute for Health and Care Excellence melanoma guidelines: good news for patients but challenging to implement.
    Br J Dermatol. 2016;174:949-50.
    PubMed     Text format    


  809. WIEGELL SR, Petersen B, Wulf HC
    Pulse photodynamic therapy reduces inflammation without compromising efficacy in the treatment of multiple mild actinic keratoses of the face and scalp: a randomized clinical trial.
    Br J Dermatol. 2016;174:979-84.
    PubMed     Text format     Abstract available


  810. INGRAM JR, Woo PN, Chua SL, Ormerod AD, et al
    Interventions for hidradenitis suppurativa: a Cochrane systematic review incorporating GRADE assessment of evidence quality.
    Br J Dermatol. 2016;174:970-8.
    PubMed     Text format     Abstract available


  811. WHITTON M, Pinart M, Batchelor JM, Leonardi-Bee J, et al
    Evidence-based management of vitiligo: summary of a Cochrane systematic review.
    Br J Dermatol. 2016;174:962-9.
    PubMed     Text format     Abstract available


  812. LAPI F, Cassano N, Pegoraro V, Cataldo N, et al
    Epidemiology of chronic spontaneous urticaria: results from a nationwide, population-based study in Italy.
    Br J Dermatol. 2016;174:996-1004.
    PubMed     Text format     Abstract available


  813. LLOYD-LAVERY A, Hodgson T, Coupe N, Bond S, et al
    Delayed oral toxicity from long-term vemurafenib therapy.
    Br J Dermatol. 2016;174:1159-60.
    PubMed     Text format    


  814. LALLAS A, Tschandl P, Kyrgidis A, Stolz W, et al
    Dermoscopic clues to differentiate facial lentigo maligna from pigmented actinic keratosis.
    Br J Dermatol. 2016;174:1079-85.
    PubMed     Text format     Abstract available


  815. GUTIERREZ-HERRERA E, Ortiz AE, Doukas A, Franco W, et al
    Fluorescence excitation photography of epidermal cellular proliferation.
    Br J Dermatol. 2016;174:1086-91.
    PubMed     Text format     Abstract available


  816. GOHAR A
    Control of tinea capitis.
    Br J Dermatol. 2016;174:1158.
    PubMed     Text format    


  817. ZIMMER S, Peveling-Oberhag A, Weber A, Gilfert T, et al
    Unique coexistence of cold and solar urticaria and its efficient treatment.
    Br J Dermatol. 2016;174:1150-2.
    PubMed     Text format    


  818. ALI S, Kelly C, Challacombe SJ, Donaldson AN, et al
    Salivary IgA and IgG antibodies to bullous pemphigoid 180 noncollagenous domain 16a as diagnostic biomarkers in mucous membrane pemphigoid.
    Br J Dermatol. 2016;174:1022-9.
    PubMed     Text format     Abstract available


  819. ZHAO Y, Li CY, Wen CM, Wei YB, et al
    The prevalence of actinic keratosis in patients visiting dermatologists in two hospitals in China.
    Br J Dermatol. 2016;174:1005-10.
    PubMed     Text format     Abstract available


  820. SCHLIPF NA, Traupe H, Gilaberte Y, Peitsch WK, et al
    Association of Cole disease with novel heterozygous mutations in the somatomedin-B domains of the ENPP1 gene: necessary, but not always sufficient.
    Br J Dermatol. 2016;174:1152-6.
    PubMed     Text format    


  821. PARK HK, Kim EJ, Ko JY
    Alitretinoin: treatment for refractory palmoplantar keratoderma.
    Br J Dermatol. 2016;174:1143-4.
    PubMed     Text format    


  822. GREVELING K, de Vries K, van Doorn MB, Prens EP, et al
    A two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod: excellent cosmesis, but frequent recurrences on the nose.
    Br J Dermatol. 2016;174:1134-6.
    PubMed     Text format    


  823. BARRICK BJ, Barrick JD, Weaver CH, Lohse CM, et al
    Herpes zoster in patients with bullous pemphigoid: a population-based case-control and cohort study.
    Br J Dermatol. 2016;174:1112-4.
    PubMed     Text format    


  824. HAWKEY S, Abdul Ghaffar S
    Glove-related hand urticaria: an increasing occupational problem among healthcare workers.
    Br J Dermatol. 2016;174:1137-40.
    PubMed     Text format    


  825. TURCZYNSKI S, Titeux M, Pironon N, Cohn HI, et al
    Marked intrafamilial phenotypic heterogeneity in dystrophic epidermolysis bullosa caused by inheritance of a mild dominant glycine substitution and a novel deep intronic recessive COL7A1 mutation.
    Br J Dermatol. 2016;174:1122-5.
    PubMed     Text format    


  826. MUN JH, Park SM, Kim GW, Song M, et al
    Clinical and dermoscopic characteristics of extramammary Paget disease: a study of 35 cases.
    Br J Dermatol. 2016;174:1104-7.
    PubMed     Text format    


  827. RAY S, Belch JJ, Craigie AM, Khan F, et al
    Can antioxidant-rich blackcurrant juice drink consumption improve photoprotection against ultraviolet radiation?
    Br J Dermatol. 2016;174:1101-3.
    PubMed     Text format    


  828. DYRING-ANDERSEN B, Kamp S, Madelung A, Zachariae C, et al
    Unilateral hyperhidrosis and hypothermia: symptoms of an intrathoracic tumour.
    Br J Dermatol. 2016;174:1147-8.
    PubMed     Text format    


    April 2016
  829. ROMITI R, Gavioli CF, Anzai A, Donati A, et al
    Image Gallery: Exuberant tufted folliculitis affecting the scalp.
    Br J Dermatol. 2016;174:e22.
    PubMed     Text format    


  830. GOLOGORSKY D, Gregori NZ, Goldhardt R
    Image Gallery: Dermatologic and retinal manifestations of pseudoxanthoma elasticum.
    Br J Dermatol. 2016;174:e21.
    PubMed     Text format    


  831. POPE V, Dupuis L, Kannu P, Mendoza-Londono R, et al
    Buschke-Ollendorff syndrome: a novel case series and systematic review.
    Br J Dermatol. 2016;174:723-9.
    PubMed     Text format     Abstract available


  832. OH SJ, Lee SE, Hashimoto T, Kim SC, et al
    A case of paraneoplastic pemphigus associated with Castleman disease reacting with multiple autoantigens, including the p200 protein.
    Br J Dermatol. 2016;174:930-2.
    PubMed     Text format    


  833. IRANZO P, Alsina-Gibert M
    Immunobullous disease and ulcerative colitis - the need of an accurate diagnosis.
    Br J Dermatol. 2016;174:934-5.
    PubMed     Text format    


  834. NILSEN LT, Hannevik M, Veierod MB
    Ultraviolet exposure from indoor tanning devices: a systematic review.
    Br J Dermatol. 2016;174:730-40.
    PubMed     Text format     Abstract available


  835. PARISER DM, Eichenfield LF, Bukhalo M, Waterman G, et al
    Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study.
    Br J Dermatol. 2016;174:770-7.
    PubMed     Text format     Abstract available


  836. ISEDEH P, Kohli I, Al-Jamal M, Agbai ON, et al
    An in vivo model for postinflammatory hyperpigmentation: an analysis of histological, spectroscopic, colorimetric and clinical traits.
    Br J Dermatol. 2016;174:862-8.
    PubMed     Text format     Abstract available


  837. BLOK JL, Li K, Brodmerkel C, Horvatovich P, et al
    Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum.
    Br J Dermatol. 2016;174:839-46.
    PubMed     Text format     Abstract available


  838. SAMIMI M, Molet L, Fleury M, Laude H, et al
    Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinoma.
    Br J Dermatol. 2016;174:813-22.
    PubMed     Text format     Abstract available


  839. SOBOCINSKI V, Duvert-Lehembre S, Bubenheim M, Lesage C, et al
    Assessment of adherence to topical corticosteroids in patients with bullous pemphigoid.
    Br J Dermatol. 2016;174:919-21.
    PubMed     Text format    


  840. VAN GEEL N, Desmedt V, De Schepper S, Boone B, et al
    Cessation of spread as a treatment objective in vitiligo: perception from the patients' point of view.
    Br J Dermatol. 2016;174:922-4.
    PubMed     Text format    


  841. POOT AM, Siland J, Jonkman MF, Pas HH, et al
    Direct and indirect immunofluorescence staining patterns in the diagnosis of paraneoplastic pemphigus.
    Br J Dermatol. 2016;174:912-5.
    PubMed     Text format    


  842. ECKERT JC, Ertas B, Falk TM, Metze D, et al
    Species identification of dermatophytes in paraffin-embedded biopsies with a new polymerase chain reaction assay targeting the internal transcribed spacer 2 region and comparison with histopathological features.
    Br J Dermatol. 2016;174:869-77.
    PubMed     Text format     Abstract available


  843. MANSOURI Y, Martin-Clavijo A, Newsome P, Kaur MR, et al
    Dissecting cellulitis of the scalp treated with tumour necrosis factor-alpha inhibitors: experience with two agents.
    Br J Dermatol. 2016;174:916-8.
    PubMed     Text format    


  844. XU H, Xiao X, Hui Y, Zhang X, et al
    Phenotype of 53 Chinese individuals with nicastrin gene mutations in association with familial hidradenitis suppurativa (acne inversa).
    Br J Dermatol. 2016;174:927-9.
    PubMed     Text format    


  845. RING HC, Theut Riis P, Miller IM, Saunte DM, et al
    Self-reported pain management in hidradenitis suppurativa.
    Br J Dermatol. 2016;174:909-11.
    PubMed     Text format    


  846. ARAKAWA M, Ohata C, Tsuruta D, Ishii N, et al
    A severe and prolonged case of pemphigoid gestationis successfully treated with combination therapies.
    Br J Dermatol. 2016;174:925-7.
    PubMed     Text format    


  847. FOO SH, Shah F, Chaganti S, Stevens A, et al
    Unmasking mycosis fungoides/Sezary syndrome from preceding or co-existing benign inflammatory dermatoses requiring systemic therapies: patients frequently present with advanced disease and have an aggressive clinical course.
    Br J Dermatol. 2016;174:901-4.
    PubMed     Text format    


  848. PAUS R, Burgoa I, Platt CI, Griffiths T, et al
    Biology of the eyelash hair follicle: an enigma in plain sight.
    Br J Dermatol. 2016;174:741-52.
    PubMed     Text format     Abstract available


  849. SILPA-ARCHA N, Griffith JL, Williams MS, Lim HW, et al
    Prospective comparison of recipient-site preparation with fractional carbon dioxide laser vs. dermabrasion and recipient-site dressing composition in melanocyte-keratinocyte transplantation procedure in vitiligo: a preliminary study.
    Br J Dermatol. 2016;174:895-7.
    PubMed     Text format    


  850. TANG MF, Sy HY, Kwok JS, Tam WH, et al
    Eczema susceptibility and composition of faecal microbiota at 4 weeks of age: a pilot study in Chinese infants.
    Br J Dermatol. 2016;174:898-900.
    PubMed     Text format    


  851. MAURER M, Staubach P, Raap U, Richter-Huhn G, et al
    ATTENTUS, a German online survey of patients with chronic urticaria highlighting the burden of disease, unmet needs and real-life clinical practice.
    Br J Dermatol. 2016;174:892-4.
    PubMed     Text format    


  852. OREGAARD JS, Jarjis RD, Venzo A, Jemec B, et al
    Cover Image: Unique presentation of a subungual malignant melanoma in situ.
    Br J Dermatol. 2016;174:935.
    PubMed     Text format    


    March 2016
  853. KAMIJO M
    Evaluating the genotypes and neuropsychiatric phenotypes in Darier disease.
    Br J Dermatol. 2016;174:488-9.
    PubMed     Text format    


  854. FREW JW
    Beyond the tip of the iceberg: the role of phosphoinositide 3-kinase/AKT in acne inversa/hidradenitis suppurativa.
    Br J Dermatol. 2016;174:484-5.
    PubMed     Text format    


  855. HAY RJ
    Diagnosing dermatophytic infections in the molecular age.
    Br J Dermatol. 2016;174:483-4.
    PubMed     Text format    


  856. MARZANO AV
    Hidradenitis suppurativa, neutrophilic dermatoses and autoinflammation: what's the link?
    Br J Dermatol. 2016;174:482-3.
    PubMed     Text format    


  857. GARMYN M
    Ingenol mebutate for actinic keratosis: a field-directed therapy with short duration.
    Br J Dermatol. 2016;174:481-2.
    PubMed     Text format    


  858. LANGAN SM, Smeeth L, West J
    Reply to: Validation of database search strategies for the epidemiological study of pemphigus and pemphigoid.
    Br J Dermatol. 2016;174:696-7.
    PubMed     Text format    


  859. SILVERBERG JI, Hsu D, Brieva J
    Reply to: Validation of database search strategies for the epidemiological study of pemphigus and pemphigoid: reply from the authors.
    Br J Dermatol. 2016;174:697.
    PubMed     Text format    


  860. PARTARRIEU-MEJIAS F, Perez-Velasquez F
    Image Gallery: Xeroderma pigmentosum.
    Br J Dermatol. 2016;174:e12.
    PubMed     Text format    


  861. ELBEHAIRY S, Elbendary A, Moussa Z
    Image Gallery: Linear unilateral basaloid follicular hamartoma: a unique presentation.
    Br J Dermatol. 2016;174:e11.
    PubMed     Text format    


  862. PIRMEZ R, Del Rei M
    Cover Image: A dashed hair.
    Br J Dermatol. 2016;174:697-8.
    PubMed     Text format    


  863. GOMEZ-MOYANO E, Crespo Erchiga V, Martinez Pilar L, Martinez Garcia S, et al
    Using dermoscopy to detect tinea of vellus hair.
    Br J Dermatol. 2016;174:636-8.
    PubMed     Text format    


  864. LANGAN SM, Benchimol EI
    The need to improve reporting of routinely collected dermatology data for patient benefit.
    Br J Dermatol. 2016;174:477-80.
    PubMed     Text format    


  865. CHON SY, Hassler AA
    Demodex inflammatory eruption due to epidermal growth factor receptor inhibitor therapy.
    Br J Dermatol. 2016;174:686-7.
    PubMed     Text format    


  866. ROUANET J, Aubin F, Gaboriaud P, Berthon P, et al
    Trichodysplasia spinulosa: a polyomavirus infection specifically targeting follicular keratinocytes in immunocompromised patients.
    Br J Dermatol. 2016;174:629-32.
    PubMed     Text format     Abstract available


  867. DE VRIES K, Greveling K, Prens LM, Munte K, et al
    Recurrence rate of lentigo maligna after micrographically controlled staged surgical excision.
    Br J Dermatol. 2016;174:588-93.
    PubMed     Text format     Abstract available


  868. TAYLOR-ROBINSON DC, Williams H, Pearce A, Law C, et al
    Do early-life exposures explain why more advantaged children get eczema? Findings from the U.K. Millennium Cohort Study.
    Br J Dermatol. 2016;174:569-78.
    PubMed     Text format     Abstract available


  869. ZHONG SY, Dong YY, Liu DX, Xu DH, et al
    Surface air plasma-induced cell death and cytokine release of human keratinocytes in the context of psoriasis.
    Br J Dermatol. 2016;174:542-52.
    PubMed     Text format     Abstract available


  870. WU JH, Nguyen HP, Rady PL, Tyring SK, et al
    Molecular insight into the viral biology and clinical features of trichodysplasia spinulosa.
    Br J Dermatol. 2016;174:490-8.
    PubMed     Text format     Abstract available


  871. SHIN S, Lee JW, Lee Y, Kim DS, et al
    Spontaneous partial regression of naevus of Ota with the development of vitiligo.
    Br J Dermatol. 2016;174:694-5.
    PubMed     Text format    


  872. SELLS RE, Chen CA, Wong MT, Zimarowski MJ, et al
    Continuous positive airway pressure-associated cutaneous amoebiasis in an immunosuppressed patient.
    Br J Dermatol. 2016;174:625-8.
    PubMed     Text format     Abstract available


  873. ARIMA Y, Namiki T, Ueno M, Kato K, et al
    Histiocytoid Sweet syndrome: a novel association with relapsing polychondritis.
    Br J Dermatol. 2016;174:691-4.
    PubMed     Text format    


  874. TANAHASHI K, Sugiura K, Sato T, Akiyama M, et al
    Noteworthy clinical findings of harlequin ichthyosis: digital autoamputation caused by cutaneous constriction bands in a case with novel ABCA12 mutations.
    Br J Dermatol. 2016;174:689-91.
    PubMed     Text format    


  875. RAJAN N, Brown S, Ward S, Hainsworth P, et al
    Mesenteric cysts in naevoid basal cell carcinoma syndrome: a mimic of metastatic disease.
    Br J Dermatol. 2016;174:684-5.
    PubMed     Text format    


  876. XIAO X, He Y, Li C, Zhang X, et al
    Nicastrin mutations in familial acne inversa impact keratinocyte proliferation and differentiation through the Notch and phosphoinositide 3-kinase/AKT signalling pathways.
    Br J Dermatol. 2016;174:522-32.
    PubMed     Text format     Abstract available


  877. WEDGEWORTH E, Glover M, Irvine AD, Neri I, et al
    Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey.
    Br J Dermatol. 2016;174:594-601.
    PubMed     Text format     Abstract available


  878. GARBE C, Basset-Seguin N, Poulin Y, Larsson T, et al
    Efficacy and safety of follow-up field treatment of actinic keratosis with ingenol mebutate 0.015% gel: a randomized, controlled 12-month study.
    Br J Dermatol. 2016;174:505-13.
    PubMed     Text format     Abstract available


  879. FRANCO W, Gutierrez-Herrera E, Kollias N, Doukas A, et al
    Review of applications of fluorescence excitation spectroscopy to dermatology.
    Br J Dermatol. 2016;174:499-504.
    PubMed     Text format     Abstract available


  880. DODIUK-GAD RP, Cohen-Barak E, Khayat M, Milo H, et al
    Darier disease in Israel: combined evaluation of genetic and neuropsychiatric aspects.
    Br J Dermatol. 2016;174:562-8.
    PubMed     Text format     Abstract available


  881. GUBAN B, Vas K, Balog Z, Manczinger M, et al
    Abnormal regulation of fibronectin production by fibroblasts in psoriasis.
    Br J Dermatol. 2016;174:533-41.
    PubMed     Text format     Abstract available


  882. LI M, Wang J, Zhang J, Ni C, et al
    Genome-wide linkage and exome sequencing analyses identify an initiation codon mutation of KRT5 in a unique Chinese family with generalized Dowling-Degos disease.
    Br J Dermatol. 2016;174:663-6.
    PubMed     Text format    


  883. LIMA AL, Karl I, Giner T, Poppe H, et al
    Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa.
    Br J Dermatol. 2016;174:514-21.
    PubMed     Text format     Abstract available


  884. FEIG JL, Gribetz ME, Lebwohl MG
    Chronic lichen sclerosus successfully treated with intralesional adalimumab.
    Br J Dermatol. 2016;174:687-9.
    PubMed     Text format    


  885. BELLON T, Lerma V, Gonzalez-Valle O, Gonzalez Herrada C, et al
    Vemurafenib-induced toxic epidermal necrolysis: possible cross-reactivity with other sulfonamide compounds.
    Br J Dermatol. 2016;174:621-4.
    PubMed     Text format     Abstract available


  886. KURATA M, Horie C, Kano Y, Shiohara T, et al
    Pompholyx as a clinical manifestation suggesting increased serum IgG levels in a patient with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    Br J Dermatol. 2016;174:681-3.
    PubMed     Text format    


  887. SBIDIAN E, Hotz C, Seneschal J, Maruani A, et al
    Antitumour necrosis factor-alpha therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 2013.
    Br J Dermatol. 2016;174:667-70.
    PubMed     Text format    


  888. OHST T, Kupsch C, Graser Y
    Detection of common dermatophytes in clinical specimens using a simple quantitative real-time TaqMan polymerase chain reaction assay.
    Br J Dermatol. 2016;174:602-9.
    PubMed     Text format     Abstract available


  889. MIYAUCHI T, Moriuchi R, Hamade Y, Suzuki S, et al
    Warts in toe webs associated with human papillomavirus type 7: a specific cutaneous manifestation of this type?
    Br J Dermatol. 2016;174:678-81.
    PubMed     Text format    


  890. GERDES S, Dethlefs B, Personke Y, Storim J, et al
    Online weight-loss coaching for patients with psoriasis: results of a pilot study.
    Br J Dermatol. 2016;174:674-6.
    PubMed     Text format    


  891. VERYKIOU S, Oliphant TJ, Rahim R, Husain A, et al
    Diagnostic biopsy before Mohs micrographic surgery, frequency of change in diagnosis and impact on management.
    Br J Dermatol. 2016;174:649-51.
    PubMed     Text format    


  892. HSU D, Brieva J, Nardone B, Silverberg JI, et al
    Validation of database search strategies for the epidemiological study of pemphigus and pemphigoid.
    Br J Dermatol. 2016;174:645-8.
    PubMed     Text format    


  893. LANIOSZ V
    The benefits of the patient experience: one dermatology resident's perspective.
    Br J Dermatol. 2016;174:681.
    PubMed     Text format    


  894. KIM A, Silverberg JI
    A systematic review of vigorous physical activity in eczema.
    Br J Dermatol. 2016;174:660-2.
    PubMed     Text format    


  895. BENNETT MF, Lowney AC, Bourke JF
    A study of occupational contact dermatitis in the pharmaceutical industry.
    Br J Dermatol. 2016;174:654-6.
    PubMed     Text format    


  896. DAUNTON A, Bridgett C, Goulding JM
    Habit reversal for refractory atopic dermatitis: a review.
    Br J Dermatol. 2016;174:657-9.
    PubMed     Text format    


  897. GAMBICHLER T, Mamali K, Patsinakidis N, Moritz R, et al
    Decreased expression of ten-eleven translocation 2 protein is associated with progressive disease and death in patients with mycosis fungoides.
    Br J Dermatol. 2016;174:652-3.
    PubMed     Text format    


  898. RYAN TD, Lucky AW, King EC, Huang G, et al
    Ventricular dysfunction and aortic dilation in patients with recessive dystrophic epidermolysis bullosa.
    Br J Dermatol. 2016;174:671-3.
    PubMed     Text format    


  899. KRENGEL S, Widmer DS, Kerl K, Levesque MP, et al
    Naevus spilus-type congenital melanocytic naevus associated with a novel NRAS codon 61 mutation.
    Br J Dermatol. 2016;174:642-4.
    PubMed     Text format    


  900. NAGAI H, Oiso N, Tomida S, Sakai K, et al
    Epidermolysis bullosa simplex with mottled pigmentation with noncicatricial alopecia: identification of a recurrent p.P25L mutation in KRT5 in four affected family members.
    Br J Dermatol. 2016;174:633-5.
    PubMed     Text format    


  901. NAZARY M, Prens EP, Boer J
    Azathioprine lacks efficacy in hidradenitis suppurativa: a retrospective study of nine patients.
    Br J Dermatol. 2016;174:639-41.
    PubMed     Text format    


    February 2016
  902. HASHIMOTO T, Ohzono A, Ishii N
    'Reply to: Clinical and immunological findings in 104 cases of paraneoplastic pemphigus': reply from the authors.
    Br J Dermatol. 2016;174:461-2.
    PubMed     Text format    


  903. AMBER KT
    Reply to: Clinical and immunological findings in 104 cases of paraneoplastic pemphigus.
    Br J Dermatol. 2016;174:461.
    PubMed     Text format    


  904. JINNIN M
    A possible mechanism of hypercoagulation status in scleroderma.
    Br J Dermatol. 2016;174:263.
    PubMed     Text format    


  905. WERNER RN, Nast A
    Treating actinic keratosis.
    Br J Dermatol. 2016;174:260-1.
    PubMed     Text format    


  906. EZZEDINE K, Pandya A
    Time for a patient-oriented outcome in vitiligo: the vitiligo noticeability scale.
    Br J Dermatol. 2016;174:255-6.
    PubMed     Text format    


  907. LONGO C, Ribero S
    Heritability of naevus pattern.
    Br J Dermatol. 2016;174:265-6.
    PubMed     Text format    


  908. PIRMEZ R, Sodre CT
    Cover Image: Music box spines.
    Br J Dermatol. 2016;174:464-5.
    PubMed     Text format    


  909. LEE S, Duffy DL, McClenahan P, Lee KJ, et al
    Heritability of naevus patterns in an adult twin cohort from the Brisbane Twin Registry: a cross-sectional study.
    Br J Dermatol. 2016;174:356-63.
    PubMed     Text format     Abstract available


  910. SINNYA S, Tan JM, Prow TW, Primiero C, et al
    A randomized, phase IIa exploratory trial to assess the safety and preliminary efficacy of LEO 43204 in patients with actinic keratosis.
    Br J Dermatol. 2016;174:305-11.
    PubMed     Text format     Abstract available


  911. VENTURINI M, Gualdi G, Zanca A, Lorenzi L, et al
    A new approach for presurgical margin assessment by reflectance confocal microscopy of basal cell carcinoma.
    Br J Dermatol. 2016;174:380-5.
    PubMed     Text format     Abstract available


  912. HAUKSSON I, Ponten A, Gruvberger B, Isaksson M, et al
    Skincare products containing low concentrations of formaldehyde detected by the chromotropic acid method cannot be safely used in formaldehyde-allergic patients.
    Br J Dermatol. 2016;174:371-9.
    PubMed     Text format     Abstract available


  913. GUNARATNE DA, Howle JR, Veness MJ
    Sentinel lymph node biopsy in Merkel cell carcinoma: a 15-year institutional experience and statistical analysis of 721 reported cases.
    Br J Dermatol. 2016;174:273-81.
    PubMed     Text format     Abstract available


  914. TIMMERMAN JG, Heederik D, Spee T, van Rooy FG, et al
    Contact dermatitis in the construction industry: the role of filaggrin loss-of-function mutations.
    Br J Dermatol. 2016;174:348-55.
    PubMed     Text format     Abstract available


  915. BATCHELOR JM, Tan W, Tour S, Yong A, et al
    Validation of the Vitiligo Noticeability Scale: a patient-reported outcome measure of vitiligo treatment success.
    Br J Dermatol. 2016;174:386-94.
    PubMed     Text format     Abstract available


  916. NEMOTO O, Furue M, Nakagawa H, Shiramoto M, et al
    The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placeb
    Br J Dermatol. 2016;174:296-304.
    PubMed     Text format     Abstract available


  917. JUNG YS, Kim M, Lee JH, Kim DW, et al
    Acneiform eruptions caused by various second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia.
    Br J Dermatol. 2016;174:456-8.
    PubMed     Text format    


  918. SAIGUSA R, Asano Y, Yamashita T, Taniguchi T, et al
    Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions.
    Br J Dermatol. 2016;174:338-47.
    PubMed     Text format     Abstract available


  919. GONZALEZ-RAMOS J, Alonso-Pacheco ML, Goiburu-Chenu B, Mayor-Ibarguren A, et al
    Successful treatment of refractory pruritic Fox-Fordyce disease with botulinum toxin type A.
    Br J Dermatol. 2016;174:458-9.
    PubMed     Text format    


  920. DIEPGEN TL, Ofenloch RF, Bruze M, Bertuccio P, et al
    Prevalence of contact allergy in the general population in different European regions.
    Br J Dermatol. 2016;174:319-29.
    PubMed     Text format     Abstract available


  921. AMMAR M, Jordan CT, Cao L, Lim E, et al
    CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts.
    Br J Dermatol. 2016;174:330-7.
    PubMed     Text format     Abstract available


  922. STINGENI L, Bianchi L, Tramontana M, Moretta I, et al
    Indoor dermatitis due to Aeroglyphus robustus.
    Br J Dermatol. 2016;174:454-6.
    PubMed     Text format    


  923. HONG KK, Gwak MJ, Song J, Kim NI, et al
    Nuclear factor-kappaB pathway activation and phosphatase and tensin homolog downregulation in psoriasis.
    Br J Dermatol. 2016;174:433-5.
    PubMed     Text format    


  924. SCHLIPF NA, Vahlquist A, Teigen N, Virtanen M, et al
    Whole-exome sequencing identifies novel autosomal recessive DSG1 mutations associated with mild SAM syndrome.
    Br J Dermatol. 2016;174:444-8.
    PubMed     Text format    


  925. AHN RS, Moslehi H, Martin MP, Abad-Santos M, et al
    Inhibitory KIR3DL1 alleles are associated with psoriasis.
    Br J Dermatol. 2016;174:449-51.
    PubMed     Text format    


  926. HATA H, Natsuga K, Kitamura S, Imafuku K, et al
    Concomitant neoplasms in the skin and stomach unveil the role of type IV collagen and E-cadherin in mucin core protein 5AC expression in vivo.
    Br J Dermatol. 2016;174:395-7.
    PubMed     Text format     Abstract available


  927. RASHIDGHAMAT E, Ozoemena L, Liu L, McGrath JA, et al
    Mutations in EXPH5 underlie a rare subtype of autosomal recessive epidermolysis bullosa simplex.
    Br J Dermatol. 2016;174:452-3.
    PubMed     Text format    


  928. JERBI M, Ben Rekaya M, Naouali C, Jones M, et al
    Clinical, genealogical and molecular investigation of the xeroderma pigmentosum type C complementation group in Tunisia.
    Br J Dermatol. 2016;174:439-43.
    PubMed     Text format    


  929. KALINSKA-BIENIAS A, Kalowska M, Kwiek B, Jakubowska B, et al
    Efficacy and safety of perilesional/intralesional triamcinolone injections in oral mucous membrane pemphigoid.
    Br J Dermatol. 2016;174:436-8.
    PubMed     Text format    


    January 2016
  930. KOCK M, Coenraads PJ, Blomeke B, Goebel C, et al
    Continuous usage of a hair dye product containing 2-methoxymethyl-p-phenylenediamine by hair dye allergic individuals.
    Br J Dermatol. 2016 Jan 8. doi: 10.1111/bjd.14390.
    PubMed     Text format     Abstract available


  931. CLIFF SH
    Five-year recurrence rate of lentigo maligna after off-label treatment with imiquimod.
    Br J Dermatol. 2016;174:22-3.
    PubMed     Text format    


  932. CALLANDER J, Piguet V
    Amyopathic dermatomyositis: evidence of systemic associations.
    Br J Dermatol. 2016;174:21-2.
    PubMed     Text format    


  933. HAMMERS CM, Stanley JR
    Patients with pemphigus foliaceus may retain antibody reactivity against calcium-stabilized, distal desmoglein 1 domains in remission.
    Br J Dermatol. 2016;174:17-8.
    PubMed     Text format    


  934. WOLF P
    Psoralen-ultraviolet A endures as one of the most powerful treatments in dermatology: reinforcement of this 'triple-product therapy' by the 2016 British guidelines.
    Br J Dermatol. 2016;174:11-4.
    PubMed     Text format    


  935. LING TC, Clayton TH, Crawley J, Exton LS, et al
    British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen-ultraviolet A therapy 2015.
    Br J Dermatol. 2016;174:24-55.
    PubMed     Text format    


  936. KAI AC, Richards T, Coleman A, Mallipeddi R, et al
    Five-year recurrence rate of lentigo maligna after treatment with imiquimod.
    Br J Dermatol. 2016;174:165-8.
    PubMed     Text format     Abstract available


  937. GALIMBERTI F, Li Y, Fernandez AP
    Clinically amyopathic dermatomyositis: clinical features, response to medications and malignancy-associated risk factors in a specific tertiary-care-centre cohort.
    Br J Dermatol. 2016;174:158-64.
    PubMed     Text format     Abstract available


  938. STEELE RB, Nugent WH, Braswell SF, Frisch S, et al
    Pyoderma gangrenosum and pregnancy: an example of abnormal inflammation and challenging treatment.
    Br J Dermatol. 2016;174:77-87.
    PubMed     Text format     Abstract available


  939. ARNAUD A, Chosidow O, Detrez MA, Bitar D, et al
    Prevalences of scabies and pediculosis corporis among homeless people in the Paris region: results from two randomized cross-sectional surveys (HYTPEAC study).
    Br J Dermatol. 2016;174:104-12.
    PubMed     Text format     Abstract available


  940. YAN XX, Yu CP, Fu XA, Bao FF, et al
    CARD9 mutation linked to Corynespora cassiicola infection in a Chinese patient.
    Br J Dermatol. 2016;174:176-9.
    PubMed     Text format     Abstract available


  941. JOHN AM, Schwartz RA
    Basal cell naevus syndrome: an update on genetics and treatment.
    Br J Dermatol. 2016;174:68-76.
    PubMed     Text format     Abstract available


  942. AL-ISMAIL D, Edwards C, Anstey AV
    Erythema action spectrum of topical 8-methoxypsoralen-sensitized skin re-evaluated: implications for routine clinical practice.
    Br J Dermatol. 2016;174:131-5.
    PubMed     Text format     Abstract available


  943. LIN CH, Wei CC, Lin CL, Lin WC, et al
    Childhood type 1 diabetes may increase the risk of atopic dermatitis.
    Br J Dermatol. 2016;174:88-94.
    PubMed     Text format     Abstract available


  944. VAN GEEL MJ, Maatkamp M, Oostveen AM, de Jong EM, et al
    Comparison of the Dermatology Life Quality Index and the Children's Dermatology Life Quality Index in assessment of quality of life in patients with psoriasis aged 16-17 years.
    Br J Dermatol. 2016;174:152-7.
    PubMed     Text format     Abstract available


  945. KRYNITZ B, Olsson H, Lundh Rozell B, Lindelof B, et al
    Risk of basal cell carcinoma in Swedish organ transplant recipients: a population-based study.
    Br J Dermatol. 2016;174:95-103.
    PubMed     Text format     Abstract available


  946. MELLERIO JE, Robertson SJ, Bernardis C, Diem A, et al
    Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines.
    Br J Dermatol. 2016;174:56-67.
    PubMed     Text format     Abstract available


  947. POFF S, Li SC, Kelsey CE, Foeldvari I, et al
    Durometry as an outcome measure in juvenile localized scleroderma.
    Br J Dermatol. 2016;174:228-30.
    PubMed     Text format    


  948. HAGA N, Iwata H, Yamaguchi Y, Shirato T, et al
    Mucocutaneous pyoderma gangrenosum due to trisomy 8 neutrophilic infiltrates in a patient with myelodysplastic syndrome.
    Br J Dermatol. 2016;174:239-41.
    PubMed     Text format    


  949. KAMIYA K, Aoyama Y, Yamasaki O, Kamata A, et al
    Epitope analysis of antidesmoglein 1 autoantibodies from patients with pemphigus foliaceus across different activity stages.
    Br J Dermatol. 2016;174:113-9.
    PubMed     Text format     Abstract available


  950. SCHNEIDER MR, Wolf E
    Genetically engineered pigs as investigative and translational models in dermatology.
    Br J Dermatol. 2016;174:237-9.
    PubMed     Text format    


  951. MANN J, Al-Niaimi F, Cooper A, Ghura V, et al
    A national survey of Mohs micrographic surgery in the U.K.
    Br J Dermatol. 2016;174:225-7.
    PubMed     Text format    


  952. MIZAWA M, Makino T, Nakano H, Sawamura D, et al
    Incomplete erythropoietic protoporphyria caused by a splice site modulator homozygous IVS3-48C polymorphism in the ferrochelatase gene.
    Br J Dermatol. 2016;174:172-5.
    PubMed     Text format     Abstract available


  953. FAHMY J, Halabi-Tawil M, Ram-Wolff C, Bagot M, et al
    Paraneoplastic acanthosis nigricans: the first reported case associated with Sezary syndrome.
    Br J Dermatol. 2016;174:233-4.
    PubMed     Text format    


  954. COATES LC, Helliwell PS
    Psoriasis flare with corticosteroid use in psoriatic arthritis.
    Br J Dermatol. 2016;174:219-21.
    PubMed     Text format    


  955. CRALL C, Morley KW, Rabinowits G, Schmidt B, et al
    Merkel cell carcinoma in a patient with GATA2 deficiency: a novel association with primary immunodeficiency.
    Br J Dermatol. 2016;174:169-71.
    PubMed     Text format     Abstract available


  956. STOECKER WV, Rader RK, Rabinovitz HS, Oliviero M, et al
    Patient concern as a predictor of cutaneous malignancy.
    Br J Dermatol. 2016;174:222-4.
    PubMed     Text format    


  957. COTTLE DL, Kretzschmar K, Gollnick HP, Quist SR, et al
    p53 activity contributes to defective interfollicular epidermal differentiation in hyperproliferative murine skin.
    Br J Dermatol. 2016;174:204-8.
    PubMed     Text format    


  958. CHIRICOZZI A, Suarez-Farinas M, Fuentes-Duculan J, Cueto I, et al
    Increased expression of interleukin-17 pathway genes in nonlesional skin of moderate-to-severe psoriasis vulgaris.
    Br J Dermatol. 2016;174:136-45.
    PubMed     Text format     Abstract available


    December 2015
  959. UTER W
    Fragrance contact allergy in the population.
    Br J Dermatol. 2015;173:1358-9.
    PubMed     Text format    


    November 2015
  960. OFENLOCH R, Diepgen TL, Bruze M, Cazzaniga S, et al
    Colophony as marker for fragrance allergy in the general European population.
    Br J Dermatol. 2015 Nov 19. doi: 10.1111/bjd.14297.
    PubMed     Text format     Abstract available


    October 2015
  961. MECHINEAUD M, Nicaise D, Martin L
    Haemangioma in an infant whose mother was receiving long-term propranolol treatment during pregnancy.
    Br J Dermatol. 2015 Oct 19. doi: 10.1111/bjd.14235.
    PubMed     Text format     Abstract available


  962. RIBERO S, Zugna D, Osella-Abate S, Glass D, et al
    Prediction of high naevus count in a healthy UK population to estimate melanoma risk.
    Br J Dermatol. 2015 Oct 19. doi: 10.1111/bjd.14216.
    PubMed     Text format     Abstract available


    September 2015
  963. MOSER J, Moshammer R, Koglbauer G, Kitzwogerer M, et al
    Sentinel-node biopsy in melanoma: A single center experience with 216 consecutive patients.
    Br J Dermatol. 2015 Sep 24. doi: 10.1111/bjd.14189.
    PubMed     Text format     Abstract available


  964. ZARAGOZA J, Caille A, Beneton N, Bens G, et al
    Neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma.
    Br J Dermatol. 2015 Sep 6. doi: 10.1111/bjd.14155.
    PubMed     Text format     Abstract available


  965. DIEPGEN TL, Ofenloch R, Bruze M, Cazzaniga S, et al
    Prevalence of fragrance contact allergy in the general population of five European countries - a cross-sectional study.
    Br J Dermatol. 2015 Sep 2. doi: 10.1111/bjd.14151.
    PubMed     Text format     Abstract available


    August 2015
  966. GEBHARDT M, Ertas B, Falk TM, Blodorn-Schlicht N, et al
    Fast, sensitive, and specific diagnosis of infections with Leishmania species by Cytochrome b PCR in formalin-fixed, paraffin-embedded skin biopsies.
    Br J Dermatol. 2015 Aug 19. doi: 10.1111/bjd.14088.
    PubMed     Text format     Abstract available


    July 2015
  967. WU J, Lee YY, Su SC, Wu TS, et al
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in patients with malignancies.
    Br J Dermatol. 2015 Jul 27. doi: 10.1111/bjd.14052.
    PubMed     Text format     Abstract available


  968. BENATI E, Argenziano G, Kyrgidis A, Moscarella E, et al
    Melanoma and naevi with globular pattern: Confocal microscopy as an aid for diagnostic differentiation.
    Br J Dermatol. 2015 Jul 25. doi: 10.1111/bjd.14049.
    PubMed     Text format     Abstract available


  969. PICARD C, Gouarin S, Comoz F, Barreau M, et al
    Chronic active EBV infection with mainly cutaneous manifestation in a Caucasian woman with long-term follow-up.
    Br J Dermatol. 2015 Jul 4. doi: 10.1111/bjd.14014.
    PubMed     Text format     Abstract available


    June 2015
  970. POLANSKY M, Patel N, Feldman R
    Complete remission after rituximab therapy in an HIV positive patient with pemphigus vulgaris.
    Br J Dermatol. 2015 Jun 30. doi: 10.1111/bjd.13990.
    PubMed     Text format     Abstract available


  971. PIRMEZ R, Fernandes AL, Melo MG
    Photoaggravated contact dermatitis to Kathon CG (methylchloroisothiazolinone/methylisothiazolinone): a novel pattern of involvement in a growing epidemic?
    Br J Dermatol. 2015 Jun 30. doi: 10.1111/bjd.13986.
    PubMed     Text format     Abstract available


    May 2015
  972. BRUIJN MS, Horvath B, van Voorst Vader PC, Willemze R, et al
    Recommendations for treatment of Lymphomatoid papulosis with methotrexate: a report from the Dutch Cutaneous Lymphoma Group.
    Br J Dermatol. 2015 May 22. doi: 10.1111/bjd.13920.
    PubMed     Text format     Abstract available


  973. POHLER E, Cunningham F, Sandilands A, Cole C, et al
    Novel autosomal dominant mutation in loricrin presenting as prominent ichthyosis.
    Br J Dermatol. 2015 May 12. doi: 10.1111/bjd.13895.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: